id	sid	tid	token	lemma	pos
ecj-11314	1	1	hrev_master	hrev_master	NOUN
ecj-11314	1	2	abstract	abstract	ADJ
ecj-11314	1	3	multiple	multiple	ADJ
ecj-11314	1	4	sclerosis	sclerosis	NOUN
ecj-11314	1	5	(	(	PUNCT
ecj-11314	1	6	ms	ms	NOUN
ecj-11314	1	7	)	)	PUNCT
ecj-11314	1	8	is	be	AUX
ecj-11314	1	9	the	the	DET
ecj-11314	1	10	most	most	ADV
ecj-11314	1	11	prevalent	prevalent	ADJ
ecj-11314	1	12	immune	immune	NOUN
ecj-11314	1	13	-	-	PUNCT
ecj-11314	1	14	mediated	mediate	VERB
ecj-11314	1	15	inflammatory	inflammatory	ADJ
ecj-11314	1	16	demyelinating	demyelinate	VERB
ecj-11314	1	17	central	central	ADJ
ecj-11314	1	18	nervous	nervous	ADJ
ecj-11314	1	19	system	system	NOUN
ecj-11314	1	20	disorder	disorder	NOUN
ecj-11314	1	21	,	,	PUNCT
ecj-11314	1	22	with	with	ADP
ecj-11314	1	23	a	a	DET
ecj-11314	1	24	diverse	diverse	ADJ
ecj-11314	1	25	set	set	NOUN
ecj-11314	1	26	of	of	ADP
ecj-11314	1	27	clinical	clinical	ADJ
ecj-11314	1	28	signs	sign	NOUN
ecj-11314	1	29	and	and	CCONJ
ecj-11314	1	30	symptoms	symptom	NOUN
ecj-11314	1	31	.	.	PUNCT
ecj-11314	2	1	this	this	DET
ecj-11314	2	2	study	study	NOUN
ecj-11314	2	3	aimed	aim	VERB
ecj-11314	2	4	to	to	PART
ecj-11314	2	5	investigate	investigate	VERB
ecj-11314	2	6	the	the	DET
ecj-11314	2	7	diagnostic	diagnostic	ADJ
ecj-11314	2	8	values	value	NOUN
ecj-11314	2	9	of	of	ADP
ecj-11314	2	10	the	the	DET
ecj-11314	2	11	monocyte	monocyte	ADJ
ecj-11314	2	12	/	/	SYM
ecj-11314	2	13	lymphocyte	lymphocyte	ADJ
ecj-11314	2	14	ratio	ratio	NOUN
ecj-11314	2	15	(	(	PUNCT
ecj-11314	2	16	mlr	mlr	PROPN
ecj-11314	2	17	)	)	PUNCT
ecj-11314	2	18	,	,	PUNCT
ecj-11314	2	19	red	red	ADJ
ecj-11314	2	20	cell	cell	NOUN
ecj-11314	2	21	distribution	distribution	NOUN
ecj-11314	2	22	width	width	NOUN
ecj-11314	2	23	/	/	SYM
ecj-11314	2	24	lymphocyte	lymphocyte	ADJ
ecj-11314	2	25	ratio	ratio	NOUN
ecj-11314	2	26	(	(	PUNCT
ecj-11314	2	27	rlr	rlr	PROPN
ecj-11314	2	28	)	)	PUNCT
ecj-11314	2	29	,	,	PUNCT
ecj-11314	2	30	and	and	CCONJ
ecj-11314	2	31	systemic	systemic	ADJ
ecj-11314	2	32	immune	immune	ADJ
ecj-11314	2	33	-	-	PUNCT
ecj-11314	2	34	inflammation	inflammation	NOUN
ecj-11314	2	35	index	index	NOUN
ecj-11314	2	36	(	(	PUNCT
ecj-11314	2	37	sii	sii	PROPN
ecj-11314	2	38	)	)	PUNCT
ecj-11314	2	39	in	in	ADP
ecj-11314	2	40	detecting	detect	VERB
ecj-11314	2	41	multiple	multiple	ADJ
ecj-11314	2	42	sclerosis	sclerosis	NOUN
ecj-11314	2	43	attacks	attack	NOUN
ecj-11314	2	44	in	in	ADP
ecj-11314	2	45	patients	patient	NOUN
ecj-11314	2	46	with	with	ADP
ecj-11314	2	47	relapsing	relapse	VERB
ecj-11314	2	48	-	-	PUNCT
ecj-11314	2	49	remitting	remit	VERB
ecj-11314	2	50	ms	ms	NOUN
ecj-11314	2	51	(	(	PUNCT
ecj-11314	2	52	rrms	rrm	NOUN
ecj-11314	2	53	)	)	PUNCT
ecj-11314	2	54	presenting	present	VERB
ecj-11314	2	55	to	to	ADP
ecj-11314	2	56	the	the	DET
ecj-11314	2	57	emergency	emergency	NOUN
ecj-11314	2	58	department	department	NOUN
ecj-11314	2	59	(	(	PUNCT
ecj-11314	2	60	ed	ed	NOUN
ecj-11314	2	61	)	)	PUNCT
ecj-11314	2	62	.	.	PUNCT
ecj-11314	3	1	this	this	DET
ecj-11314	3	2	retrospective	retrospective	ADJ
ecj-11314	3	3	observational	observational	ADJ
ecj-11314	3	4	study	study	NOUN
ecj-11314	3	5	was	be	AUX
ecj-11314	3	6	conducted	conduct	VERB
ecj-11314	3	7	among	among	ADP
ecj-11314	3	8	patients	patient	NOUN
ecj-11314	3	9	with	with	ADP
ecj-11314	3	10	rrms	rrm	NOUN
ecj-11314	3	11	presenting	present	VERB
ecj-11314	3	12	to	to	ADP
ecj-11314	3	13	the	the	DET
ecj-11314	3	14	ed	ed	NOUN
ecj-11314	3	15	of	of	ADP
ecj-11314	3	16	a	a	DET
ecj-11314	3	17	third	third	ADJ
ecj-11314	3	18	-	-	PUNCT
ecj-11314	3	19	level	level	NOUN
ecj-11314	3	20	hospital	hospital	NOUN
ecj-11314	3	21	.	.	PUNCT
ecj-11314	4	1	the	the	DET
ecj-11314	4	2	laboratory	laboratory	NOUN
ecj-11314	4	3	parameters	parameter	NOUN
ecj-11314	4	4	of	of	ADP
ecj-11314	4	5	165	165	NUM
ecj-11314	4	6	patients	patient	NOUN
ecj-11314	4	7	were	be	AUX
ecj-11314	4	8	compared	compare	VERB
ecj-11314	4	9	during	during	ADP
ecj-11314	4	10	the	the	DET
ecj-11314	4	11	attack	attack	NOUN
ecj-11314	4	12	and	and	CCONJ
ecj-11314	4	13	non	non	ADJ
ecj-11314	4	14	-	-	ADJ
ecj-11314	4	15	attack	attack	ADJ
ecj-11314	4	16	periods	period	NOUN
ecj-11314	4	17	.	.	PUNCT
ecj-11314	5	1	the	the	DET
ecj-11314	5	2	paired	pair	VERB
ecj-11314	5	3	t	t	PROPN
ecj-11314	5	4	-	-	PUNCT
ecj-11314	5	5	test	test	NOUN
ecj-11314	5	6	statistic	statistic	NOUN
ecj-11314	5	7	was	be	AUX
ecj-11314	5	8	used	use	VERB
ecj-11314	5	9	to	to	PART
ecj-11314	5	10	compare	compare	VERB
ecj-11314	5	11	means	mean	NOUN
ecj-11314	5	12	of	of	ADP
ecj-11314	5	13	inflammatory	inflammatory	ADJ
ecj-11314	5	14	biomarker	biomarker	NOUN
ecj-11314	5	15	measurements	measurement	NOUN
ecj-11314	5	16	between	between	ADP
ecj-11314	5	17	attack	attack	NOUN
ecj-11314	5	18	and	and	CCONJ
ecj-11314	5	19	non	non	ADJ
ecj-11314	5	20	-	-	ADJ
ecj-11314	5	21	attack	attack	ADJ
ecj-11314	5	22	groups	group	NOUN
ecj-11314	5	23	.	.	PUNCT
ecj-11314	6	1	the	the	DET
ecj-11314	6	2	neutrophil	neutrophil	ADJ
ecj-11314	6	3	/	/	SYM
ecj-11314	6	4	lymphocyte	lymphocyte	ADJ
ecj-11314	6	5	ratio	ratio	NOUN
ecj-11314	6	6	(	(	PUNCT
ecj-11314	6	7	nlr	nlr	PROPN
ecj-11314	6	8	)	)	PUNCT
ecj-11314	6	9	,	,	PUNCT
ecj-11314	6	10	mlr	mlr	PROPN
ecj-11314	6	11	,	,	PUNCT
ecj-11314	6	12	rlr	rlr	PROPN
ecj-11314	6	13	,	,	PUNCT
ecj-11314	6	14	and	and	CCONJ
ecj-11314	6	15	sii	sii	PROPN
ecj-11314	6	16	mean	mean	NOUN
ecj-11314	6	17	of	of	ADP
ecj-11314	6	18	the	the	DET
ecj-11314	6	19	patients	patient	NOUN
ecj-11314	6	20	in	in	ADP
ecj-11314	6	21	the	the	DET
ecj-11314	6	22	ms	ms	PROPN
ecj-11314	6	23	attack	attack	NOUN
ecj-11314	6	24	periods	period	NOUN
ecj-11314	6	25	were	be	AUX
ecj-11314	6	26	higher	high	ADJ
ecj-11314	6	27	than	than	ADP
ecj-11314	6	28	those	those	PRON
ecj-11314	6	29	in	in	ADP
ecj-11314	6	30	the	the	DET
ecj-11314	6	31	non	non	ADJ
ecj-11314	6	32	-	-	ADJ
ecj-11314	6	33	attack	attack	ADJ
ecj-11314	6	34	period	period	NOUN
ecj-11314	6	35	.	.	PUNCT
ecj-11314	7	1	the	the	DET
ecj-11314	7	2	mean	mean	ADJ
ecj-11314	7	3	difference	difference	NOUN
ecj-11314	7	4	of	of	ADP
ecj-11314	7	5	nlr	nlr	PROPN
ecj-11314	7	6	,	,	PUNCT
ecj-11314	7	7	mlr	mlr	PROPN
ecj-11314	7	8	,	,	PUNCT
ecj-11314	7	9	rlr	rlr	PROPN
ecj-11314	7	10	,	,	PUNCT
ecj-11314	7	11	and	and	CCONJ
ecj-11314	7	12	sii	sii	ADV
ecj-11314	7	13	between	between	ADP
ecj-11314	7	14	both	both	DET
ecj-11314	7	15	groups	group	NOUN
ecj-11314	7	16	was	be	AUX
ecj-11314	7	17	5.40±7.25	5.40±7.25	NUM
ecj-11314	7	18	,	,	PUNCT
ecj-11314	7	19	0.37±0.43	0.37±0.43	NUM
ecj-11314	7	20	,	,	PUNCT
ecj-11314	7	21	7.77±11.61	7.77±11.61	NUM
ecj-11314	7	22	,	,	PUNCT
ecj-11314	7	23	1469.19±1978.88	1469.19±1978.88	NUM
ecj-11314	7	24	,	,	PUNCT
ecj-11314	7	25	respectively	respectively	ADV
ecj-11314	7	26	(	(	PUNCT
ecj-11314	7	27	p<0.001	p<0.001	PROPN
ecj-11314	7	28	)	)	PUNCT
ecj-11314	7	29	.	.	PUNCT
ecj-11314	8	1	in	in	ADP
ecj-11314	8	2	roc	roc	PROPN
ecj-11314	8	3	analysis	analysis	NOUN
ecj-11314	8	4	,	,	PUNCT
ecj-11314	8	5	nlr	nlr	PROPN
ecj-11314	8	6	,	,	PUNCT
ecj-11314	8	7	rlr	rlr	PROPN
ecj-11314	8	8	,	,	PUNCT
ecj-11314	8	9	mlr	mlr	PROPN
ecj-11314	8	10	,	,	PUNCT
ecj-11314	8	11	and	and	CCONJ
ecj-11314	8	12	sii	sii	PROPN
ecj-11314	8	13	had	have	VERB
ecj-11314	8	14	excellent	excellent	ADJ
ecj-11314	8	15	diagnostic	diagnostic	ADJ
ecj-11314	8	16	power	power	NOUN
ecj-11314	8	17	in	in	ADP
ecj-11314	8	18	detecting	detect	VERB
ecj-11314	8	19	ms	ms	PROPN
ecj-11314	8	20	relapse	relapse	NOUN
ecj-11314	8	21	(	(	PUNCT
ecj-11314	8	22	auc	auc	NOUN
ecj-11314	8	23	:	:	PUNCT
ecj-11314	8	24	0.87	0.87	NUM
ecj-11314	8	25	,	,	PUNCT
ecj-11314	8	26	0.81	0.81	NUM
ecj-11314	8	27	,	,	PUNCT
ecj-11314	8	28	0.86	0.86	NUM
ecj-11314	8	29	,	,	PUNCT
ecj-11314	8	30	and	and	CCONJ
ecj-11314	8	31	0.87	0.87	NUM
ecj-11314	8	32	,	,	PUNCT
ecj-11314	8	33	respectively	respectively	ADV
ecj-11314	8	34	)	)	PUNCT
ecj-11314	8	35	.	.	PUNCT
ecj-11314	9	1	according	accord	VERB
ecj-11314	9	2	to	to	ADP
ecj-11314	9	3	our	our	PRON
ecj-11314	9	4	findings	finding	NOUN
ecj-11314	9	5	,	,	PUNCT
ecj-11314	9	6	sii	sii	PROPN
ecj-11314	9	7	,	,	PUNCT
ecj-11314	9	8	mlr	mlr	PROPN
ecj-11314	9	9	,	,	PUNCT
ecj-11314	9	10	nlr	nlr	PROPN
ecj-11314	9	11	,	,	PUNCT
ecj-11314	9	12	and	and	CCONJ
ecj-11314	9	13	rlr	rlr	PROPN
ecj-11314	9	14	may	may	AUX
ecj-11314	9	15	be	be	AUX
ecj-11314	9	16	beneficial	beneficial	ADJ
ecj-11314	9	17	in	in	ADP
ecj-11314	9	18	confirming	confirm	VERB
ecj-11314	9	19	the	the	DET
ecj-11314	9	20	diagnosis	diagnosis	NOUN
ecj-11314	9	21	of	of	ADP
ecj-11314	9	22	attack	attack	NOUN
ecj-11314	9	23	in	in	ADP
ecj-11314	9	24	patients	patient	NOUN
ecj-11314	9	25	with	with	ADP
ecj-11314	9	26	rrms	rrm	NOUN
ecj-11314	9	27	.	.	PUNCT
ecj-11314	10	1	introduction	introduction	NOUN
ecj-11314	10	2	multiple	multiple	ADJ
ecj-11314	10	3	sclerosis	sclerosis	NOUN
ecj-11314	10	4	(	(	PUNCT
ecj-11314	10	5	ms	ms	NOUN
ecj-11314	10	6	)	)	PUNCT
ecj-11314	10	7	is	be	AUX
ecj-11314	10	8	the	the	DET
ecj-11314	10	9	most	most	ADV
ecj-11314	10	10	prevalent	prevalent	ADJ
ecj-11314	10	11	immune	immune	NOUN
ecj-11314	10	12	-	-	PUNCT
ecj-11314	10	13	mediated	mediate	VERB
ecj-11314	10	14	inflammatory	inflammatory	ADJ
ecj-11314	10	15	demyelinating	demyelinate	VERB
ecj-11314	10	16	central	central	ADJ
ecj-11314	10	17	nervous	nervous	ADJ
ecj-11314	10	18	system	system	NOUN
ecj-11314	10	19	disorder	disorder	NOUN
ecj-11314	10	20	,	,	PUNCT
ecj-11314	10	21	with	with	ADP
ecj-11314	10	22	a	a	DET
ecj-11314	10	23	diverse	diverse	ADJ
ecj-11314	10	24	set	set	NOUN
ecj-11314	10	25	of	of	ADP
ecj-11314	10	26	clinical	clinical	ADJ
ecj-11314	10	27	signs	sign	NOUN
ecj-11314	10	28	and	and	CCONJ
ecj-11314	10	29	symptoms.1,2	symptoms.1,2	NOUN
ecj-11314	10	30	ms	ms	NOUN
ecj-11314	10	31	exhibits	exhibit	VERB
ecj-11314	10	32	significant	significant	ADJ
ecj-11314	10	33	heterogeneity	heterogeneity	NOUN
ecj-11314	10	34	in	in	ADP
ecj-11314	10	35	radiological	radiological	ADJ
ecj-11314	10	36	and	and	CCONJ
ecj-11314	10	37	histopathological	histopathological	ADJ
ecj-11314	10	38	changes	change	NOUN
ecj-11314	10	39	,	,	PUNCT
ecj-11314	10	40	clinical	clinical	ADJ
ecj-11314	10	41	presentation	presentation	NOUN
ecj-11314	10	42	,	,	PUNCT
ecj-11314	10	43	disease	disease	NOUN
ecj-11314	10	44	progression	progression	NOUN
ecj-11314	10	45	,	,	PUNCT
ecj-11314	10	46	and	and	CCONJ
ecj-11314	10	47	treatment	treatment	NOUN
ecj-11314	10	48	response.3	response.3	PROPN
ecj-11314	10	49	regarding	regard	VERB
ecj-11314	10	50	its	its	PRON
ecj-11314	10	51	pathogenesis	pathogenesis	NOUN
ecj-11314	10	52	,	,	PUNCT
ecj-11314	10	53	it	it	PRON
ecj-11314	10	54	has	have	AUX
ecj-11314	10	55	been	be	AUX
ecj-11314	10	56	suggested	suggest	VERB
ecj-11314	10	57	that	that	SCONJ
ecj-11314	10	58	the	the	DET
ecj-11314	10	59	innate	innate	ADJ
ecj-11314	10	60	and	and	CCONJ
ecj-11314	10	61	adaptive	adaptive	ADJ
ecj-11314	10	62	immune	immune	ADJ
ecj-11314	10	63	system	system	NOUN
ecj-11314	10	64	causes	cause	VERB
ecj-11314	10	65	inflammation	inflammation	NOUN
ecj-11314	10	66	of	of	ADP
ecj-11314	10	67	a	a	DET
ecj-11314	10	68	dynamic	dynamic	ADJ
ecj-11314	10	69	interaction	interaction	NOUN
ecj-11314	10	70	between	between	ADP
ecj-11314	10	71	glia	glia	NOUN
ecj-11314	10	72	and	and	CCONJ
ecj-11314	10	73	neurons	neuron	NOUN
ecj-11314	10	74	,	,	PUNCT
ecj-11314	10	75	disorders	disorder	NOUN
ecj-11314	10	76	of	of	ADP
ecj-11314	10	77	the	the	DET
ecj-11314	10	78	blood	blood	NOUN
ecj-11314	10	79	-	-	PUNCT
ecj-11314	10	80	brain	brain	NOUN
ecj-11314	10	81	barrier	barrier	NOUN
ecj-11314	10	82	,	,	PUNCT
ecj-11314	10	83	demyelination	demyelination	NOUN
ecj-11314	10	84	,	,	PUNCT
ecj-11314	10	85	and	and	CCONJ
ecj-11314	10	86	neuroaxonal	neuroaxonal	ADJ
ecj-11314	10	87	injury	injury	NOUN
ecj-11314	10	88	to	to	ADP
ecj-11314	10	89	the	the	DET
ecj-11314	10	90	brain	brain	NOUN
ecj-11314	10	91	and	and	CCONJ
ecj-11314	10	92	spinal	spinal	NOUN
ecj-11314	10	93	cord.4,5	cord.4,5	NOUN
ecj-11314	10	94	since	since	SCONJ
ecj-11314	10	95	ms	ms	ADJ
ecj-11314	10	96	patients	patient	NOUN
ecj-11314	10	97	admitted	admit	VERB
ecj-11314	10	98	to	to	ADP
ecj-11314	10	99	the	the	DET
ecj-11314	10	100	emergency	emergency	NOUN
ecj-11314	10	101	department	department	NOUN
ecj-11314	10	102	(	(	PUNCT
ecj-11314	10	103	ed	ed	NOUN
ecj-11314	10	104	)	)	PUNCT
ecj-11314	10	105	have	have	VERB
ecj-11314	10	106	variable	variable	ADJ
ecj-11314	10	107	clinical	clinical	ADJ
ecj-11314	10	108	symptoms	symptom	NOUN
ecj-11314	10	109	,	,	PUNCT
ecj-11314	10	110	it	it	PRON
ecj-11314	10	111	is	be	AUX
ecj-11314	10	112	very	very	ADV
ecj-11314	10	113	important	important	ADJ
ecj-11314	10	114	to	to	PART
ecj-11314	10	115	distinguish	distinguish	VERB
ecj-11314	10	116	between	between	ADP
ecj-11314	10	117	those	those	PRON
ecj-11314	10	118	in	in	ADP
ecj-11314	10	119	the	the	DET
ecj-11314	10	120	attack	attack	NOUN
ecj-11314	10	121	(	(	PUNCT
ecj-11314	10	122	exacerbation	exacerbation	NOUN
ecj-11314	10	123	,	,	PUNCT
ecj-11314	10	124	relapse	relapse	NOUN
ecj-11314	10	125	,	,	PUNCT
ecj-11314	10	126	episode	episode	NOUN
ecj-11314	10	127	)	)	PUNCT
ecj-11314	10	128	period	period	NOUN
ecj-11314	10	129	and	and	CCONJ
ecj-11314	10	130	those	those	PRON
ecj-11314	10	131	who	who	PRON
ecj-11314	10	132	do	do	VERB
ecj-11314	10	133	not	not	PART
ecj-11314	10	134	.	.	PUNCT
ecj-11314	11	1	in	in	ADP
ecj-11314	11	2	this	this	DET
ecj-11314	11	3	process	process	NOUN
ecj-11314	11	4	,	,	PUNCT
ecj-11314	11	5	inflammatory	inflammatory	ADJ
ecj-11314	11	6	markers	marker	NOUN
ecj-11314	11	7	were	be	AUX
ecj-11314	11	8	needed	need	VERB
ecj-11314	11	9	in	in	ADP
ecj-11314	11	10	addition	addition	NOUN
ecj-11314	11	11	to	to	ADP
ecj-11314	11	12	clinical	clinical	ADJ
ecj-11314	11	13	findings	finding	NOUN
ecj-11314	11	14	and	and	CCONJ
ecj-11314	11	15	cranial	cranial	ADJ
ecj-11314	11	16	imaging	imaging	NOUN
ecj-11314	11	17	.	.	PUNCT
ecj-11314	12	1	the	the	DET
ecj-11314	12	2	differential	differential	ADJ
ecj-11314	12	3	count	count	NOUN
ecj-11314	12	4	of	of	ADP
ecj-11314	12	5	white	white	ADJ
ecj-11314	12	6	blood	blood	NOUN
ecj-11314	12	7	cells	cell	NOUN
ecj-11314	12	8	is	be	AUX
ecj-11314	12	9	extensively	extensively	ADV
ecj-11314	12	10	utilized	utilize	VERB
ecj-11314	12	11	as	as	ADP
ecj-11314	12	12	a	a	DET
ecj-11314	12	13	biomarker	biomarker	NOUN
ecj-11314	12	14	of	of	ADP
ecj-11314	12	15	systemic	systemic	ADJ
ecj-11314	12	16	inflammation	inflammation	NOUN
ecj-11314	12	17	and	and	CCONJ
ecj-11314	12	18	infection	infection	NOUN
ecj-11314	12	19	;	;	PUNCT
ecj-11314	12	20	the	the	DET
ecj-11314	12	21	latest	late	ADJ
ecj-11314	12	22	review	review	NOUN
ecj-11314	12	23	article	article	NOUN
ecj-11314	12	24	proposed	propose	VERB
ecj-11314	12	25	that	that	SCONJ
ecj-11314	12	26	neutrophils	neutrophil	NOUN
ecj-11314	12	27	and	and	CCONJ
ecj-11314	12	28	their	their	PRON
ecj-11314	12	29	phenotype	phenotype	NOUN
ecj-11314	12	30	could	could	AUX
ecj-11314	12	31	potentially	potentially	ADV
ecj-11314	12	32	be	be	AUX
ecj-11314	12	33	linked	link	VERB
ecj-11314	12	34	to	to	ADP
ecj-11314	12	35	the	the	DET
ecj-11314	12	36	specific	specific	ADJ
ecj-11314	12	37	disease	disease	NOUN
ecj-11314	12	38	course	course	NOUN
ecj-11314	12	39	of	of	ADP
ecj-11314	12	40	ms.6–8	ms.6–8	NOUN
ecj-11314	12	41	observation	observation	NOUN
ecj-11314	12	42	of	of	ADP
ecj-11314	12	43	enlargement	enlargement	NOUN
ecj-11314	12	44	of	of	ADP
ecj-11314	12	45	cd15	cd15	PROPN
ecj-11314	12	46	+	+	CCONJ
ecj-11314	12	47	neutrophils	neutrophil	NOUN
ecj-11314	12	48	in	in	ADP
ecj-11314	12	49	inactive	inactive	ADJ
ecj-11314	12	50	relapsing	relapsing	NOUN
ecj-11314	12	51	-	-	PUNCT
ecj-11314	12	52	remitting	remit	VERB
ecj-11314	12	53	ms	ms	NOUN
ecj-11314	12	54	(	(	PUNCT
ecj-11314	12	55	rrms	rrm	NOUN
ecj-11314	12	56	)	)	PUNCT
ecj-11314	12	57	may	may	AUX
ecj-11314	12	58	be	be	AUX
ecj-11314	12	59	helpful	helpful	ADJ
ecj-11314	12	60	for	for	ADP
ecj-11314	12	61	early	early	ADJ
ecj-11314	12	62	diagnosis	diagnosis	NOUN
ecj-11314	12	63	and	and	CCONJ
ecj-11314	12	64	determination	determination	NOUN
ecj-11314	12	65	of	of	ADP
ecj-11314	12	66	response	response	NOUN
ecj-11314	12	67	to	to	ADP
ecj-11314	12	68	therapy.6	therapy.6	PROPN
ecj-11314	12	69	it	it	PRON
ecj-11314	12	70	was	be	AUX
ecj-11314	12	71	also	also	ADV
ecj-11314	12	72	observed	observe	VERB
ecj-11314	12	73	that	that	SCONJ
ecj-11314	12	74	granulocyte	granulocyte	NOUN
ecj-11314	12	75	counts	count	NOUN
ecj-11314	12	76	decreased	decrease	VERB
ecj-11314	12	77	in	in	ADP
ecj-11314	12	78	rrms	rrm	NOUN
ecj-11314	12	79	patients	patient	NOUN
ecj-11314	12	80	during	during	ADP
ecj-11314	12	81	the	the	DET
ecj-11314	12	82	remission	remission	NOUN
ecj-11314	12	83	phase.6	phase.6	AUX
ecj-11314	12	84	the	the	DET
ecj-11314	12	85	peripheral	peripheral	ADJ
ecj-11314	12	86	blood	blood	NOUN
ecj-11314	12	87	neutrophil	neutrophil	NOUN
ecj-11314	12	88	-	-	PUNCT
ecj-11314	12	89	to	to	ADP
ecj-11314	12	90	-	-	PUNCT
ecj-11314	12	91	lymphocyte	lymphocyte	NOUN
ecj-11314	12	92	ratio	ratio	NOUN
ecj-11314	12	93	(	(	PUNCT
ecj-11314	12	94	nlr	nlr	PROPN
ecj-11314	12	95	)	)	PUNCT
ecj-11314	12	96	in	in	ADP
ecj-11314	12	97	autoimmune	autoimmune	ADJ
ecj-11314	12	98	disease	disease	NOUN
ecj-11314	12	99	has	have	AUX
ecj-11314	12	100	recently	recently	ADV
ecj-11314	12	101	been	be	AUX
ecj-11314	12	102	suggested	suggest	VERB
ecj-11314	12	103	as	as	ADP
ecj-11314	12	104	a	a	DET
ecj-11314	12	105	potential	potential	NOUN
ecj-11314	12	106	,	,	PUNCT
ecj-11314	12	107	emergency	emergency	NOUN
ecj-11314	12	108	care	care	NOUN
ecj-11314	12	109	journal	journal	PROPN
ecj-11314	12	110	2023	2023	NUM
ecj-11314	12	111	;	;	PUNCT
ecj-11314	12	112	volume	volume	NOUN
ecj-11314	12	113	19:11314	19:11314	NUM
ecj-11314	13	1	[	[	X
ecj-11314	13	2	emergency	emergency	NOUN
ecj-11314	13	3	care	care	NOUN
ecj-11314	13	4	journal	journal	PROPN
ecj-11314	13	5	2023	2023	NUM
ecj-11314	13	6	;	;	PUNCT
ecj-11314	13	7	19:11314	19:11314	NUM
ecj-11314	13	8	]	]	X
ecj-11314	14	1	[	[	X
ecj-11314	14	2	page	page	NOUN
ecj-11314	14	3	37	37	NUM
ecj-11314	14	4	]	]	PUNCT
ecj-11314	14	5	the	the	DET
ecj-11314	14	6	predictive	predictive	ADJ
ecj-11314	14	7	value	value	NOUN
ecj-11314	14	8	of	of	ADP
ecj-11314	14	9	inflammatory	inflammatory	ADJ
ecj-11314	14	10	biomarkers	biomarker	NOUN
ecj-11314	14	11	in	in	ADP
ecj-11314	14	12	the	the	DET
ecj-11314	14	13	detection	detection	NOUN
ecj-11314	14	14	of	of	ADP
ecj-11314	14	15	multiple	multiple	ADJ
ecj-11314	14	16	sclerosis	sclerosis	NOUN
ecj-11314	14	17	attacks	attack	NOUN
ecj-11314	14	18	nafis	nafis	VERB
ecj-11314	14	19	vural,1	vural,1	PROPN
ecj-11314	14	20	murat	murat	PROPN
ecj-11314	14	21	duyan,2	duyan,2	PROPN
ecj-11314	14	22	ali	ali	PROPN
ecj-11314	14	23	saridas,3	saridas,3	NOUN
ecj-11314	14	24	elif	elif	PROPN
ecj-11314	14	25	ertas,4	ertas,4	PROPN
ecj-11314	14	26	asım	asım	NOUN
ecj-11314	14	27	kalkan,3	kalkan,3	ADV
ecj-11314	14	28	1department	1department	NUM
ecj-11314	14	29	of	of	ADP
ecj-11314	14	30	emergency	emergency	NOUN
ecj-11314	14	31	medicine	medicine	NOUN
ecj-11314	14	32	,	,	PUNCT
ecj-11314	14	33	ereğli	ereğli	PROPN
ecj-11314	14	34	state	state	NOUN
ecj-11314	14	35	hospital	hospital	NOUN
ecj-11314	14	36	,	,	PUNCT
ecj-11314	14	37	konya	konya	PROPN
ecj-11314	14	38	;	;	PUNCT
ecj-11314	14	39	2department	2department	NUM
ecj-11314	14	40	of	of	ADP
ecj-11314	14	41	emergency	emergency	NOUN
ecj-11314	14	42	medicine	medicine	NOUN
ecj-11314	14	43	,	,	PUNCT
ecj-11314	14	44	antalya	antalya	NOUN
ecj-11314	14	45	training	training	NOUN
ecj-11314	14	46	and	and	CCONJ
ecj-11314	14	47	research	research	NOUN
ecj-11314	14	48	hospital	hospital	NOUN
ecj-11314	14	49	,	,	PUNCT
ecj-11314	14	50	antalya	antalya	PROPN
ecj-11314	14	51	;	;	PUNCT
ecj-11314	14	52	3department	3department	NUM
ecj-11314	14	53	of	of	ADP
ecj-11314	14	54	emergency	emergency	NOUN
ecj-11314	14	55	medicine	medicine	NOUN
ecj-11314	14	56	,	,	PUNCT
ecj-11314	14	57	prof	prof	PROPN
ecj-11314	14	58	.	.	PUNCT
ecj-11314	15	1	dr	dr	PROPN
ecj-11314	15	2	.	.	PROPN
ecj-11314	15	3	cemil	cemil	PROPN
ecj-11314	15	4	taşçıoğlu	taşçıoğlu	PROPN
ecj-11314	15	5	city	city	PROPN
ecj-11314	15	6	hospital	hospital	PROPN
ecj-11314	15	7	,	,	PUNCT
ecj-11314	15	8	istanbul	istanbul	PROPN
ecj-11314	15	9	;	;	PUNCT
ecj-11314	15	10	4department	4department	NUM
ecj-11314	15	11	of	of	ADP
ecj-11314	15	12	biostatistics	biostatistics	PROPN
ecj-11314	15	13	,	,	PUNCT
ecj-11314	15	14	mersin	mersin	PROPN
ecj-11314	15	15	university	university	PROPN
ecj-11314	15	16	,	,	PUNCT
ecj-11314	15	17	mersin	mersin	PROPN
ecj-11314	15	18	,	,	PUNCT
ecj-11314	15	19	turkey	turkey	NOUN
ecj-11314	15	20	correspondence	correspondence	NOUN
ecj-11314	15	21	:	:	PUNCT
ecj-11314	15	22	nafis	nafis	PROPN
ecj-11314	15	23	vural	vural	PROPN
ecj-11314	15	24	,	,	PUNCT
ecj-11314	15	25	department	department	NOUN
ecj-11314	15	26	of	of	ADP
ecj-11314	15	27	emergency	emergency	NOUN
ecj-11314	15	28	medicine	medicine	NOUN
ecj-11314	15	29	,	,	PUNCT
ecj-11314	15	30	ereğli	ereğli	PROPN
ecj-11314	15	31	state	state	NOUN
ecj-11314	15	32	hospital	hospital	NOUN
ecj-11314	15	33	,	,	PUNCT
ecj-11314	15	34	gülbahçe	gülbahçe	NOUN
ecj-11314	15	35	district	district	NOUN
ecj-11314	15	36	,	,	PUNCT
ecj-11314	15	37	92578th	92578th	ADJ
ecj-11314	15	38	street	street	NOUN
ecj-11314	15	39	,	,	PUNCT
ecj-11314	15	40	42310	42310	NUM
ecj-11314	15	41	,	,	PUNCT
ecj-11314	15	42	ereğli	ereğli	PROPN
ecj-11314	15	43	,	,	PUNCT
ecj-11314	15	44	konya	konya	PROPN
ecj-11314	15	45	,	,	PUNCT
ecj-11314	15	46	turkey	turkey	PROPN
ecj-11314	15	47	.	.	PUNCT
ecj-11314	16	1	tel	tel	ADP
ecj-11314	16	2	:	:	PUNCT
ecj-11314	16	3	+90.546.5067813	+90.546.5067813	ADJ
ecj-11314	16	4	fax	fax	NOUN
ecj-11314	16	5	:	:	PUNCT
ecj-11314	16	6	+90.0332.2235000	+90.0332.2235000	ADJ
ecj-11314	16	7	e	e	NOUN
ecj-11314	16	8	-	-	NOUN
ecj-11314	16	9	mail	mail	NOUN
ecj-11314	16	10	:	:	PUNCT
ecj-11314	17	1	42nafisvural@gmail.com	42nafisvural@gmail.com	X
ecj-11314	17	2	.	.	PUNCT
ecj-11314	18	1	key	key	ADJ
ecj-11314	18	2	words	word	NOUN
ecj-11314	18	3	:	:	PUNCT
ecj-11314	18	4	multiple	multiple	ADJ
ecj-11314	18	5	sclerosis	sclerosis	NOUN
ecj-11314	18	6	,	,	PUNCT
ecj-11314	18	7	monocyte	monocyte	NOUN
ecj-11314	18	8	-	-	PUNCT
ecj-11314	18	9	to	to	ADP
ecj-11314	18	10	-	-	PUNCT
ecj-11314	18	11	lymphocyte	lymphocyte	NOUN
ecj-11314	18	12	ratio	ratio	NOUN
ecj-11314	18	13	,	,	PUNCT
ecj-11314	18	14	neutrophil	neutrophil	NOUN
ecj-11314	18	15	-	-	PUNCT
ecj-11314	18	16	to	to	ADP
ecj-11314	18	17	-	-	PUNCT
ecj-11314	18	18	lymphocyte	lymphocyte	NOUN
ecj-11314	18	19	ratio	ratio	NOUN
ecj-11314	18	20	,	,	PUNCT
ecj-11314	18	21	systemic	systemic	ADJ
ecj-11314	18	22	immune	immune	ADJ
ecj-11314	18	23	inflammation	inflammation	NOUN
ecj-11314	18	24	index	index	NOUN
ecj-11314	18	25	,	,	PUNCT
ecj-11314	18	26	red	red	ADJ
ecj-11314	18	27	cell	cell	NOUN
ecj-11314	18	28	distribution	distribution	NOUN
ecj-11314	18	29	width	width	NOUN
ecj-11314	18	30	-	-	PUNCT
ecj-11314	18	31	to	to	ADP
ecj-11314	18	32	-	-	PUNCT
ecj-11314	18	33	lymphocyte	lymphocyte	NOUN
ecj-11314	18	34	ratio	ratio	NOUN
ecj-11314	18	35	.	.	PUNCT
ecj-11314	19	1	contributors	contributor	NOUN
ecj-11314	19	2	:	:	PUNCT
ecj-11314	19	3	nv	nv	PROPN
ecj-11314	19	4	,	,	PUNCT
ecj-11314	19	5	md	md	PROPN
ecj-11314	19	6	,	,	PUNCT
ecj-11314	19	7	as	as	ADP
ecj-11314	19	8	,	,	PUNCT
ecj-11314	19	9	ak	ak	PROPN
ecj-11314	19	10	,	,	PUNCT
ecj-11314	19	11	onception	onception	NOUN
ecj-11314	19	12	and	and	CCONJ
ecj-11314	19	13	design	design	NOUN
ecj-11314	19	14	,	,	PUNCT
ecj-11314	19	15	data	data	NOUN
ecj-11314	19	16	collection	collection	NOUN
ecj-11314	19	17	,	,	PUNCT
ecj-11314	19	18	analysis	analysis	NOUN
ecj-11314	19	19	and	and	CCONJ
ecj-11314	19	20	interpretation	interpretation	NOUN
ecj-11314	19	21	,	,	PUNCT
ecj-11314	19	22	manuscript	manuscript	NOUN
ecj-11314	19	23	writing	writing	NOUN
ecj-11314	19	24	,	,	PUNCT
ecj-11314	19	25	critical	critical	ADJ
ecj-11314	19	26	revision	revision	NOUN
ecj-11314	19	27	of	of	ADP
ecj-11314	19	28	the	the	DET
ecj-11314	19	29	manuscript	manuscript	NOUN
ecj-11314	19	30	;	;	PUNCT
ecj-11314	19	31	ee	ee	PROPN
ecj-11314	19	32	,	,	PUNCT
ecj-11314	19	33	statistic	statistic	ADJ
ecj-11314	19	34	advisor	advisor	NOUN
ecj-11314	19	35	,	,	PUNCT
ecj-11314	19	36	manuscript	manuscript	NOUN
ecj-11314	19	37	editing	editing	NOUN
ecj-11314	19	38	,	,	PUNCT
ecj-11314	19	39	critical	critical	ADJ
ecj-11314	19	40	revision	revision	NOUN
ecj-11314	19	41	of	of	ADP
ecj-11314	19	42	the	the	DET
ecj-11314	19	43	manuscript	manuscript	NOUN
ecj-11314	19	44	.	.	PUNCT
ecj-11314	20	1	conflict	conflict	NOUN
ecj-11314	20	2	of	of	ADP
ecj-11314	20	3	interest	interest	NOUN
ecj-11314	20	4	:	:	PUNCT
ecj-11314	20	5	the	the	DET
ecj-11314	20	6	authors	author	NOUN
ecj-11314	20	7	declare	declare	VERB
ecj-11314	20	8	no	no	DET
ecj-11314	20	9	potential	potential	ADJ
ecj-11314	20	10	conflict	conflict	NOUN
ecj-11314	20	11	of	of	ADP
ecj-11314	20	12	interest	interest	NOUN
ecj-11314	20	13	,	,	PUNCT
ecj-11314	20	14	and	and	CCONJ
ecj-11314	20	15	all	all	DET
ecj-11314	20	16	authors	author	NOUN
ecj-11314	20	17	confirm	confirm	VERB
ecj-11314	20	18	accuracy	accuracy	NOUN
ecj-11314	20	19	.	.	PUNCT
ecj-11314	21	1	ethics	ethic	NOUN
ecj-11314	21	2	approval	approval	NOUN
ecj-11314	21	3	and	and	CCONJ
ecj-11314	21	4	consent	consent	NOUN
ecj-11314	21	5	to	to	PART
ecj-11314	21	6	participate	participate	VERB
ecj-11314	21	7	:	:	PUNCT
ecj-11314	21	8	the	the	DET
ecj-11314	21	9	study	study	NOUN
ecj-11314	21	10	was	be	AUX
ecj-11314	21	11	performed	perform	VERB
ecj-11314	21	12	retrospectively	retrospectively	ADV
ecj-11314	21	13	after	after	ADP
ecj-11314	21	14	approval	approval	NOUN
ecj-11314	21	15	by	by	ADP
ecj-11314	21	16	the	the	DET
ecj-11314	21	17	ethics	ethic	NOUN
ecj-11314	21	18	committee	committee	PROPN
ecj-11314	21	19	of	of	ADP
ecj-11314	21	20	the	the	DET
ecj-11314	21	21	istanbul	istanbul	PROPN
ecj-11314	21	22	prof	prof	PROPN
ecj-11314	21	23	dr	dr	PROPN
ecj-11314	21	24	.	.	PROPN
ecj-11314	21	25	cemil	cemil	PROPN
ecj-11314	21	26	tascioglu	tascioglu	PROPN
ecj-11314	21	27	city	city	NOUN
ecj-11314	21	28	hospital	hospital	NOUN
ecj-11314	21	29	(	(	PUNCT
ecj-11314	21	30	protocol	protocol	NOUN
ecj-11314	21	31	code:240	code:240	NOUN
ecj-11314	21	32	,	,	PUNCT
ecj-11314	21	33	decision	decision	NOUN
ecj-11314	21	34	number:240	number:240	NUM
ecj-11314	21	35	,	,	PUNCT
ecj-11314	21	36	issue	issue	NOUN
ecj-11314	21	37	:	:	PUNCT
ecj-11314	21	38	e-48670771	e-48670771	PROPN
ecj-11314	21	39	-	-	PUNCT
ecj-11314	21	40	020	020	NUM
ecj-11314	21	41	date	date	NOUN
ecj-11314	21	42	:	:	PUNCT
ecj-11314	21	43	08	08	NUM
ecj-11314	21	44	august	august	PROPN
ecj-11314	21	45	2022	2022	NUM
ecj-11314	21	46	)	)	PUNCT
ecj-11314	21	47	.	.	PUNCT
ecj-11314	22	1	the	the	DET
ecj-11314	22	2	present	present	ADJ
ecj-11314	22	3	study	study	NOUN
ecj-11314	22	4	was	be	AUX
ecj-11314	22	5	conducted	conduct	VERB
ecj-11314	22	6	in	in	ADP
ecj-11314	22	7	line	line	NOUN
ecj-11314	22	8	with	with	ADP
ecj-11314	22	9	the	the	DET
ecj-11314	22	10	declaration	declaration	NOUN
ecj-11314	22	11	of	of	ADP
ecj-11314	22	12	helsinki	helsinki	PROPN
ecj-11314	22	13	.	.	PUNCT
ecj-11314	23	1	informed	informed	ADJ
ecj-11314	23	2	consent	consent	NOUN
ecj-11314	23	3	:	:	PUNCT
ecj-11314	23	4	all	all	DET
ecj-11314	23	5	patients	patient	NOUN
ecj-11314	23	6	participating	participate	VERB
ecj-11314	23	7	in	in	ADP
ecj-11314	23	8	this	this	DET
ecj-11314	23	9	study	study	NOUN
ecj-11314	23	10	signed	sign	VERB
ecj-11314	23	11	a	a	DET
ecj-11314	23	12	written	write	VERB
ecj-11314	23	13	informed	inform	VERB
ecj-11314	23	14	consent	consent	NOUN
ecj-11314	23	15	form	form	NOUN
ecj-11314	23	16	for	for	ADP
ecj-11314	23	17	participating	participate	VERB
ecj-11314	23	18	in	in	ADP
ecj-11314	23	19	this	this	DET
ecj-11314	23	20	study	study	NOUN
ecj-11314	23	21	.	.	PUNCT
ecj-11314	24	1	patient	patient	ADJ
ecj-11314	24	2	consent	consent	NOUN
ecj-11314	24	3	for	for	ADP
ecj-11314	24	4	publication	publication	NOUN
ecj-11314	24	5	:	:	PUNCT
ecj-11314	24	6	written	write	VERB
ecj-11314	24	7	informed	informed	ADJ
ecj-11314	24	8	consent	consent	NOUN
ecj-11314	24	9	was	be	AUX
ecj-11314	24	10	obtained	obtain	VERB
ecj-11314	24	11	from	from	ADP
ecj-11314	24	12	a	a	DET
ecj-11314	24	13	legally	legally	ADV
ecj-11314	24	14	authorized	authorize	VERB
ecj-11314	24	15	representative(s	representative(s	NOUN
ecj-11314	24	16	)	)	PUNCT
ecj-11314	24	17	for	for	ADP
ecj-11314	24	18	anonymized	anonymize	VERB
ecj-11314	24	19	patient	patient	ADJ
ecj-11314	24	20	information	information	NOUN
ecj-11314	24	21	to	to	PART
ecj-11314	24	22	be	be	AUX
ecj-11314	24	23	published	publish	VERB
ecj-11314	24	24	in	in	ADP
ecj-11314	24	25	this	this	DET
ecj-11314	24	26	article	article	NOUN
ecj-11314	24	27	.	.	PUNCT
ecj-11314	25	1	availability	availability	NOUN
ecj-11314	25	2	of	of	ADP
ecj-11314	25	3	data	datum	NOUN
ecj-11314	25	4	and	and	CCONJ
ecj-11314	25	5	materials	material	NOUN
ecj-11314	25	6	:	:	PUNCT
ecj-11314	25	7	all	all	DET
ecj-11314	25	8	data	datum	NOUN
ecj-11314	25	9	generated	generate	VERB
ecj-11314	25	10	or	or	CCONJ
ecj-11314	25	11	analyzed	analyze	VERB
ecj-11314	25	12	during	during	ADP
ecj-11314	25	13	this	this	DET
ecj-11314	25	14	study	study	NOUN
ecj-11314	25	15	are	be	AUX
ecj-11314	25	16	included	include	VERB
ecj-11314	25	17	in	in	ADP
ecj-11314	25	18	this	this	DET
ecj-11314	25	19	published	publish	VERB
ecj-11314	25	20	article	article	NOUN
ecj-11314	25	21	.	.	PUNCT
ecj-11314	26	1	received	receive	VERB
ecj-11314	26	2	for	for	ADP
ecj-11314	26	3	publication	publication	NOUN
ecj-11314	26	4	:	:	PUNCT
ecj-11314	26	5	14	14	NUM
ecj-11314	26	6	march	march	NOUN
ecj-11314	26	7	2023	2023	NUM
ecj-11314	26	8	.	.	PUNCT
ecj-11314	27	1	accepted	accept	VERB
ecj-11314	27	2	for	for	ADP
ecj-11314	27	3	publication	publication	NOUN
ecj-11314	27	4	:	:	PUNCT
ecj-11314	27	5	23	23	NUM
ecj-11314	27	6	april	april	PROPN
ecj-11314	27	7	2023	2023	NUM
ecj-11314	27	8	.	.	PUNCT
ecj-11314	28	1	this	this	DET
ecj-11314	28	2	work	work	NOUN
ecj-11314	28	3	is	be	AUX
ecj-11314	28	4	licensed	license	VERB
ecj-11314	28	5	under	under	ADP
ecj-11314	28	6	a	a	DET
ecj-11314	28	7	creative	creative	ADJ
ecj-11314	28	8	commons	common	NOUN
ecj-11314	28	9	attribution	attribution	NOUN
ecj-11314	28	10	4.0	4.0	NUM
ecj-11314	28	11	license	license	NOUN
ecj-11314	28	12	(	(	PUNCT
ecj-11314	28	13	by	by	ADP
ecj-11314	28	14	-	-	PUNCT
ecj-11314	28	15	nc	nc	PROPN
ecj-11314	28	16	4.0	4.0	NUM
ecj-11314	28	17	)	)	PUNCT
ecj-11314	28	18	.	.	PUNCT
ecj-11314	29	1	©	©	PROPN
ecj-11314	29	2	copyright	copyright	NOUN
ecj-11314	29	3	:	:	PUNCT
ecj-11314	29	4	the	the	DET
ecj-11314	29	5	author(s	author(s	PROPN
ecj-11314	29	6	)	)	PUNCT
ecj-11314	29	7	,	,	PUNCT
ecj-11314	29	8	2023	2023	NUM
ecj-11314	29	9	licensee	licensee	NOUN
ecj-11314	29	10	pagepress	pagepress	NOUN
ecj-11314	29	11	,	,	PUNCT
ecj-11314	29	12	italy	italy	PROPN
ecj-11314	29	13	emergency	emergency	PROPN
ecj-11314	29	14	care	care	PROPN
ecj-11314	29	15	journal	journal	PROPN
ecj-11314	29	16	2023	2023	NUM
ecj-11314	29	17	;	;	PUNCT
ecj-11314	29	18	19:11314	19:11314	NUM
ecj-11314	29	19	doi:10.4081	doi:10.4081	NOUN
ecj-11314	29	20	/	/	SYM
ecj-11314	29	21	ecj.2023.11314	ecj.2023.11314	PROPN
ecj-11314	29	22	publisher	publisher	NOUN
ecj-11314	29	23	's	's	PART
ecj-11314	29	24	note	note	NOUN
ecj-11314	29	25	:	:	PUNCT
ecj-11314	29	26	all	all	DET
ecj-11314	29	27	claims	claim	NOUN
ecj-11314	29	28	expressed	express	VERB
ecj-11314	29	29	in	in	ADP
ecj-11314	29	30	this	this	DET
ecj-11314	29	31	article	article	NOUN
ecj-11314	29	32	are	be	AUX
ecj-11314	29	33	solely	solely	ADV
ecj-11314	29	34	those	those	PRON
ecj-11314	29	35	of	of	ADP
ecj-11314	29	36	the	the	DET
ecj-11314	29	37	authors	author	NOUN
ecj-11314	29	38	and	and	CCONJ
ecj-11314	29	39	do	do	AUX
ecj-11314	29	40	not	not	PART
ecj-11314	29	41	necessarily	necessarily	ADV
ecj-11314	29	42	represent	represent	VERB
ecj-11314	29	43	those	those	PRON
ecj-11314	29	44	of	of	ADP
ecj-11314	29	45	their	their	PRON
ecj-11314	29	46	affiliated	affiliated	ADJ
ecj-11314	29	47	organizations	organization	NOUN
ecj-11314	29	48	,	,	PUNCT
ecj-11314	29	49	or	or	CCONJ
ecj-11314	29	50	those	those	PRON
ecj-11314	29	51	of	of	ADP
ecj-11314	29	52	the	the	DET
ecj-11314	29	53	publisher	publisher	NOUN
ecj-11314	29	54	,	,	PUNCT
ecj-11314	29	55	the	the	DET
ecj-11314	29	56	editors	editor	NOUN
ecj-11314	29	57	and	and	CCONJ
ecj-11314	29	58	the	the	DET
ecj-11314	29	59	reviewers	reviewer	NOUN
ecj-11314	29	60	.	.	PUNCT
ecj-11314	30	1	any	any	DET
ecj-11314	30	2	product	product	NOUN
ecj-11314	30	3	that	that	PRON
ecj-11314	30	4	may	may	AUX
ecj-11314	30	5	be	be	AUX
ecj-11314	30	6	evaluated	evaluate	VERB
ecj-11314	30	7	in	in	ADP
ecj-11314	30	8	this	this	DET
ecj-11314	30	9	article	article	NOUN
ecj-11314	30	10	or	or	CCONJ
ecj-11314	30	11	claim	claim	NOUN
ecj-11314	30	12	that	that	PRON
ecj-11314	30	13	may	may	AUX
ecj-11314	30	14	be	be	AUX
ecj-11314	30	15	made	make	VERB
ecj-11314	30	16	by	by	ADP
ecj-11314	30	17	its	its	PRON
ecj-11314	30	18	manufacturer	manufacturer	NOUN
ecj-11314	30	19	is	be	AUX
ecj-11314	30	20	not	not	PART
ecj-11314	30	21	guaranteed	guarantee	VERB
ecj-11314	30	22	or	or	CCONJ
ecj-11314	30	23	endorsed	endorse	VERB
ecj-11314	30	24	by	by	ADP
ecj-11314	30	25	the	the	DET
ecj-11314	30	26	publisher	publisher	NOUN
ecj-11314	30	27	.	.	PUNCT
ecj-11314	31	1	non	non	ADJ
ecj-11314	31	2	-co	-co	PROPN
ecj-11314	31	3	mmerc	mmerc	PROPN
ecj-11314	31	4	ial	ial	PROPN
ecj-11314	31	5	us	us	PROPN
ecj-11314	31	6	e	e	NOUN
ecj-11314	31	7	o	o	NOUN
ecj-11314	31	8	nly	nly	ADV
ecj-11314	31	9	inexpensive	inexpensive	ADJ
ecj-11314	31	10	,	,	PUNCT
ecj-11314	31	11	and	and	CCONJ
ecj-11314	31	12	effective	effective	ADJ
ecj-11314	31	13	surrogate	surrogate	ADJ
ecj-11314	31	14	biomarker	biomarker	NOUN
ecj-11314	31	15	for	for	ADP
ecj-11314	31	16	systemic	systemic	ADJ
ecj-11314	31	17	inflammatory	inflammatory	ADJ
ecj-11314	31	18	status	status	NOUN
ecj-11314	31	19	and	and	CCONJ
ecj-11314	31	20	,	,	PUNCT
ecj-11314	31	21	thus	thus	ADV
ecj-11314	31	22	,	,	PUNCT
ecj-11314	31	23	disease	disease	NOUN
ecj-11314	31	24	activity.8–12	activity.8–12	NUM
ecj-11314	31	25	the	the	DET
ecj-11314	31	26	value	value	NOUN
ecj-11314	31	27	of	of	ADP
ecj-11314	31	28	the	the	DET
ecj-11314	31	29	monocyte	monocyte	NOUN
ecj-11314	31	30	-	-	PUNCT
ecj-11314	31	31	to	to	ADP
ecj-11314	31	32	-	-	PUNCT
ecj-11314	31	33	lymphocyte	lymphocyte	ADJ
ecj-11314	31	34	ratio	ratio	NOUN
ecj-11314	31	35	(	(	PUNCT
ecj-11314	31	36	mlr	mlr	PROPN
ecj-11314	31	37	)	)	PUNCT
ecj-11314	31	38	,	,	PUNCT
ecj-11314	31	39	red	red	ADJ
ecj-11314	31	40	cell	cell	NOUN
ecj-11314	31	41	distribution	distribution	NOUN
ecj-11314	31	42	width	width	NOUN
ecj-11314	31	43	(	(	PUNCT
ecj-11314	31	44	rdw	rdw	X
ecj-11314	31	45	)	)	PUNCT
ecj-11314	31	46	to	to	ADP
ecj-11314	31	47	lymphocyte	lymphocyte	ADJ
ecj-11314	31	48	ratio	ratio	NOUN
ecj-11314	31	49	(	(	PUNCT
ecj-11314	31	50	rlr	rlr	PROPN
ecj-11314	31	51	)	)	PUNCT
ecj-11314	31	52	,	,	PUNCT
ecj-11314	31	53	and	and	CCONJ
ecj-11314	31	54	systemic	systemic	ADJ
ecj-11314	31	55	immune	immune	ADJ
ecj-11314	31	56	inflammation	inflammation	NOUN
ecj-11314	31	57	index	index	NOUN
ecj-11314	31	58	(	(	PUNCT
ecj-11314	31	59	sii	sii	PROPN
ecj-11314	31	60	)	)	PUNCT
ecj-11314	31	61	as	as	ADP
ecj-11314	31	62	a	a	DET
ecj-11314	31	63	marker	marker	NOUN
ecj-11314	31	64	of	of	ADP
ecj-11314	31	65	disease	disease	NOUN
ecj-11314	31	66	activity	activity	NOUN
ecj-11314	31	67	in	in	ADP
ecj-11314	31	68	patients	patient	NOUN
ecj-11314	31	69	with	with	ADP
ecj-11314	31	70	rrms	rrm	NOUN
ecj-11314	31	71	is	be	AUX
ecj-11314	31	72	unknown	unknown	ADJ
ecj-11314	31	73	.	.	PUNCT
ecj-11314	32	1	the	the	DET
ecj-11314	32	2	aim	aim	NOUN
ecj-11314	32	3	of	of	ADP
ecj-11314	32	4	this	this	DET
ecj-11314	32	5	study	study	NOUN
ecj-11314	32	6	was	be	AUX
ecj-11314	32	7	to	to	PART
ecj-11314	32	8	investigate	investigate	VERB
ecj-11314	32	9	the	the	DET
ecj-11314	32	10	diagnostic	diagnostic	ADJ
ecj-11314	32	11	values	value	NOUN
ecj-11314	32	12	of	of	ADP
ecj-11314	32	13	mlr	mlr	PROPN
ecj-11314	32	14	,	,	PUNCT
ecj-11314	32	15	rlr	rlr	PROPN
ecj-11314	32	16	,	,	PUNCT
ecj-11314	32	17	and	and	CCONJ
ecj-11314	32	18	sii	sii	ADV
ecj-11314	32	19	in	in	ADP
ecj-11314	32	20	detecting	detect	VERB
ecj-11314	32	21	an	an	DET
ecj-11314	32	22	ms	ms	NOUN
ecj-11314	32	23	attack	attack	NOUN
ecj-11314	32	24	in	in	ADP
ecj-11314	32	25	a	a	DET
ecj-11314	32	26	cohort	cohort	NOUN
ecj-11314	32	27	of	of	ADP
ecj-11314	32	28	rrms	rrm	NOUN
ecj-11314	32	29	patients	patient	NOUN
ecj-11314	32	30	.	.	PUNCT
ecj-11314	33	1	materials	material	NOUN
ecj-11314	33	2	and	and	CCONJ
ecj-11314	33	3	methods	method	NOUN
ecj-11314	33	4	participants	participant	NOUN
ecj-11314	33	5	in	in	ADP
ecj-11314	33	6	this	this	DET
ecj-11314	33	7	study	study	NOUN
ecj-11314	33	8	,	,	PUNCT
ecj-11314	33	9	223	223	NUM
ecj-11314	33	10	patients	patient	NOUN
ecj-11314	33	11	with	with	ADP
ecj-11314	33	12	rrms	rrm	NOUN
ecj-11314	33	13	who	who	PRON
ecj-11314	33	14	were	be	AUX
ecj-11314	33	15	admitted	admit	VERB
ecj-11314	33	16	to	to	ADP
ecj-11314	33	17	the	the	DET
ecj-11314	33	18	emergency	emergency	NOUN
ecj-11314	33	19	department	department	NOUN
ecj-11314	33	20	of	of	ADP
ecj-11314	33	21	a	a	DET
ecj-11314	33	22	third	third	ADJ
ecj-11314	33	23	-	-	PUNCT
ecj-11314	33	24	level	level	NOUN
ecj-11314	33	25	hospital	hospital	NOUN
ecj-11314	33	26	between	between	ADP
ecj-11314	33	27	january	january	PROPN
ecj-11314	33	28	2016	2016	NUM
ecj-11314	33	29	and	and	CCONJ
ecj-11314	33	30	august	august	PROPN
ecj-11314	33	31	2022	2022	NUM
ecj-11314	33	32	were	be	AUX
ecj-11314	33	33	examined	examine	VERB
ecj-11314	33	34	.	.	PUNCT
ecj-11314	34	1	some	some	DET
ecj-11314	34	2	patients	patient	NOUN
ecj-11314	34	3	examined	examine	VERB
ecj-11314	34	4	are	be	AUX
ecj-11314	34	5	untreated	untreated	ADJ
ecj-11314	34	6	,	,	PUNCT
ecj-11314	34	7	and	and	CCONJ
ecj-11314	34	8	some	some	PRON
ecj-11314	34	9	receive	receive	VERB
ecj-11314	34	10	first	first	ADJ
ecj-11314	34	11	-	-	PUNCT
ecj-11314	34	12	line	line	NOUN
ecj-11314	34	13	treatment	treatment	NOUN
ecj-11314	34	14	(	(	PUNCT
ecj-11314	34	15	interferon	interferon	ADJ
ecj-11314	34	16	-	-	PUNCT
ecj-11314	34	17	beta	beta	NOUN
ecj-11314	34	18	,	,	PUNCT
ecj-11314	34	19	sphingosine-1	sphingosine-1	ADJ
ecj-11314	34	20	-	-	PUNCT
ecj-11314	34	21	phosphate	phosphate	ADJ
ecj-11314	34	22	inhibitors	inhibitor	NOUN
ecj-11314	34	23	)	)	PUNCT
ecj-11314	34	24	.	.	PUNCT
ecj-11314	35	1	however	however	ADV
ecj-11314	35	2	,	,	PUNCT
ecj-11314	35	3	we	we	PRON
ecj-11314	35	4	do	do	AUX
ecj-11314	35	5	not	not	PART
ecj-11314	35	6	have	have	VERB
ecj-11314	35	7	any	any	DET
ecj-11314	35	8	patients	patient	NOUN
ecj-11314	35	9	who	who	PRON
ecj-11314	35	10	received	receive	VERB
ecj-11314	35	11	second	second	ADJ
ecj-11314	35	12	-	-	PUNCT
ecj-11314	35	13	line	line	NOUN
ecj-11314	35	14	treatment	treatment	NOUN
ecj-11314	35	15	(	(	PUNCT
ecj-11314	35	16	anticd20	anticd20	NOUN
ecj-11314	35	17	,	,	PUNCT
ecj-11314	35	18	natalizumab	natalizumab	NOUN
ecj-11314	35	19	,	,	PUNCT
ecj-11314	35	20	cladribine	cladribine	INTJ
ecj-11314	35	21	)	)	PUNCT
ecj-11314	35	22	.	.	PUNCT
ecj-11314	36	1	one	one	NUM
ecj-11314	36	2	hundred	hundred	NUM
ecj-11314	36	3	sixty	sixty	NUM
ecj-11314	36	4	-	-	PUNCT
ecj-11314	36	5	five	five	NUM
ecj-11314	36	6	patients	patient	NOUN
ecj-11314	36	7	aged	age	VERB
ecj-11314	36	8	18	18	NUM
ecj-11314	36	9	years	year	NOUN
ecj-11314	36	10	and	and	CCONJ
ecj-11314	36	11	over	over	ADP
ecj-11314	36	12	who	who	PRON
ecj-11314	36	13	were	be	AUX
ecj-11314	36	14	diagnosed	diagnose	VERB
ecj-11314	36	15	with	with	ADP
ecj-11314	36	16	rrms	rrm	NOUN
ecj-11314	36	17	according	accord	VERB
ecj-11314	36	18	to	to	ADP
ecj-11314	36	19	the	the	DET
ecj-11314	36	20	2017	2017	NUM
ecj-11314	36	21	mcdonald	mcdonald	NOUN
ecj-11314	36	22	criteria	criterion	NOUN
ecj-11314	36	23	and	and	CCONJ
ecj-11314	36	24	were	be	AUX
ecj-11314	36	25	in	in	ADP
ecj-11314	36	26	the	the	DET
ecj-11314	36	27	ms	ms	PROPN
ecj-11314	36	28	attack	attack	NOUN
ecj-11314	36	29	period	period	NOUN
ecj-11314	36	30	were	be	AUX
ecj-11314	36	31	involved	involve	VERB
ecj-11314	36	32	in	in	ADP
ecj-11314	36	33	the	the	DET
ecj-11314	36	34	study.13	study.13	NOUN
ecj-11314	36	35	an	an	DET
ecj-11314	36	36	ms	ms	NOUN
ecj-11314	36	37	attack	attack	NOUN
ecj-11314	36	38	was	be	AUX
ecj-11314	36	39	defined	define	VERB
ecj-11314	36	40	as	as	ADP
ecj-11314	36	41	a	a	DET
ecj-11314	36	42	monophasic	monophasic	ADJ
ecj-11314	36	43	clinical	clinical	ADJ
ecj-11314	36	44	episode	episode	NOUN
ecj-11314	36	45	with	with	ADP
ecj-11314	36	46	patient	patient	NOUN
ecj-11314	36	47	-	-	PUNCT
ecj-11314	36	48	reported	report	VERB
ecj-11314	36	49	symptoms	symptom	NOUN
ecj-11314	36	50	and	and	CCONJ
ecj-11314	36	51	objective	objective	ADJ
ecj-11314	36	52	signs	sign	NOUN
ecj-11314	36	53	,	,	PUNCT
ecj-11314	36	54	developing	develop	VERB
ecj-11314	36	55	acutely	acutely	ADV
ecj-11314	36	56	or	or	CCONJ
ecj-11314	36	57	subacutely	subacutely	ADV
ecj-11314	36	58	in	in	ADP
ecj-11314	36	59	the	the	DET
ecj-11314	36	60	cns	cns	NOUN
ecj-11314	36	61	,	,	PUNCT
ecj-11314	36	62	lasting	last	VERB
ecj-11314	36	63	at	at	ADP
ecj-11314	36	64	least	least	ADV
ecj-11314	36	65	24	24	NUM
ecj-11314	36	66	hours	hour	NOUN
ecj-11314	36	67	,	,	PUNCT
ecj-11314	36	68	and	and	CCONJ
ecj-11314	36	69	reflecting	reflect	VERB
ecj-11314	36	70	a	a	DET
ecj-11314	36	71	focal	focal	ADJ
ecj-11314	36	72	or	or	CCONJ
ecj-11314	36	73	multifocal	multifocal	ADJ
ecj-11314	36	74	inflammatory	inflammatory	ADJ
ecj-11314	36	75	demyelinating	demyelinate	VERB
ecj-11314	36	76	event	event	NOUN
ecj-11314	36	77	in	in	ADP
ecj-11314	36	78	the	the	DET
ecj-11314	36	79	absence	absence	NOUN
ecj-11314	36	80	of	of	ADP
ecj-11314	36	81	fever	fever	NOUN
ecj-11314	36	82	or	or	CCONJ
ecj-11314	36	83	infection.13	infection.13	VERB
ecj-11314	36	84	these	these	DET
ecj-11314	36	85	symptoms	symptom	NOUN
ecj-11314	36	86	and	and	CCONJ
ecj-11314	36	87	signs	sign	NOUN
ecj-11314	36	88	were	be	AUX
ecj-11314	36	89	optic	optic	ADJ
ecj-11314	36	90	neuritis	neuritis	NOUN
ecj-11314	36	91	,	,	PUNCT
ecj-11314	36	92	ophthalmoplegia	ophthalmoplegia	ADJ
ecj-11314	36	93	,	,	PUNCT
ecj-11314	36	94	focal	focal	ADJ
ecj-11314	36	95	supratentorial	supratentorial	ADJ
ecj-11314	36	96	syndrome	syndrome	NOUN
ecj-11314	36	97	,	,	PUNCT
ecj-11314	36	98	focal	focal	ADJ
ecj-11314	36	99	brainstem	brainstem	NOUN
ecj-11314	36	100	or	or	CCONJ
ecj-11314	36	101	cerebellar	cerebellar	ADJ
ecj-11314	36	102	syndrome	syndrome	NOUN
ecj-11314	36	103	,	,	PUNCT
ecj-11314	36	104	myelopathy	myelopathy	ADJ
ecj-11314	36	105	,	,	PUNCT
ecj-11314	36	106	encephalopathy	encephalopathy	ADJ
ecj-11314	36	107	,	,	PUNCT
ecj-11314	36	108	headache	headache	NOUN
ecj-11314	36	109	,	,	PUNCT
ecj-11314	36	110	altered	alter	VERB
ecj-11314	36	111	consciousness	consciousness	NOUN
ecj-11314	36	112	,	,	PUNCT
ecj-11314	36	113	meningismus	meningismus	PROPN
ecj-11314	36	114	,	,	PUNCT
ecj-11314	36	115	or	or	CCONJ
ecj-11314	36	116	isolated	isolate	VERB
ecj-11314	36	117	fatigue.14	fatigue.14	NOUN
ecj-11314	36	118	ten	ten	NUM
ecj-11314	36	119	patients	patient	NOUN
ecj-11314	36	120	were	be	AUX
ecj-11314	36	121	excluded	exclude	VERB
ecj-11314	36	122	for	for	ADP
ecj-11314	36	123	lack	lack	NOUN
ecj-11314	36	124	of	of	ADP
ecj-11314	36	125	data	datum	NOUN
ecj-11314	36	126	,	,	PUNCT
ecj-11314	36	127	20	20	NUM
ecj-11314	36	128	due	due	ADP
ecj-11314	36	129	to	to	ADP
ecj-11314	36	130	steroid	steroid	NOUN
ecj-11314	36	131	use	use	NOUN
ecj-11314	36	132	within	within	ADP
ecj-11314	36	133	30	30	NUM
ecj-11314	36	134	days	day	NOUN
ecj-11314	36	135	or	or	CCONJ
ecj-11314	36	136	recent	recent	ADJ
ecj-11314	36	137	infection	infection	NOUN
ecj-11314	36	138	(	(	PUNCT
ecj-11314	36	139	≤1	≤1	ADJ
ecj-11314	36	140	month	month	NOUN
ecj-11314	36	141	)	)	PUNCT
ecj-11314	36	142	,	,	PUNCT
ecj-11314	36	143	and	and	CCONJ
ecj-11314	36	144	28	28	NUM
ecj-11314	36	145	for	for	ADP
ecj-11314	36	146	other	other	ADJ
ecj-11314	36	147	reasons	reason	NOUN
ecj-11314	36	148	(	(	PUNCT
ecj-11314	36	149	stressful	stressful	ADJ
ecj-11314	36	150	co	co	ADJ
ecj-11314	36	151	-	-	ADJ
ecj-11314	36	152	occurring	occurring	ADJ
ecj-11314	36	153	events	event	NOUN
ecj-11314	36	154	in	in	ADP
ecj-11314	36	155	the	the	DET
ecj-11314	36	156	past	past	ADJ
ecj-11314	36	157	six	six	NUM
ecj-11314	36	158	months	month	NOUN
ecj-11314	36	159	(	(	PUNCT
ecj-11314	36	160	e.g.	e.g.	ADV
ecj-11314	36	161	,	,	PUNCT
ecj-11314	36	162	traumatic	traumatic	ADJ
ecj-11314	36	163	bone	bone	NOUN
ecj-11314	36	164	fractures	fracture	NOUN
ecj-11314	36	165	)	)	PUNCT
ecj-11314	36	166	,	,	PUNCT
ecj-11314	36	167	tumor	tumor	NOUN
ecj-11314	36	168	history	history	NOUN
ecj-11314	36	169	,	,	PUNCT
ecj-11314	36	170	pregnancy	pregnancy	NOUN
ecj-11314	36	171	,	,	PUNCT
ecj-11314	36	172	autoimmune	autoimmune	ADJ
ecj-11314	36	173	comorbidities	comorbiditie	NOUN
ecj-11314	36	174	(	(	PUNCT
ecj-11314	36	175	rheumatoid	rheumatoid	NOUN
ecj-11314	36	176	arthritis	arthritis	NOUN
ecj-11314	36	177	,	,	PUNCT
ecj-11314	36	178	psoriasis	psoriasis	NOUN
ecj-11314	36	179	,	,	PUNCT
ecj-11314	36	180	sjögren	sjögren	PROPN
ecj-11314	36	181	’s	’s	PART
ecj-11314	36	182	syndrome	syndrome	NOUN
ecj-11314	36	183	,	,	PUNCT
ecj-11314	36	184	etc	etc	X
ecj-11314	36	185	.	.	X
ecj-11314	36	186	;	;	PUNCT
ecj-11314	36	187	figure	figure	NOUN
ecj-11314	36	188	1	1	NUM
ecj-11314	36	189	)	)	PUNCT
ecj-11314	36	190	.	.	PUNCT
ecj-11314	37	1	study	study	NOUN
ecj-11314	37	2	design	design	NOUN
ecj-11314	37	3	and	and	CCONJ
ecj-11314	37	4	settings	setting	NOUN
ecj-11314	37	5	this	this	DET
ecj-11314	37	6	study	study	NOUN
ecj-11314	37	7	was	be	AUX
ecj-11314	37	8	conducted	conduct	VERB
ecj-11314	37	9	according	accord	VERB
ecj-11314	37	10	to	to	ADP
ecj-11314	37	11	a	a	DET
ecj-11314	37	12	retrospective	retrospective	ADJ
ecj-11314	37	13	observational	observational	ADJ
ecj-11314	37	14	study	study	NOUN
ecj-11314	37	15	design	design	NOUN
ecj-11314	37	16	.	.	PUNCT
ecj-11314	38	1	the	the	DET
ecj-11314	38	2	study	study	NOUN
ecj-11314	38	3	was	be	AUX
ecj-11314	38	4	performed	perform	VERB
ecj-11314	38	5	retrospectively	retrospectively	ADV
ecj-11314	38	6	after	after	ADP
ecj-11314	38	7	approval	approval	NOUN
ecj-11314	38	8	by	by	ADP
ecj-11314	38	9	the	the	DET
ecj-11314	38	10	ethics	ethic	NOUN
ecj-11314	38	11	committee	committee	PROPN
ecj-11314	38	12	of	of	ADP
ecj-11314	38	13	the	the	DET
ecj-11314	38	14	istanbul	istanbul	PROPN
ecj-11314	38	15	prof	prof	PROPN
ecj-11314	38	16	dr	dr	PROPN
ecj-11314	38	17	.	.	PROPN
ecj-11314	38	18	cemil	cemil	PROPN
ecj-11314	38	19	tascioglu	tascioglu	PROPN
ecj-11314	38	20	city	city	NOUN
ecj-11314	38	21	hospital	hospital	NOUN
ecj-11314	38	22	(	(	PUNCT
ecj-11314	38	23	protocol	protocol	PROPN
ecj-11314	38	24	code	code	NOUN
ecj-11314	38	25	:	:	PUNCT
ecj-11314	38	26	240	240	NUM
ecj-11314	38	27	,	,	PUNCT
ecj-11314	38	28	decision	decision	NOUN
ecj-11314	38	29	number	number	NOUN
ecj-11314	38	30	:	:	PUNCT
ecj-11314	38	31	240	240	NUM
ecj-11314	38	32	,	,	PUNCT
ecj-11314	38	33	issue	issue	NOUN
ecj-11314	38	34	:	:	PUNCT
ecj-11314	38	35	e-48670771	e-48670771	PROPN
ecj-11314	38	36	-	-	PUNCT
ecj-11314	38	37	020	020	NUM
ecj-11314	38	38	date	date	NOUN
ecj-11314	38	39	:	:	PUNCT
ecj-11314	38	40	08	08	NUM
ecj-11314	38	41	august	august	PROPN
ecj-11314	38	42	2022	2022	NUM
ecj-11314	38	43	)	)	PUNCT
ecj-11314	38	44	.	.	PUNCT
ecj-11314	39	1	the	the	DET
ecj-11314	39	2	present	present	ADJ
ecj-11314	39	3	study	study	NOUN
ecj-11314	39	4	was	be	AUX
ecj-11314	39	5	conducted	conduct	VERB
ecj-11314	39	6	in	in	ADP
ecj-11314	39	7	line	line	NOUN
ecj-11314	39	8	with	with	ADP
ecj-11314	39	9	the	the	DET
ecj-11314	39	10	declaration	declaration	NOUN
ecj-11314	39	11	of	of	ADP
ecj-11314	39	12	helsinki	helsinki	PROPN
ecj-11314	39	13	.	.	PUNCT
ecj-11314	40	1	study	study	NOUN
ecj-11314	40	2	protocol	protocol	VERB
ecj-11314	40	3	the	the	DET
ecj-11314	40	4	laboratory	laboratory	NOUN
ecj-11314	40	5	parameters	parameter	NOUN
ecj-11314	40	6	of	of	ADP
ecj-11314	40	7	these	these	DET
ecj-11314	40	8	patients	patient	NOUN
ecj-11314	40	9	were	be	AUX
ecj-11314	40	10	compared	compare	VERB
ecj-11314	40	11	in	in	ADP
ecj-11314	40	12	the	the	DET
ecj-11314	40	13	emergency	emergency	NOUN
ecj-11314	40	14	service	service	NOUN
ecj-11314	40	15	admissions	admission	NOUN
ecj-11314	40	16	during	during	ADP
ecj-11314	40	17	the	the	DET
ecj-11314	40	18	attack	attack	NOUN
ecj-11314	40	19	and	and	CCONJ
ecj-11314	40	20	non	non	ADJ
ecj-11314	40	21	-	-	ADJ
ecj-11314	40	22	attack	attack	ADJ
ecj-11314	40	23	periods	period	NOUN
ecj-11314	40	24	.	.	PUNCT
ecj-11314	41	1	a	a	DET
ecj-11314	41	2	neurologist	neurologist	NOUN
ecj-11314	41	3	evaluated	evaluate	VERB
ecj-11314	41	4	the	the	DET
ecj-11314	41	5	ms	ms	PROPN
ecj-11314	41	6	attack	attack	NOUN
ecj-11314	41	7	status	status	NOUN
ecj-11314	41	8	.	.	PUNCT
ecj-11314	42	1	after	after	ADP
ecj-11314	42	2	the	the	DET
ecj-11314	42	3	evaluation	evaluation	NOUN
ecj-11314	42	4	,	,	PUNCT
ecj-11314	42	5	patients	patient	NOUN
ecj-11314	42	6	with	with	ADP
ecj-11314	42	7	ms	ms	NOUN
ecj-11314	42	8	attacks	attack	NOUN
ecj-11314	42	9	were	be	AUX
ecj-11314	42	10	included	include	VERB
ecj-11314	42	11	in	in	ADP
ecj-11314	42	12	the	the	DET
ecj-11314	42	13	study	study	NOUN
ecj-11314	42	14	consecutively	consecutively	ADV
ecj-11314	42	15	(	(	PUNCT
ecj-11314	42	16	attack	attack	NOUN
ecj-11314	42	17	period	period	NOUN
ecj-11314	42	18	)	)	PUNCT
ecj-11314	42	19	.	.	PUNCT
ecj-11314	43	1	the	the	DET
ecj-11314	43	2	same	same	ADJ
ecj-11314	43	3	patients	patient	NOUN
ecj-11314	43	4	were	be	AUX
ecj-11314	43	5	compared	compare	VERB
ecj-11314	43	6	to	to	ADP
ecj-11314	43	7	the	the	DET
ecj-11314	43	8	emergency	emergency	NOUN
ecj-11314	43	9	service	service	NOUN
ecj-11314	43	10	applications	application	NOUN
ecj-11314	43	11	in	in	ADP
ecj-11314	43	12	the	the	DET
ecj-11314	43	13	attack	attack	NOUN
ecj-11314	43	14	-	-	PUNCT
ecj-11314	43	15	free	free	ADJ
ecj-11314	43	16	period	period	NOUN
ecj-11314	43	17	(	(	PUNCT
ecj-11314	43	18	non	non	ADJ
ecj-11314	43	19	-	-	ADJ
ecj-11314	43	20	attack	attack	ADJ
ecj-11314	43	21	period	period	NOUN
ecj-11314	43	22	)	)	PUNCT
ecj-11314	43	23	.	.	PUNCT
ecj-11314	44	1	two	two	NUM
ecj-11314	44	2	independent	independent	ADJ
ecj-11314	44	3	observers	observer	NOUN
ecj-11314	44	4	reviewed	review	VERB
ecj-11314	44	5	the	the	DET
ecj-11314	44	6	data	datum	NOUN
ecj-11314	44	7	,	,	PUNCT
ecj-11314	44	8	and	and	CCONJ
ecj-11314	44	9	patients	patient	NOUN
ecj-11314	44	10	were	be	AUX
ecj-11314	44	11	selected	select	VERB
ecj-11314	44	12	based	base	VERB
ecj-11314	44	13	on	on	ADP
ecj-11314	44	14	eligibility	eligibility	NOUN
ecj-11314	44	15	criteria	criterion	NOUN
ecj-11314	44	16	.	.	PUNCT
ecj-11314	45	1	laboratory	laboratory	NOUN
ecj-11314	45	2	tests	test	NOUN
ecj-11314	45	3	of	of	ADP
ecj-11314	45	4	patients	patient	NOUN
ecj-11314	45	5	with	with	ADP
ecj-11314	45	6	and	and	CCONJ
ecj-11314	45	7	without	without	ADP
ecj-11314	45	8	attacks	attack	NOUN
ecj-11314	45	9	were	be	AUX
ecj-11314	45	10	evaluated	evaluate	VERB
ecj-11314	45	11	within	within	ADP
ecj-11314	45	12	60	60	NUM
ecj-11314	45	13	minutes	minute	NOUN
ecj-11314	45	14	after	after	ADP
ecj-11314	45	15	admission	admission	NOUN
ecj-11314	45	16	to	to	ADP
ecj-11314	45	17	the	the	DET
ecj-11314	45	18	ed	ed	NOUN
ecj-11314	45	19	.	.	PUNCT
ecj-11314	46	1	hematological	hematological	ADJ
ecj-11314	46	2	and	and	CCONJ
ecj-11314	46	3	biochemical	biochemical	ADJ
ecj-11314	46	4	tests	test	NOUN
ecj-11314	46	5	taken	take	VERB
ecj-11314	46	6	from	from	ADP
ecj-11314	46	7	the	the	DET
ecj-11314	46	8	patients	patient	NOUN
ecj-11314	46	9	were	be	AUX
ecj-11314	46	10	recorded	record	VERB
ecj-11314	46	11	.	.	PUNCT
ecj-11314	47	1	nlr	nlr	PROPN
ecj-11314	47	2	,	,	PUNCT
ecj-11314	47	3	mlr	mlr	PROPN
ecj-11314	47	4	,	,	PUNCT
ecj-11314	47	5	rlr	rlr	PROPN
ecj-11314	47	6	,	,	PUNCT
ecj-11314	47	7	and	and	CCONJ
ecj-11314	47	8	sii	sii	ADJ
ecj-11314	47	9	ratios	ratio	NOUN
ecj-11314	47	10	were	be	AUX
ecj-11314	47	11	calculated	calculate	VERB
ecj-11314	47	12	individually	individually	ADV
ecj-11314	47	13	.	.	PUNCT
ecj-11314	48	1	sii	sii	PROPN
ecj-11314	48	2	is	be	AUX
ecj-11314	48	3	computed	compute	VERB
ecj-11314	48	4	by	by	ADP
ecj-11314	48	5	multiplying	multiply	VERB
ecj-11314	48	6	platelet	platelet	NOUN
ecj-11314	48	7	count	count	NOUN
ecj-11314	48	8	by	by	ADP
ecj-11314	48	9	nlr.15	nlr.15	NOUN
ecj-11314	48	10	article	article	NOUN
ecj-11314	48	11	[	[	X
ecj-11314	48	12	page	page	NOUN
ecj-11314	48	13	38	38	NUM
ecj-11314	48	14	]	]	PUNCT
ecj-11314	49	1	[	[	X
ecj-11314	49	2	emergency	emergency	NOUN
ecj-11314	49	3	care	care	NOUN
ecj-11314	49	4	journal	journal	PROPN
ecj-11314	49	5	2023	2023	NUM
ecj-11314	49	6	;	;	PUNCT
ecj-11314	49	7	19:11314	19:11314	NUM
ecj-11314	49	8	]	]	PUNCT
ecj-11314	49	9	figure	figure	NOUN
ecj-11314	49	10	1	1	NUM
ecj-11314	49	11	.	.	PUNCT
ecj-11314	49	12	patients	patient	NOUN
ecj-11314	49	13	’	'	PUNCT
ecj-11314	49	14	selection	selection	NOUN
ecj-11314	49	15	flow	flow	NOUN
ecj-11314	49	16	chart	chart	NOUN
ecj-11314	49	17	.	.	PUNCT
ecj-11314	50	1	ms	ms	NOUN
ecj-11314	50	2	,	,	PUNCT
ecj-11314	50	3	multiple	multiple	ADJ
ecj-11314	50	4	sclerosis	sclerosis	NOUN
ecj-11314	50	5	.	.	PUNCT
ecj-11314	51	1	non	non	ADJ
ecj-11314	52	1	-co	-co	PROPN
ecj-11314	52	2	mmerc	mmerc	PROPN
ecj-11314	52	3	ial	ial	PROPN
ecj-11314	52	4	us	us	PROPN
ecj-11314	52	5	e	e	NOUN
ecj-11314	52	6	o	o	NOUN
ecj-11314	52	7	nly	nly	ADV
ecj-11314	52	8	power	power	VERB
ecj-11314	52	9	analysis	analysis	NOUN
ecj-11314	52	10	according	accord	VERB
ecj-11314	52	11	to	to	ADP
ecj-11314	52	12	the	the	DET
ecj-11314	52	13	quasi	quasi	ADJ
ecj-11314	52	14	-	-	ADJ
ecj-11314	52	15	experimental	experimental	ADJ
ecj-11314	52	16	research	research	NOUN
ecj-11314	52	17	design	design	NOUN
ecj-11314	52	18	to	to	PART
ecj-11314	52	19	determine	determine	VERB
ecj-11314	52	20	the	the	DET
ecj-11314	52	21	difference	difference	NOUN
ecj-11314	52	22	in	in	ADP
ecj-11314	52	23	the	the	DET
ecj-11314	52	24	mean	mean	ADJ
ecj-11314	52	25	measurement	measurement	NOUN
ecj-11314	52	26	values	value	NOUN
ecj-11314	52	27	of	of	ADP
ecj-11314	52	28	rlr	rlr	PROPN
ecj-11314	52	29	,	,	PUNCT
ecj-11314	52	30	nlr	nlr	PROPN
ecj-11314	52	31	,	,	PUNCT
ecj-11314	52	32	mlr	mlr	NOUN
ecj-11314	52	33	,	,	PUNCT
ecj-11314	52	34	and	and	CCONJ
ecj-11314	52	35	sii	sii	ADV
ecj-11314	52	36	in	in	ADP
ecj-11314	52	37	patients	patient	NOUN
ecj-11314	52	38	with	with	ADP
ecj-11314	52	39	rrms	rrm	NOUN
ecj-11314	52	40	who	who	PRON
ecj-11314	52	41	came	come	VERB
ecj-11314	52	42	to	to	ADP
ecj-11314	52	43	the	the	DET
ecj-11314	52	44	emergency	emergency	NOUN
ecj-11314	52	45	department	department	NOUN
ecj-11314	52	46	during	during	ADP
ecj-11314	52	47	the	the	DET
ecj-11314	52	48	attack	attack	NOUN
ecj-11314	52	49	and	and	CCONJ
ecj-11314	52	50	non	non	ADJ
ecj-11314	52	51	-	-	ADJ
ecj-11314	52	52	attack	attack	ADJ
ecj-11314	52	53	periods	period	NOUN
ecj-11314	52	54	;	;	PUNCT
ecj-11314	52	55	the	the	DET
ecj-11314	52	56	number	number	NOUN
ecj-11314	52	57	of	of	ADP
ecj-11314	52	58	patients	patient	NOUN
ecj-11314	52	59	to	to	PART
ecj-11314	52	60	be	be	AUX
ecj-11314	52	61	included	include	VERB
ecj-11314	52	62	in	in	ADP
ecj-11314	52	63	the	the	DET
ecj-11314	52	64	study	study	NOUN
ecj-11314	52	65	was	be	AUX
ecj-11314	52	66	determined	determine	VERB
ecj-11314	52	67	as	as	ADP
ecj-11314	52	68	165	165	NUM
ecj-11314	52	69	,	,	PUNCT
ecj-11314	52	70	with	with	ADP
ecj-11314	52	71	an	an	DET
ecj-11314	52	72	effect	effect	NOUN
ecj-11314	52	73	size	size	NOUN
ecj-11314	52	74	of	of	ADP
ecj-11314	52	75	0.2	0.2	NUM
ecj-11314	52	76	(	(	PUNCT
ecj-11314	52	77	minimum	minimum	ADJ
ecj-11314	52	78	accepted	accept	VERB
ecj-11314	52	79	clinical	clinical	ADJ
ecj-11314	52	80	significance	significance	NOUN
ecj-11314	52	81	)	)	PUNCT
ecj-11314	52	82	,	,	PUNCT
ecj-11314	52	83	a	a	DET
ecj-11314	52	84	maximum	maximum	ADJ
ecj-11314	52	85	type	type	NOUN
ecj-11314	52	86	1	1	NUM
ecj-11314	52	87	error	error	NOUN
ecj-11314	52	88	of	of	ADP
ecj-11314	52	89	5	5	NUM
ecj-11314	52	90	%	%	NOUN
ecj-11314	52	91	,	,	PUNCT
ecj-11314	52	92	and	and	CCONJ
ecj-11314	52	93	a	a	DET
ecj-11314	52	94	minimum	minimum	ADJ
ecj-11314	52	95	power	power	NOUN
ecj-11314	52	96	of	of	ADP
ecj-11314	52	97	80	80	NUM
ecj-11314	52	98	%	%	NOUN
ecj-11314	52	99	.	.	PUNCT
ecj-11314	53	1	statistical	statistical	ADJ
ecj-11314	53	2	analysis	analysis	NOUN
ecj-11314	53	3	according	accord	VERB
ecj-11314	53	4	to	to	ADP
ecj-11314	53	5	the	the	DET
ecj-11314	53	6	central	central	ADJ
ecj-11314	53	7	limit	limit	NOUN
ecj-11314	53	8	theorem	theorem	VERB
ecj-11314	53	9	,	,	PUNCT
ecj-11314	53	10	continuous	continuous	ADJ
ecj-11314	53	11	measurements	measurement	NOUN
ecj-11314	53	12	(	(	PUNCT
ecj-11314	53	13	such	such	ADJ
ecj-11314	53	14	as	as	ADP
ecj-11314	53	15	hematological	hematological	ADJ
ecj-11314	53	16	data	datum	NOUN
ecj-11314	53	17	)	)	PUNCT
ecj-11314	53	18	should	should	AUX
ecj-11314	53	19	test	test	VERB
ecj-11314	53	20	whether	whether	SCONJ
ecj-11314	53	21	the	the	DET
ecj-11314	53	22	means	mean	NOUN
ecj-11314	53	23	are	be	AUX
ecj-11314	53	24	normally	normally	ADV
ecj-11314	53	25	distributed	distribute	VERB
ecj-11314	53	26	,	,	PUNCT
ecj-11314	53	27	not	not	PART
ecj-11314	53	28	the	the	DET
ecj-11314	53	29	data.16	data.16	NOUN
ecj-11314	53	30	this	this	DET
ecj-11314	53	31	study	study	NOUN
ecj-11314	53	32	’s	’s	PART
ecj-11314	53	33	standard	standard	ADJ
ecj-11314	53	34	deviations	deviation	NOUN
ecj-11314	53	35	were	be	AUX
ecj-11314	53	36	not	not	PART
ecj-11314	53	37	higher	high	ADJ
ecj-11314	53	38	than	than	ADP
ecj-11314	53	39	the	the	DET
ecj-11314	53	40	mean	mean	NOUN
ecj-11314	53	41	for	for	ADP
ecj-11314	53	42	continuous	continuous	ADJ
ecj-11314	53	43	measurements	measurement	NOUN
ecj-11314	53	44	.	.	PUNCT
ecj-11314	54	1	therefore	therefore	ADV
ecj-11314	54	2	,	,	PUNCT
ecj-11314	54	3	this	this	DET
ecj-11314	54	4	theory	theory	NOUN
ecj-11314	54	5	was	be	AUX
ecj-11314	54	6	found	find	VERB
ecj-11314	54	7	suitable	suitable	ADJ
ecj-11314	54	8	,	,	PUNCT
ecj-11314	54	9	and	and	CCONJ
ecj-11314	54	10	parametric	parametric	ADJ
ecj-11314	54	11	tests	test	NOUN
ecj-11314	54	12	were	be	AUX
ecj-11314	54	13	used	use	VERB
ecj-11314	54	14	.	.	PUNCT
ecj-11314	55	1	the	the	DET
ecj-11314	55	2	minimum	minimum	ADJ
ecj-11314	55	3	and	and	CCONJ
ecj-11314	55	4	maximum	maximum	ADJ
ecj-11314	55	5	values	value	NOUN
ecj-11314	55	6	of	of	ADP
ecj-11314	55	7	the	the	DET
ecj-11314	55	8	variables	variable	NOUN
ecj-11314	55	9	,	,	PUNCT
ecj-11314	55	10	as	as	ADV
ecj-11314	55	11	well	well	ADV
ecj-11314	55	12	as	as	ADP
ecj-11314	55	13	the	the	DET
ecj-11314	55	14	mean	mean	ADJ
ecj-11314	55	15	and	and	CCONJ
ecj-11314	55	16	standard	standard	ADJ
ecj-11314	55	17	deviation	deviation	NOUN
ecj-11314	55	18	,	,	PUNCT
ecj-11314	55	19	were	be	AUX
ecj-11314	55	20	used	use	VERB
ecj-11314	55	21	in	in	ADP
ecj-11314	55	22	the	the	DET
ecj-11314	55	23	data	data	NOUN
ecj-11314	55	24	analysis	analysis	NOUN
ecj-11314	55	25	to	to	PART
ecj-11314	55	26	perform	perform	VERB
ecj-11314	55	27	the	the	DET
ecj-11314	55	28	statistics	statistic	NOUN
ecj-11314	55	29	on	on	ADP
ecj-11314	55	30	the	the	DET
ecj-11314	55	31	continuous	continuous	ADJ
ecj-11314	55	32	data	datum	NOUN
ecj-11314	55	33	.	.	PUNCT
ecj-11314	56	1	frequency	frequency	NOUN
ecj-11314	56	2	and	and	CCONJ
ecj-11314	56	3	percentage	percentage	NOUN
ecj-11314	56	4	values	value	NOUN
ecj-11314	56	5	were	be	AUX
ecj-11314	56	6	used	use	VERB
ecj-11314	56	7	to	to	PART
ecj-11314	56	8	identify	identify	VERB
ecj-11314	56	9	the	the	DET
ecj-11314	56	10	categorical	categorical	ADJ
ecj-11314	56	11	data	datum	NOUN
ecj-11314	56	12	.	.	PUNCT
ecj-11314	57	1	the	the	DET
ecj-11314	57	2	mean	mean	NOUN
ecj-11314	57	3	of	of	ADP
ecj-11314	57	4	inflammatory	inflammatory	ADJ
ecj-11314	57	5	biomarker	biomarker	NOUN
ecj-11314	57	6	measurements	measurement	NOUN
ecj-11314	57	7	between	between	ADP
ecj-11314	57	8	attack	attack	NOUN
ecj-11314	57	9	and	and	CCONJ
ecj-11314	57	10	non	non	ADJ
ecj-11314	57	11	-	-	ADJ
ecj-11314	57	12	attack	attack	ADJ
ecj-11314	57	13	groups	group	NOUN
ecj-11314	57	14	were	be	AUX
ecj-11314	57	15	compared	compare	VERB
ecj-11314	57	16	using	use	VERB
ecj-11314	57	17	the	the	DET
ecj-11314	57	18	paired	pair	VERB
ecj-11314	57	19	t	t	NOUN
ecj-11314	57	20	-	-	PUNCT
ecj-11314	57	21	test	test	NOUN
ecj-11314	57	22	statistic	statistic	NOUN
ecj-11314	57	23	.	.	PUNCT
ecj-11314	58	1	the	the	DET
ecj-11314	58	2	receiver	receiver	NOUN
ecj-11314	58	3	operating	operate	VERB
ecj-11314	58	4	characteristic	characteristic	NOUN
ecj-11314	58	5	(	(	PUNCT
ecj-11314	58	6	roc	roc	PROPN
ecj-11314	58	7	)	)	PUNCT
ecj-11314	58	8	analysis	analysis	NOUN
ecj-11314	58	9	was	be	AUX
ecj-11314	58	10	used	use	VERB
ecj-11314	58	11	to	to	PART
ecj-11314	58	12	ascertain	ascertain	VERB
ecj-11314	58	13	the	the	DET
ecj-11314	58	14	cut	cut	VERB
ecj-11314	58	15	-	-	PUNCT
ecj-11314	58	16	off	off	ADP
ecj-11314	58	17	point	point	NOUN
ecj-11314	58	18	in	in	ADP
ecj-11314	58	19	diagnostic	diagnostic	ADJ
ecj-11314	58	20	value	value	NOUN
ecj-11314	58	21	measurements	measurement	NOUN
ecj-11314	58	22	.	.	PUNCT
ecj-11314	59	1	sensitivity	sensitivity	NOUN
ecj-11314	59	2	,	,	PUNCT
ecj-11314	59	3	specificity	specificity	NOUN
ecj-11314	59	4	,	,	PUNCT
ecj-11314	59	5	positive	positive	ADJ
ecj-11314	59	6	predictive	predictive	ADJ
ecj-11314	59	7	value	value	NOUN
ecj-11314	59	8	(	(	PUNCT
ecj-11314	59	9	ppv	ppv	NOUN
ecj-11314	59	10	)	)	PUNCT
ecj-11314	59	11	,	,	PUNCT
ecj-11314	59	12	and	and	CCONJ
ecj-11314	59	13	negative	negative	ADJ
ecj-11314	59	14	predictive	predictive	ADJ
ecj-11314	59	15	value	value	NOUN
ecj-11314	59	16	(	(	PUNCT
ecj-11314	59	17	npv	npv	NOUN
ecj-11314	59	18	)	)	PUNCT
ecj-11314	59	19	statistics	statistic	NOUN
ecj-11314	59	20	were	be	AUX
ecj-11314	59	21	used	use	VERB
ecj-11314	59	22	to	to	PART
ecj-11314	59	23	identify	identify	VERB
ecj-11314	59	24	statistical	statistical	ADJ
ecj-11314	59	25	significance	significance	NOUN
ecj-11314	59	26	.	.	PUNCT
ecj-11314	60	1	auc	auc	NOUN
ecj-11314	60	2	values	value	NOUN
ecj-11314	60	3	between	between	ADP
ecj-11314	60	4	0.5	0.5	NUM
ecj-11314	60	5	and	and	CCONJ
ecj-11314	60	6	0.6	0.6	NUM
ecj-11314	60	7	were	be	AUX
ecj-11314	60	8	evaluated	evaluate	VERB
ecj-11314	60	9	as	as	ADP
ecj-11314	60	10	poor	poor	ADJ
ecj-11314	60	11	,	,	PUNCT
ecj-11314	60	12	between	between	ADP
ecj-11314	60	13	0.6	0.6	NUM
ecj-11314	60	14	and	and	CCONJ
ecj-11314	60	15	0.7	0.7	NUM
ecj-11314	60	16	as	as	ADV
ecj-11314	60	17	fair	fair	ADJ
ecj-11314	60	18	,	,	PUNCT
ecj-11314	60	19	between	between	ADP
ecj-11314	60	20	0.7	0.7	NUM
ecj-11314	60	21	and	and	CCONJ
ecj-11314	60	22	0.8	0.8	NUM
ecj-11314	60	23	as	as	ADP
ecj-11314	60	24	acceptable	acceptable	ADJ
ecj-11314	60	25	,	,	PUNCT
ecj-11314	60	26	between	between	ADP
ecj-11314	60	27	0.8	0.8	NUM
ecj-11314	60	28	and	and	CCONJ
ecj-11314	60	29	0.9	0.9	NUM
ecj-11314	60	30	as	as	ADP
ecj-11314	60	31	excellent	excellent	ADJ
ecj-11314	60	32	,	,	PUNCT
ecj-11314	60	33	and	and	CCONJ
ecj-11314	60	34	above	above	ADP
ecj-11314	60	35	0.9	0.9	NUM
ecj-11314	60	36	as	as	ADP
ecj-11314	60	37	outstanding	outstanding	ADJ
ecj-11314	60	38	.	.	PUNCT
ecj-11314	61	1	the	the	DET
ecj-11314	61	2	level	level	NOUN
ecj-11314	61	3	of	of	ADP
ecj-11314	61	4	statistical	statistical	ADJ
ecj-11314	61	5	significance	significance	NOUN
ecj-11314	61	6	of	of	ADP
ecj-11314	61	7	the	the	DET
ecj-11314	61	8	data	datum	NOUN
ecj-11314	61	9	is	be	AUX
ecj-11314	61	10	considered	consider	VERB
ecj-11314	61	11	p<0.05	p<0.05	NOUN
ecj-11314	61	12	.	.	PUNCT
ecj-11314	62	1	data	datum	NOUN
ecj-11314	62	2	evaluation	evaluation	NOUN
ecj-11314	62	3	and	and	CCONJ
ecj-11314	62	4	study	study	NOUN
ecj-11314	62	5	power	power	NOUN
ecj-11314	62	6	analysis	analysis	NOUN
ecj-11314	62	7	were	be	AUX
ecj-11314	62	8	performed	perform	VERB
ecj-11314	62	9	using	use	VERB
ecj-11314	62	10	the	the	DET
ecj-11314	62	11	www.e-picos.com	www.e-picos.com	PROPN
ecj-11314	62	12	new	new	PROPN
ecj-11314	62	13	york	york	PROPN
ecj-11314	62	14	software	software	NOUN
ecj-11314	62	15	and	and	CCONJ
ecj-11314	62	16	the	the	DET
ecj-11314	62	17	medcalc	medcalc	ADJ
ecj-11314	62	18	statistical	statistical	ADJ
ecj-11314	62	19	package	package	NOUN
ecj-11314	62	20	program	program	NOUN
ecj-11314	62	21	.	.	PUNCT
ecj-11314	63	1	results	result	VERB
ecj-11314	63	2	a	a	DET
ecj-11314	63	3	total	total	NOUN
ecj-11314	63	4	of	of	ADP
ecj-11314	63	5	165	165	NUM
ecj-11314	63	6	patients	patient	NOUN
ecj-11314	63	7	,	,	PUNCT
ecj-11314	63	8	106	106	NUM
ecj-11314	63	9	female	female	ADJ
ecj-11314	63	10	(	(	PUNCT
ecj-11314	63	11	64.2	64.2	NUM
ecj-11314	63	12	%	%	NOUN
ecj-11314	63	13	)	)	PUNCT
ecj-11314	63	14	,	,	PUNCT
ecj-11314	63	15	were	be	AUX
ecj-11314	63	16	included	include	VERB
ecj-11314	63	17	in	in	ADP
ecj-11314	63	18	our	our	PRON
ecj-11314	63	19	study	study	NOUN
ecj-11314	63	20	.	.	PUNCT
ecj-11314	64	1	the	the	DET
ecj-11314	64	2	mean	mean	ADJ
ecj-11314	64	3	age	age	NOUN
ecj-11314	64	4	of	of	ADP
ecj-11314	64	5	the	the	DET
ecj-11314	64	6	patients	patient	NOUN
ecj-11314	64	7	was	be	AUX
ecj-11314	64	8	39.3±11.7	39.3±11.7	NUM
ecj-11314	64	9	years	year	NOUN
ecj-11314	64	10	(	(	PUNCT
ecj-11314	64	11	tables	table	NOUN
ecj-11314	64	12	1	1	NUM
ecj-11314	64	13	,	,	PUNCT
ecj-11314	64	14	2	2	NUM
ecj-11314	64	15	)	)	PUNCT
ecj-11314	64	16	.	.	PUNCT
ecj-11314	65	1	the	the	DET
ecj-11314	65	2	mean	mean	NOUN
ecj-11314	65	3	of	of	ADP
ecj-11314	65	4	nlr	nlr	PROPN
ecj-11314	65	5	was	be	AUX
ecj-11314	65	6	8.22±7.35	8.22±7.35	NOUN
ecj-11314	65	7	in	in	ADP
ecj-11314	65	8	patients	patient	NOUN
ecj-11314	65	9	with	with	ADP
ecj-11314	65	10	ms	ms	NOUN
ecj-11314	65	11	attack	attack	NOUN
ecj-11314	65	12	,	,	PUNCT
ecj-11314	65	13	and	and	CCONJ
ecj-11314	65	14	the	the	DET
ecj-11314	65	15	mean	mean	NOUN
ecj-11314	65	16	of	of	ADP
ecj-11314	65	17	nlr	nlr	PROPN
ecj-11314	65	18	of	of	ADP
ecj-11314	65	19	patients	patient	NOUN
ecj-11314	65	20	in	in	ADP
ecj-11314	65	21	the	the	DET
ecj-11314	65	22	non	non	ADJ
ecj-11314	65	23	-	-	ADJ
ecj-11314	65	24	attack	attack	ADJ
ecj-11314	65	25	period	period	NOUN
ecj-11314	65	26	was	be	AUX
ecj-11314	65	27	2.81±1.65	2.81±1.65	PRON
ecj-11314	65	28	.	.	PUNCT
ecj-11314	66	1	the	the	DET
ecj-11314	66	2	difference	difference	NOUN
ecj-11314	66	3	between	between	ADP
ecj-11314	66	4	the	the	DET
ecj-11314	66	5	mean	mean	NOUN
ecj-11314	66	6	of	of	ADP
ecj-11314	66	7	nlr	nlr	PROPN
ecj-11314	66	8	of	of	ADP
ecj-11314	66	9	both	both	DET
ecj-11314	66	10	groups	group	NOUN
ecj-11314	66	11	was	be	AUX
ecj-11314	66	12	5.40±7.25	5.40±7.25	NUM
ecj-11314	66	13	and	and	CCONJ
ecj-11314	66	14	was	be	AUX
ecj-11314	66	15	statistically	statistically	ADV
ecj-11314	66	16	significant	significant	ADJ
ecj-11314	66	17	(	(	PUNCT
ecj-11314	66	18	p<0.001	p<0.001	ADJ
ecj-11314	66	19	;	;	PUNCT
ecj-11314	66	20	table	table	NOUN
ecj-11314	66	21	3	3	NUM
ecj-11314	66	22	,	,	PUNCT
ecj-11314	66	23	figure	figure	NOUN
ecj-11314	66	24	2	2	NUM
ecj-11314	66	25	)	)	PUNCT
ecj-11314	66	26	.	.	PUNCT
ecj-11314	67	1	the	the	DET
ecj-11314	67	2	mean	mean	NOUN
ecj-11314	67	3	of	of	ADP
ecj-11314	67	4	mlr	mlr	PROPN
ecj-11314	67	5	was	be	AUX
ecj-11314	67	6	0.67±0.43	0.67±0.43	NOUN
ecj-11314	67	7	in	in	ADP
ecj-11314	67	8	patients	patient	NOUN
ecj-11314	67	9	with	with	ADP
ecj-11314	67	10	ms	ms	NOUN
ecj-11314	67	11	attack	attack	NOUN
ecj-11314	67	12	,	,	PUNCT
ecj-11314	67	13	and	and	CCONJ
ecj-11314	67	14	the	the	DET
ecj-11314	67	15	mean	mean	NOUN
ecj-11314	67	16	of	of	ADP
ecj-11314	67	17	mlr	mlr	NOUN
ecj-11314	67	18	of	of	ADP
ecj-11314	67	19	patients	patient	NOUN
ecj-11314	67	20	in	in	ADP
ecj-11314	67	21	the	the	DET
ecj-11314	67	22	non	non	ADJ
ecj-11314	67	23	-	-	ADJ
ecj-11314	67	24	attack	attack	ADJ
ecj-11314	67	25	period	period	NOUN
ecj-11314	67	26	was	be	AUX
ecj-11314	67	27	0.30±0.17	0.30±0.17	NUM
ecj-11314	67	28	.	.	PUNCT
ecj-11314	68	1	the	the	DET
ecj-11314	68	2	difference	difference	NOUN
ecj-11314	68	3	between	between	ADP
ecj-11314	68	4	the	the	DET
ecj-11314	68	5	mean	mean	NOUN
ecj-11314	68	6	of	of	ADP
ecj-11314	68	7	mlr	mlr	NOUN
ecj-11314	68	8	of	of	ADP
ecj-11314	68	9	both	both	DET
ecj-11314	68	10	groups	group	NOUN
ecj-11314	68	11	was	be	AUX
ecj-11314	68	12	0.37±0.43	0.37±0.43	ADJ
ecj-11314	68	13	and	and	CCONJ
ecj-11314	68	14	was	be	AUX
ecj-11314	68	15	statistically	statistically	ADV
ecj-11314	68	16	significant	significant	ADJ
ecj-11314	68	17	(	(	PUNCT
ecj-11314	68	18	p<0.001	p<0.001	ADJ
ecj-11314	68	19	;	;	PUNCT
ecj-11314	68	20	table	table	NOUN
ecj-11314	68	21	3	3	NUM
ecj-11314	68	22	,	,	PUNCT
ecj-11314	68	23	figure	figure	NOUN
ecj-11314	68	24	2	2	NUM
ecj-11314	68	25	)	)	PUNCT
ecj-11314	68	26	.	.	PUNCT
ecj-11314	69	1	the	the	DET
ecj-11314	69	2	mean	mean	NOUN
ecj-11314	69	3	of	of	ADP
ecj-11314	69	4	rlr	rlr	PROPN
ecj-11314	69	5	was	be	AUX
ecj-11314	69	6	15.45±12.06	15.45±12.06	NUM
ecj-11314	69	7	article	article	NOUN
ecj-11314	69	8	[	[	X
ecj-11314	69	9	emergency	emergency	NOUN
ecj-11314	69	10	care	care	NOUN
ecj-11314	69	11	journal	journal	PROPN
ecj-11314	69	12	2023	2023	NUM
ecj-11314	69	13	;	;	PUNCT
ecj-11314	69	14	19:11314	19:11314	NUM
ecj-11314	69	15	]	]	X
ecj-11314	70	1	[	[	X
ecj-11314	70	2	page	page	NOUN
ecj-11314	70	3	39	39	NUM
ecj-11314	70	4	]	]	PUNCT
ecj-11314	70	5	table	table	NOUN
ecj-11314	70	6	1	1	NUM
ecj-11314	70	7	.	.	PUNCT
ecj-11314	70	8	distribution	distribution	NOUN
ecj-11314	70	9	of	of	ADP
ecj-11314	70	10	descriptive	descriptive	ADJ
ecj-11314	70	11	characteristics	characteristic	NOUN
ecj-11314	70	12	(	(	PUNCT
ecj-11314	70	13	n=165	n=165	NUM
ecj-11314	70	14	)	)	PUNCT
ecj-11314	70	15	.	.	PUNCT
ecj-11314	71	1	characteristics	characteristic	NOUN
ecj-11314	71	2	groups	group	NOUN
ecj-11314	71	3	count	count	VERB
ecj-11314	71	4	(	(	PUNCT
ecj-11314	71	5	n	n	CCONJ
ecj-11314	71	6	)	)	PUNCT
ecj-11314	71	7	percent	percent	NOUN
ecj-11314	71	8	(	(	PUNCT
ecj-11314	71	9	%	%	NOUN
ecj-11314	71	10	)	)	PUNCT
ecj-11314	71	11	sex	sex	NOUN
ecj-11314	71	12	female	female	NOUN
ecj-11314	71	13	106	106	NUM
ecj-11314	71	14	64.2	64.2	NUM
ecj-11314	71	15	male	male	NOUN
ecj-11314	71	16	59	59	NUM
ecj-11314	71	17	35.8	35.8	NUM
ecj-11314	71	18	table	table	NOUN
ecj-11314	71	19	2	2	NUM
ecj-11314	71	20	.	.	PUNCT
ecj-11314	72	1	evaluation	evaluation	NOUN
ecj-11314	72	2	of	of	ADP
ecj-11314	72	3	the	the	DET
ecj-11314	72	4	difference	difference	NOUN
ecj-11314	72	5	in	in	ADP
ecj-11314	72	6	biochemistry	biochemistry	NOUN
ecj-11314	72	7	and	and	CCONJ
ecj-11314	72	8	hemogram	hemogram	PROPN
ecj-11314	72	9	parameters	parameter	NOUN
ecj-11314	72	10	between	between	ADP
ecj-11314	72	11	attack	attack	NOUN
ecj-11314	72	12	and	and	CCONJ
ecj-11314	72	13	non	non	ADJ
ecj-11314	72	14	-	-	ADJ
ecj-11314	72	15	attack	attack	ADJ
ecj-11314	72	16	periods	period	NOUN
ecj-11314	72	17	(	(	PUNCT
ecj-11314	72	18	n=165	n=165	NUM
ecj-11314	72	19	)	)	PUNCT
ecj-11314	72	20	.	.	PUNCT
ecj-11314	73	1	characteristics	characteristics	PROPN
ecj-11314	73	2	min	min	PROPN
ecj-11314	73	3	-	-	ADJ
ecj-11314	73	4	max	max	ADJ
ecj-11314	73	5	median	median	PROPN
ecj-11314	73	6	mean	mean	PROPN
ecj-11314	73	7	±s.d	±s.d	PROPN
ecj-11314	73	8	age	age	NOUN
ecj-11314	73	9	19	19	NUM
ecj-11314	73	10	-	-	SYM
ecj-11314	73	11	69	69	NUM
ecj-11314	73	12	38	38	NUM
ecj-11314	73	13	39.3±11.7	39.3±11.7	NUM
ecj-11314	73	14	min	min	NOUN
ecj-11314	73	15	,	,	PUNCT
ecj-11314	73	16	minimum	minimum	NOUN
ecj-11314	73	17	;	;	PUNCT
ecj-11314	73	18	max	max	PROPN
ecj-11314	73	19	,	,	PUNCT
ecj-11314	73	20	maximum	maximum	ADJ
ecj-11314	73	21	;	;	PUNCT
ecj-11314	73	22	s.d	s.d	PROPN
ecj-11314	73	23	,	,	PUNCT
ecj-11314	73	24	standard	standard	ADJ
ecj-11314	73	25	deviation	deviation	NOUN
ecj-11314	73	26	.	.	PUNCT
ecj-11314	74	1	figure	figure	NOUN
ecj-11314	74	2	2	2	NUM
ecj-11314	74	3	.	.	PUNCT
ecj-11314	75	1	the	the	DET
ecj-11314	75	2	mean	mean	ADJ
ecj-11314	75	3	difference	difference	NOUN
ecj-11314	75	4	of	of	ADP
ecj-11314	75	5	nlr	nlr	PROPN
ecj-11314	75	6	,	,	PUNCT
ecj-11314	75	7	mlr	mlr	PROPN
ecj-11314	75	8	,	,	PUNCT
ecj-11314	75	9	rlr	rlr	PROPN
ecj-11314	75	10	and	and	CCONJ
ecj-11314	75	11	sii	sii	PROPN
ecj-11314	75	12	between	between	ADP
ecj-11314	75	13	ms	ms	NOUN
ecj-11314	75	14	attack	attack	NOUN
ecj-11314	75	15	and	and	CCONJ
ecj-11314	75	16	non	non	ADJ
ecj-11314	75	17	-	-	ADJ
ecj-11314	75	18	attack	attack	ADJ
ecj-11314	75	19	groups	group	NOUN
ecj-11314	75	20	.	.	PUNCT
ecj-11314	76	1	ci	ci	NOUN
ecj-11314	76	2	,	,	PUNCT
ecj-11314	76	3	confidence	confidence	NOUN
ecj-11314	76	4	interval	interval	NOUN
ecj-11314	76	5	;	;	PUNCT
ecj-11314	76	6	ms	ms	PROPN
ecj-11314	76	7	,	,	PUNCT
ecj-11314	76	8	multiple	multiple	ADJ
ecj-11314	76	9	sclerosis	sclerosis	NOUN
ecj-11314	76	10	;	;	PUNCT
ecj-11314	76	11	rlr	rlr	PROPN
ecj-11314	76	12	,	,	PUNCT
ecj-11314	76	13	red	red	ADJ
ecj-11314	76	14	blood	blood	NOUN
ecj-11314	76	15	cell	cell	NOUN
ecj-11314	76	16	distribution	distribution	NOUN
ecj-11314	76	17	width	width	NOUN
ecj-11314	76	18	to	to	ADP
ecj-11314	76	19	lymphocyte	lymphocyte	ADJ
ecj-11314	76	20	ratio	ratio	NOUN
ecj-11314	76	21	;	;	PUNCT
ecj-11314	76	22	mlr	mlr	NOUN
ecj-11314	76	23	,	,	PUNCT
ecj-11314	76	24	monocyte	monocyte	NOUN
ecj-11314	76	25	to	to	ADP
ecj-11314	76	26	lymphocyte	lymphocyte	ADJ
ecj-11314	76	27	ratio	ratio	NOUN
ecj-11314	76	28	;	;	PUNCT
ecj-11314	76	29	nlr	nlr	PROPN
ecj-11314	76	30	,	,	PUNCT
ecj-11314	76	31	neutrophil	neutrophil	ADJ
ecj-11314	76	32	to	to	ADP
ecj-11314	76	33	lymphocyte	lymphocyte	ADJ
ecj-11314	76	34	ratio	ratio	NOUN
ecj-11314	76	35	;	;	PUNCT
ecj-11314	76	36	sii	sii	NUM
ecj-11314	76	37	,	,	PUNCT
ecj-11314	76	38	systemic	systemic	ADJ
ecj-11314	76	39	immune	immune	ADJ
ecj-11314	76	40	inflammation	inflammation	NOUN
ecj-11314	76	41	index	index	NOUN
ecj-11314	76	42	.	.	PUNCT
ecj-11314	77	1	non	non	ADJ
ecj-11314	77	2	-co	-co	PROPN
ecj-11314	77	3	mmerc	mmerc	PROPN
ecj-11314	77	4	ial	ial	PROPN
ecj-11314	77	5	us	us	PROPN
ecj-11314	77	6	e	e	NOUN
ecj-11314	77	7	o	o	X
ecj-11314	77	8	nly	nly	ADV
ecj-11314	77	9	in	in	ADP
ecj-11314	77	10	patients	patient	NOUN
ecj-11314	77	11	with	with	ADP
ecj-11314	77	12	ms	ms	NOUN
ecj-11314	77	13	attack	attack	NOUN
ecj-11314	77	14	,	,	PUNCT
ecj-11314	77	15	and	and	CCONJ
ecj-11314	77	16	the	the	DET
ecj-11314	77	17	mean	mean	NOUN
ecj-11314	77	18	of	of	ADP
ecj-11314	77	19	rlr	rlr	PROPN
ecj-11314	77	20	of	of	ADP
ecj-11314	77	21	patients	patient	NOUN
ecj-11314	77	22	in	in	ADP
ecj-11314	77	23	the	the	DET
ecj-11314	77	24	non	non	ADJ
ecj-11314	77	25	-	-	ADJ
ecj-11314	77	26	attack	attack	ADJ
ecj-11314	77	27	period	period	NOUN
ecj-11314	77	28	was	be	AUX
ecj-11314	77	29	7.68±3.88	7.68±3.88	ADJ
ecj-11314	77	30	.	.	PUNCT
ecj-11314	78	1	the	the	DET
ecj-11314	78	2	difference	difference	NOUN
ecj-11314	78	3	between	between	ADP
ecj-11314	78	4	the	the	DET
ecj-11314	78	5	mean	mean	NOUN
ecj-11314	78	6	of	of	ADP
ecj-11314	78	7	rlr	rlr	PROPN
ecj-11314	78	8	of	of	ADP
ecj-11314	78	9	both	both	DET
ecj-11314	78	10	groups	group	NOUN
ecj-11314	78	11	was	be	AUX
ecj-11314	78	12	7.77±11.61	7.77±11.61	NUM
ecj-11314	78	13	and	and	CCONJ
ecj-11314	78	14	was	be	AUX
ecj-11314	78	15	statistically	statistically	ADV
ecj-11314	78	16	significant	significant	ADJ
ecj-11314	78	17	(	(	PUNCT
ecj-11314	78	18	p<0.001	p<0.001	ADJ
ecj-11314	78	19	;	;	PUNCT
ecj-11314	78	20	table	table	NOUN
ecj-11314	78	21	3	3	NUM
ecj-11314	78	22	,	,	PUNCT
ecj-11314	78	23	figure	figure	NOUN
ecj-11314	78	24	2	2	NUM
ecj-11314	78	25	)	)	PUNCT
ecj-11314	78	26	.	.	PUNCT
ecj-11314	79	1	the	the	DET
ecj-11314	79	2	mean	mean	NOUN
ecj-11314	79	3	of	of	ADP
ecj-11314	79	4	sii	sii	PROPN
ecj-11314	79	5	was	be	AUX
ecj-11314	79	6	2195.76±2011.06	2195.76±2011.06	NUM
ecj-11314	79	7	in	in	ADP
ecj-11314	79	8	patients	patient	NOUN
ecj-11314	79	9	with	with	ADP
ecj-11314	79	10	ms	ms	NOUN
ecj-11314	79	11	attack	attack	NOUN
ecj-11314	79	12	,	,	PUNCT
ecj-11314	79	13	and	and	CCONJ
ecj-11314	79	14	the	the	DET
ecj-11314	79	15	mean	mean	NOUN
ecj-11314	79	16	of	of	ADP
ecj-11314	79	17	sii	sii	PROPN
ecj-11314	79	18	of	of	ADP
ecj-11314	79	19	patients	patient	NOUN
ecj-11314	79	20	in	in	ADP
ecj-11314	79	21	the	the	DET
ecj-11314	79	22	non	non	ADJ
ecj-11314	79	23	-	-	ADJ
ecj-11314	79	24	attack	attack	ADJ
ecj-11314	79	25	period	period	NOUN
ecj-11314	79	26	was	be	AUX
ecj-11314	79	27	726.57±457.92	726.57±457.92	NUM
ecj-11314	79	28	.	.	PUNCT
ecj-11314	80	1	the	the	DET
ecj-11314	80	2	difference	difference	NOUN
ecj-11314	80	3	between	between	ADP
ecj-11314	80	4	the	the	DET
ecj-11314	80	5	mean	mean	NOUN
ecj-11314	80	6	of	of	ADP
ecj-11314	80	7	sii	sii	PROPN
ecj-11314	80	8	of	of	ADP
ecj-11314	80	9	both	both	DET
ecj-11314	80	10	groups	group	NOUN
ecj-11314	80	11	was	be	AUX
ecj-11314	80	12	1469.19±1978.88	1469.19±1978.88	NUM
ecj-11314	80	13	and	and	CCONJ
ecj-11314	80	14	was	be	AUX
ecj-11314	80	15	statistically	statistically	ADV
ecj-11314	80	16	significant	significant	ADJ
ecj-11314	80	17	(	(	PUNCT
ecj-11314	80	18	p<0.001	p<0.001	ADJ
ecj-11314	80	19	;	;	PUNCT
ecj-11314	80	20	table	table	NOUN
ecj-11314	80	21	3	3	NUM
ecj-11314	80	22	,	,	PUNCT
ecj-11314	80	23	figure	figure	NOUN
ecj-11314	80	24	2	2	NUM
ecj-11314	80	25	)	)	PUNCT
ecj-11314	80	26	.	.	PUNCT
ecj-11314	81	1	there	there	PRON
ecj-11314	81	2	was	be	VERB
ecj-11314	81	3	a	a	DET
ecj-11314	81	4	statistically	statistically	ADV
ecj-11314	81	5	significant	significant	ADJ
ecj-11314	81	6	difference	difference	NOUN
ecj-11314	81	7	in	in	ADP
ecj-11314	81	8	the	the	DET
ecj-11314	81	9	mean	mean	NOUN
ecj-11314	81	10	of	of	ADP
ecj-11314	81	11	white	white	ADJ
ecj-11314	81	12	blood	blood	NOUN
ecj-11314	81	13	cells	cell	NOUN
ecj-11314	81	14	,	,	PUNCT
ecj-11314	81	15	rdw	rdw	ADJ
ecj-11314	81	16	,	,	PUNCT
ecj-11314	81	17	platelets	platelet	NOUN
ecj-11314	81	18	,	,	PUNCT
ecj-11314	81	19	neutrophils	neutrophil	NOUN
ecj-11314	81	20	,	,	PUNCT
ecj-11314	81	21	lymphocytes	lymphocyte	NOUN
ecj-11314	81	22	,	,	PUNCT
ecj-11314	81	23	monocytes	monocyte	NOUN
ecj-11314	81	24	,	,	PUNCT
ecj-11314	81	25	and	and	CCONJ
ecj-11314	81	26	eosinophils	eosinophil	NOUN
ecj-11314	81	27	between	between	ADP
ecj-11314	81	28	the	the	DET
ecj-11314	81	29	attack	attack	NOUN
ecj-11314	81	30	and	and	CCONJ
ecj-11314	81	31	non	non	ADJ
ecj-11314	81	32	-	-	ADJ
ecj-11314	81	33	attack	attack	ADJ
ecj-11314	81	34	groups	group	NOUN
ecj-11314	81	35	(	(	PUNCT
ecj-11314	81	36	table	table	NOUN
ecj-11314	81	37	3	3	NUM
ecj-11314	81	38	)	)	PUNCT
ecj-11314	81	39	.	.	PUNCT
ecj-11314	82	1	while	while	SCONJ
ecj-11314	82	2	there	there	PRON
ecj-11314	82	3	was	be	VERB
ecj-11314	82	4	a	a	DET
ecj-11314	82	5	statistically	statistically	ADV
ecj-11314	82	6	significant	significant	ADJ
ecj-11314	82	7	difference	difference	NOUN
ecj-11314	82	8	between	between	ADP
ecj-11314	82	9	the	the	DET
ecj-11314	82	10	means	mean	NOUN
ecj-11314	82	11	of	of	ADP
ecj-11314	82	12	glucose	glucose	NOUN
ecj-11314	82	13	,	,	PUNCT
ecj-11314	82	14	alanine	alanine	NOUN
ecj-11314	82	15	aminotransferase	aminotransferase	NOUN
ecj-11314	82	16	,	,	PUNCT
ecj-11314	82	17	aspartate	aspartate	NOUN
ecj-11314	82	18	aminotransferase	aminotransferase	NOUN
ecj-11314	82	19	,	,	PUNCT
ecj-11314	82	20	and	and	CCONJ
ecj-11314	82	21	c	c	X
ecj-11314	82	22	-	-	ADJ
ecj-11314	82	23	reactive	reactive	ADJ
ecj-11314	82	24	protein	protein	NOUN
ecj-11314	82	25	in	in	ADP
ecj-11314	82	26	both	both	DET
ecj-11314	82	27	groups	group	NOUN
ecj-11314	82	28	,	,	PUNCT
ecj-11314	82	29	there	there	PRON
ecj-11314	82	30	was	be	VERB
ecj-11314	82	31	no	no	DET
ecj-11314	82	32	statistically	statistically	ADV
ecj-11314	82	33	significant	significant	ADJ
ecj-11314	82	34	difference	difference	NOUN
ecj-11314	82	35	between	between	ADP
ecj-11314	82	36	the	the	DET
ecj-11314	82	37	means	mean	NOUN
ecj-11314	82	38	of	of	ADP
ecj-11314	82	39	urea	urea	NOUN
ecj-11314	82	40	,	,	PUNCT
ecj-11314	82	41	creatinine	creatinine	NOUN
ecj-11314	82	42	,	,	PUNCT
ecj-11314	82	43	hemoglobin	hemoglobin	NOUN
ecj-11314	82	44	,	,	PUNCT
ecj-11314	82	45	and	and	CCONJ
ecj-11314	82	46	hematocrit	hematocrit	NOUN
ecj-11314	82	47	(	(	PUNCT
ecj-11314	82	48	table	table	NOUN
ecj-11314	82	49	3	3	NUM
ecj-11314	82	50	)	)	PUNCT
ecj-11314	82	51	.	.	PUNCT
ecj-11314	83	1	in	in	ADP
ecj-11314	83	2	roc	roc	PROPN
ecj-11314	83	3	analysis	analysis	NOUN
ecj-11314	83	4	,	,	PUNCT
ecj-11314	83	5	nlr	nlr	PROPN
ecj-11314	83	6	,	,	PUNCT
ecj-11314	83	7	rlr	rlr	PROPN
ecj-11314	83	8	,	,	PUNCT
ecj-11314	83	9	mlr	mlr	PROPN
ecj-11314	83	10	,	,	PUNCT
ecj-11314	83	11	and	and	CCONJ
ecj-11314	83	12	sii	sii	PROPN
ecj-11314	83	13	had	have	VERB
ecj-11314	83	14	excellent	excellent	ADJ
ecj-11314	83	15	diagnostic	diagnostic	ADJ
ecj-11314	83	16	power	power	NOUN
ecj-11314	83	17	in	in	ADP
ecj-11314	83	18	detecting	detect	VERB
ecj-11314	83	19	ms	ms	PROPN
ecj-11314	83	20	relapse	relapse	NOUN
ecj-11314	83	21	(	(	PUNCT
ecj-11314	83	22	auc	auc	NOUN
ecj-11314	83	23	:	:	PUNCT
ecj-11314	83	24	0.87	0.87	NUM
ecj-11314	83	25	,	,	PUNCT
ecj-11314	83	26	0.81	0.81	NUM
ecj-11314	83	27	,	,	PUNCT
ecj-11314	83	28	0.86	0.86	NUM
ecj-11314	83	29	,	,	PUNCT
ecj-11314	83	30	and	and	CCONJ
ecj-11314	83	31	0.87	0.87	NUM
ecj-11314	83	32	,	,	PUNCT
ecj-11314	83	33	respectively	respectively	ADV
ecj-11314	83	34	;	;	PUNCT
ecj-11314	83	35	table	table	NOUN
ecj-11314	83	36	4	4	NUM
ecj-11314	83	37	)	)	PUNCT
ecj-11314	83	38	.	.	PUNCT
ecj-11314	84	1	discussion	discussion	NOUN
ecj-11314	84	2	it	it	PRON
ecj-11314	84	3	is	be	AUX
ecj-11314	84	4	very	very	ADV
ecj-11314	84	5	crucial	crucial	ADJ
ecj-11314	84	6	to	to	PART
ecj-11314	84	7	determine	determine	VERB
ecj-11314	84	8	that	that	SCONJ
ecj-11314	84	9	patients	patient	NOUN
ecj-11314	84	10	with	with	ADP
ecj-11314	84	11	rrms	rrm	NOUN
ecj-11314	84	12	who	who	PRON
ecj-11314	84	13	applied	apply	VERB
ecj-11314	84	14	to	to	ADP
ecj-11314	84	15	the	the	DET
ecj-11314	84	16	emergency	emergency	NOUN
ecj-11314	84	17	department	department	NOUN
ecj-11314	84	18	are	be	AUX
ecj-11314	84	19	in	in	ADP
ecj-11314	84	20	the	the	DET
ecj-11314	84	21	attack	attack	NOUN
ecj-11314	84	22	period	period	NOUN
ecj-11314	84	23	.	.	PUNCT
ecj-11314	85	1	although	although	SCONJ
ecj-11314	85	2	many	many	ADJ
ecj-11314	85	3	biomarkers	biomarker	NOUN
ecj-11314	85	4	have	have	AUX
ecj-11314	85	5	been	be	AUX
ecj-11314	85	6	used	use	VERB
ecj-11314	85	7	for	for	ADP
ecj-11314	85	8	differential	differential	ADJ
ecj-11314	85	9	diagnosis	diagnosis	NOUN
ecj-11314	85	10	,	,	PUNCT
ecj-11314	85	11	the	the	DET
ecj-11314	85	12	search	search	NOUN
ecj-11314	85	13	for	for	ADP
ecj-11314	85	14	the	the	DET
ecj-11314	85	15	perfect	perfect	ADJ
ecj-11314	85	16	biomarker	biomarker	NOUN
ecj-11314	85	17	continues	continue	VERB
ecj-11314	85	18	.	.	PUNCT
ecj-11314	86	1	although	although	SCONJ
ecj-11314	86	2	laboratory	laboratory	NOUN
ecj-11314	86	3	parameters	parameter	NOUN
ecj-11314	86	4	obtained	obtain	VERB
ecj-11314	86	5	from	from	ADP
ecj-11314	86	6	peripheral	peripheral	ADJ
ecj-11314	86	7	blood	blood	NOUN
ecj-11314	86	8	are	be	AUX
ecj-11314	86	9	inexpensive	inexpensive	ADJ
ecj-11314	86	10	and	and	CCONJ
ecj-11314	86	11	easily	easily	ADV
ecj-11314	86	12	accessible	accessible	ADJ
ecj-11314	86	13	,	,	PUNCT
ecj-11314	86	14	biomarkers	biomarker	NOUN
ecj-11314	86	15	obtained	obtain	VERB
ecj-11314	86	16	from	from	ADP
ecj-11314	86	17	cerebrospinal	cerebrospinal	ADJ
ecj-11314	86	18	fluid	fluid	NOUN
ecj-11314	86	19	(	(	PUNCT
ecj-11314	86	20	csf	csf	NOUN
ecj-11314	86	21	)	)	PUNCT
ecj-11314	86	22	are	be	AUX
ecj-11314	86	23	more	more	ADV
ecj-11314	86	24	valuable	valuable	ADJ
ecj-11314	86	25	in	in	ADP
ecj-11314	86	26	diagnostic	diagnostic	ADJ
ecj-11314	86	27	terms	term	NOUN
ecj-11314	86	28	.	.	PUNCT
ecj-11314	87	1	however	however	ADV
ecj-11314	87	2	,	,	PUNCT
ecj-11314	87	3	csf	csf	ADJ
ecj-11314	87	4	analysis	analysis	NOUN
ecj-11314	87	5	requires	require	VERB
ecj-11314	87	6	additional	additional	ADJ
ecj-11314	87	7	technical	technical	ADJ
ecj-11314	87	8	knowledge	knowledge	NOUN
ecj-11314	87	9	and	and	CCONJ
ecj-11314	87	10	is	be	AUX
ecj-11314	87	11	more	more	ADV
ecj-11314	87	12	costly	costly	ADJ
ecj-11314	87	13	.	.	PUNCT
ecj-11314	88	1	in	in	ADP
ecj-11314	88	2	addition	addition	NOUN
ecj-11314	88	3	,	,	PUNCT
ecj-11314	88	4	there	there	PRON
ecj-11314	88	5	is	be	VERB
ecj-11314	88	6	a	a	DET
ecj-11314	88	7	risk	risk	NOUN
ecj-11314	88	8	of	of	ADP
ecj-11314	88	9	developing	develop	VERB
ecj-11314	88	10	complications	complication	NOUN
ecj-11314	88	11	during	during	ADP
ecj-11314	88	12	the	the	DET
ecj-11314	88	13	procedure17	procedure17	NOUN
ecj-11314	88	14	therefore	therefore	ADV
ecj-11314	88	15	,	,	PUNCT
ecj-11314	88	16	low	low	ADJ
ecj-11314	88	17	cost	cost	NOUN
ecj-11314	88	18	and	and	CCONJ
ecj-11314	88	19	easy	easy	ADJ
ecj-11314	88	20	to	to	PART
ecj-11314	88	21	calculate	calculate	VERB
ecj-11314	88	22	hematological	hematological	ADJ
ecj-11314	88	23	inflammatory	inflammatory	ADJ
ecj-11314	88	24	biomarkers	biomarker	NOUN
ecj-11314	88	25	have	have	AUX
ecj-11314	88	26	gained	gain	VERB
ecj-11314	88	27	prominence	prominence	NOUN
ecj-11314	88	28	.	.	PUNCT
ecj-11314	89	1	nlr	nlr	PROPN
ecj-11314	89	2	,	,	PUNCT
ecj-11314	89	3	which	which	PRON
ecj-11314	89	4	represents	represent	VERB
ecj-11314	89	5	the	the	DET
ecj-11314	89	6	balance	balance	NOUN
ecj-11314	89	7	between	between	ADP
ecj-11314	89	8	neutrophil	neutrophil	ADJ
ecj-11314	89	9	and	and	CCONJ
ecj-11314	89	10	lymphocyte	lymphocyte	ADJ
ecj-11314	89	11	levels	level	NOUN
ecj-11314	89	12	,	,	PUNCT
ecj-11314	89	13	has	have	AUX
ecj-11314	89	14	been	be	AUX
ecj-11314	89	15	recently	recently	ADV
ecj-11314	89	16	proposed	propose	VERB
ecj-11314	89	17	as	as	ADP
ecj-11314	89	18	an	an	DET
ecj-11314	89	19	informative	informative	ADJ
ecj-11314	89	20	article	article	NOUN
ecj-11314	89	21	table	table	NOUN
ecj-11314	90	1	3	3	NUM
ecj-11314	90	2	.	.	PUNCT
ecj-11314	90	3	evaluation	evaluation	NOUN
ecj-11314	90	4	of	of	ADP
ecj-11314	90	5	the	the	DET
ecj-11314	90	6	difference	difference	NOUN
ecj-11314	90	7	in	in	ADP
ecj-11314	90	8	biochemistry	biochemistry	NOUN
ecj-11314	90	9	and	and	CCONJ
ecj-11314	90	10	hemogram	hemogram	PROPN
ecj-11314	90	11	parameters	parameter	NOUN
ecj-11314	90	12	between	between	ADP
ecj-11314	90	13	attack	attack	NOUN
ecj-11314	90	14	and	and	CCONJ
ecj-11314	90	15	non	non	ADJ
ecj-11314	90	16	-	-	ADJ
ecj-11314	90	17	attack	attack	ADJ
ecj-11314	90	18	periods	period	NOUN
ecj-11314	90	19	.	.	PUNCT
ecj-11314	91	1	attack	attack	NOUN
ecj-11314	91	2	period	period	NOUN
ecj-11314	91	3	non	non	ADJ
ecj-11314	91	4	-	-	ADJ
ecj-11314	91	5	attack	attack	ADJ
ecj-11314	91	6	period	period	NOUN
ecj-11314	91	7	mean	mean	NOUN
ecj-11314	91	8	difference	difference	NOUN
ecj-11314	91	9	95	95	NUM
ecj-11314	91	10	%	%	NOUN
ecj-11314	91	11	confidence	confidence	NOUN
ecj-11314	91	12	p	p	NOUN
ecj-11314	91	13	(	(	PUNCT
ecj-11314	91	14	mean	mean	PROPN
ecj-11314	91	15	±s.d	±s.d	PROPN
ecj-11314	91	16	)	)	PUNCT
ecj-11314	91	17	(	(	PUNCT
ecj-11314	91	18	mean	mean	PROPN
ecj-11314	91	19	±s.d	±s.d	PROPN
ecj-11314	91	20	)	)	PUNCT
ecj-11314	91	21	(	(	PUNCT
ecj-11314	91	22	mean	mean	PROPN
ecj-11314	91	23	±s.d	±s.d	PROPN
ecj-11314	91	24	)	)	PUNCT
ecj-11314	91	25	interval	interval	NOUN
ecj-11314	91	26	of	of	ADP
ecj-11314	91	27	the	the	DET
ecj-11314	91	28	difference	difference	NOUN
ecj-11314	91	29	glucose	glucose	NOUN
ecj-11314	92	1	108.55±27.99	108.55±27.99	NUM
ecj-11314	92	2	100.37±23,51	100.37±23,51	NOUN
ecj-11314	92	3	8.17±28.74	8.17±28.74	NUM
ecj-11314	92	4	3.76	3.76	NUM
ecj-11314	92	5	-	-	SYM
ecj-11314	92	6	12.59	12.59	NUM
ecj-11314	92	7	<	<	NOUN
ecj-11314	92	8	0.001	0.001	NUM
ecj-11314	92	9	urea	urea	NOUN
ecj-11314	92	10	29.47±10.16	29.47±10.16	NUM
ecj-11314	92	11	27.83±7.64	27.83±7.64	NUM
ecj-11314	92	12	1.64±10.15	1.64±10.15	NUM
ecj-11314	92	13	0.75	0.75	NUM
ecj-11314	92	14	-	-	SYM
ecj-11314	92	15	3.19	3.19	NUM
ecj-11314	92	16	0.4	0.4	NUM
ecj-11314	92	17	creatininen	creatininen	NOUN
ecj-11314	92	18	0.96±3.30	0.96±3.30	PROPN
ecj-11314	93	1	0.70±0.23	0.70±0.23	PROPN
ecj-11314	93	2	0.25±3.33	0.25±3.33	NOUN
ecj-11314	93	3	-0.26	-0.26	NOUN
ecj-11314	93	4	-	-	SYM
ecj-11314	93	5	0.76	0.76	NUM
ecj-11314	93	6	0.33	0.33	NUM
ecj-11314	93	7	alt	alt	NOUN
ecj-11314	93	8	28.87±30.63	28.87±30.63	NUM
ecj-11314	93	9	19.37±14.02	19.37±14.02	NUM
ecj-11314	93	10	9.46±30.83	9.46±30.83	NUM
ecj-11314	93	11	4.76	4.76	NUM
ecj-11314	93	12	-	-	SYM
ecj-11314	93	13	14.24	14.24	NUM
ecj-11314	93	14	<	<	NOUN
ecj-11314	93	15	0.001	0.001	NUM
ecj-11314	93	16	ast	ast	NOUN
ecj-11314	93	17	28.38±22.29	28.38±22.29	NUM
ecj-11314	93	18	20.95±10.17	20.95±10.17	NUM
ecj-11314	93	19	7.42±20.74	7.42±20.74	NUM
ecj-11314	93	20	4.24	4.24	NUM
ecj-11314	93	21	-	-	SYM
ecj-11314	93	22	10.61	10.61	NUM
ecj-11314	93	23	<	<	NOUN
ecj-11314	93	24	0.001	0.001	NUM
ecj-11314	93	25	crp	crp	NOUN
ecj-11314	93	26	6.84±8.46	6.84±8.46	NUM
ecj-11314	93	27	4.88±7.78	4.88±7.78	NOUN
ecj-11314	93	28	1.97±10.38	1.97±10.38	NUM
ecj-11314	93	29	0.37	0.37	NUM
ecj-11314	93	30	-	-	SYM
ecj-11314	93	31	3.56	3.56	NUM
ecj-11314	93	32	0.02	0.02	NUM
ecj-11314	93	33	wbc	wbc	NOUN
ecj-11314	93	34	9.76±3.32	9.76±3.32	NUM
ecj-11314	93	35	7.79±2.03	7.79±2.03	ADJ
ecj-11314	93	36	1.97±3.31	1.97±3.31	NUM
ecj-11314	93	37	1.46	1.46	NUM
ecj-11314	93	38	-	-	SYM
ecj-11314	93	39	2.47	2.47	NUM
ecj-11314	93	40	<	<	NOUN
ecj-11314	93	41	0.001	0.001	NUM
ecj-11314	93	42	hgb	hgb	NOUN
ecj-11314	93	43	12.98±1.73	12.98±1.73	NUM
ecj-11314	93	44	13.08±1.71	13.08±1.71	NUM
ecj-11314	93	45	-0.11±1.72	-0.11±1.72	NOUN
ecj-11314	93	46	-0.37	-0.37	NUM
ecj-11314	93	47	-	-	PUNCT
ecj-11314	93	48	1.62	1.62	NUM
ecj-11314	93	49	0.45	0.45	NUM
ecj-11314	93	50	hct	hct	PROPN
ecj-11314	93	51	39.09±4.78	39.09±4.78	PROPN
ecj-11314	93	52	39.34±4.65	39.34±4.65	NUM
ecj-11314	93	53	-0.25±4.76	-0.25±4.76	PUNCT
ecj-11314	93	54	-0.98	-0.98	NUM
ecj-11314	93	55	-	-	PUNCT
ecj-11314	93	56	0.48	0.48	NUM
ecj-11314	93	57	0.5	0.5	NUM
ecj-11314	93	58	plt	plt	NOUN
ecj-11314	93	59	270.25±57.66	270.25±57.66	ADP
ecj-11314	93	60	258.88±56.08	258.88±56.08	NUM
ecj-11314	93	61	11.37±57.29	11.37±57.29	NUM
ecj-11314	93	62	2.56	2.56	NUM
ecj-11314	93	63	-	-	SYM
ecj-11314	93	64	20.18	20.18	NUM
ecj-11314	93	65	0.01	0.01	NUM
ecj-11314	93	66	rdw	rdw	NOUN
ecj-11314	94	1	14.06±1.51	14.06±1.51	NUM
ecj-11314	94	2	13.47±1.01	13.47±1.01	NUM
ecj-11314	94	3	0.58±1.26	0.58±1.26	ADJ
ecj-11314	94	4	0.39	0.39	NUM
ecj-11314	94	5	-	-	SYM
ecj-11314	94	6	0.78	0.78	NUM
ecj-11314	94	7	<	<	NOUN
ecj-11314	94	8	0.001	0.001	NUM
ecj-11314	94	9	neu	neu	NOUN
ecj-11314	94	10	7.52±3.11	7.52±3.11	NUM
ecj-11314	94	11	4.99±1.76	4.99±1.76	PROPN
ecj-11314	94	12	2.52±3.31	2.52±3.31	NUM
ecj-11314	94	13	2.01	2.01	NUM
ecj-11314	94	14	-	-	SYM
ecj-11314	94	15	3.03	3.03	NUM
ecj-11314	94	16	<	<	NOUN
ecj-11314	94	17	0.001	0.001	NUM
ecj-11314	94	18	lym	lym	PROPN
ecj-11314	94	19	1.26±0.61	1.26±0.61	NOUN
ecj-11314	94	20	2.11±0.85	2.11±0.85	PROPN
ecj-11314	94	21	-0.85±0.76	-0.85±0.76	PROPN
ecj-11314	94	22	-0.96(-0.72	-0.96(-0.72	PROPN
ecj-11314	94	23	)	)	PUNCT
ecj-11314	94	24	<	<	X
ecj-11314	94	25	0.001	0.001	NUM
ecj-11314	94	26	mon	mon	NOUN
ecj-11314	94	27	0.67±0.26	0.67±0.26	NOUN
ecj-11314	95	1	0.54±0.16	0.54±0.16	PROPN
ecj-11314	95	2	0.13±.025	0.13±.025	NOUN
ecj-11314	95	3	0.09	0.09	NUM
ecj-11314	95	4	-	-	SYM
ecj-11314	95	5	0.17	0.17	NUM
ecj-11314	95	6	<	<	NOUN
ecj-11314	95	7	0.001	0.001	NUM
ecj-11314	95	8	eos	eos	PROPN
ecj-11314	95	9	0.18±0.14	0.18±0.14	NOUN
ecj-11314	95	10	0.15±0.11	0.15±0.11	VERB
ecj-11314	95	11	0.03±0.14	0.03±0.14	NUM
ecj-11314	95	12	0.01	0.01	NUM
ecj-11314	95	13	-	-	PUNCT
ecj-11314	95	14	0.05	0.05	NUM
ecj-11314	95	15	0.009	0.009	NUM
ecj-11314	95	16	rlr	rlr	NOUN
ecj-11314	95	17	15.45±12.06	15.45±12.06	NUM
ecj-11314	95	18	7.68±3.88	7.68±3.88	NUM
ecj-11314	95	19	7.77±11.61	7.77±11.61	NUM
ecj-11314	95	20	5.98	5.98	NUM
ecj-11314	95	21	-	-	SYM
ecj-11314	95	22	9.55	9.55	NUM
ecj-11314	95	23	<	<	NOUN
ecj-11314	95	24	0.001	0.001	NUM
ecj-11314	95	25	mlr	mlr	NOUN
ecj-11314	95	26	0.67±0.43	0.67±0.43	NOUN
ecj-11314	95	27	0.30±0.17	0.30±0.17	PROPN
ecj-11314	95	28	0.37±0.43	0.37±0.43	PROPN
ecj-11314	95	29	0.31	0.31	NUM
ecj-11314	95	30	-	-	SYM
ecj-11314	95	31	0.44	0.44	NUM
ecj-11314	95	32	<	<	NOUN
ecj-11314	95	33	0.001	0.001	NUM
ecj-11314	95	34	nlr	nlr	PROPN
ecj-11314	95	35	8.22±7.35	8.22±7.35	PROPN
ecj-11314	95	36	2.81±1.65	2.81±1.65	NOUN
ecj-11314	95	37	5.40±7.25	5.40±7.25	NUM
ecj-11314	95	38	4.29	4.29	NUM
ecj-11314	95	39	-	-	SYM
ecj-11314	95	40	6.52	6.52	NUM
ecj-11314	95	41	<	<	NOUN
ecj-11314	95	42	0.001	0.001	NUM
ecj-11314	95	43	sii	sii	PROPN
ecj-11314	95	44	2195.76±2011.06	2195.76±2011.06	NUM
ecj-11314	95	45	726.57±457.92	726.57±457.92	NUM
ecj-11314	95	46	1469.19±1978.88	1469.19±1978.88	NUM
ecj-11314	95	47	1165.01	1165.01	NUM
ecj-11314	95	48	-	-	SYM
ecj-11314	95	49	1773.38	1773.38	NUM
ecj-11314	95	50	<	<	NOUN
ecj-11314	95	51	0.001	0.001	NUM
ecj-11314	95	52	paired	pair	VERB
ecj-11314	95	53	t	t	NOUN
ecj-11314	95	54	test	test	NOUN
ecj-11314	95	55	(	(	PUNCT
ecj-11314	95	56	p<0.05	p<0.05	NOUN
ecj-11314	95	57	significance	significance	NOUN
ecj-11314	95	58	)	)	PUNCT
ecj-11314	95	59	;	;	PUNCT
ecj-11314	95	60	s.d	s.d	PROPN
ecj-11314	95	61	,	,	PUNCT
ecj-11314	95	62	standard	standard	ADJ
ecj-11314	95	63	deviation	deviation	NOUN
ecj-11314	95	64	;	;	PUNCT
ecj-11314	95	65	alt	alt	ADJ
ecj-11314	95	66	,	,	PUNCT
ecj-11314	95	67	alanine	alanine	NOUN
ecj-11314	95	68	aminotransferase	aminotransferase	NOUN
ecj-11314	95	69	;	;	PUNCT
ecj-11314	95	70	ast	ast	NOUN
ecj-11314	95	71	,	,	PUNCT
ecj-11314	95	72	aspartate	aspartate	NOUN
ecj-11314	95	73	aminotransferase	aminotransferase	NOUN
ecj-11314	95	74	;	;	PUNCT
ecj-11314	95	75	crp	crp	PROPN
ecj-11314	95	76	,	,	PUNCT
ecj-11314	95	77	c	c	NOUN
ecj-11314	95	78	-	-	PUNCT
ecj-11314	95	79	reactive	reactive	ADJ
ecj-11314	95	80	protein	protein	NOUN
ecj-11314	95	81	;	;	PUNCT
ecj-11314	95	82	wbc	wbc	PROPN
ecj-11314	95	83	,	,	PUNCT
ecj-11314	95	84	white	white	ADJ
ecj-11314	95	85	blood	blood	NOUN
ecj-11314	95	86	cells	cell	NOUN
ecj-11314	95	87	;	;	PUNCT
ecj-11314	96	1	hgb	hgb	PROPN
ecj-11314	96	2	,	,	PUNCT
ecj-11314	96	3	hemoglobin	hemoglobin	NOUN
ecj-11314	96	4	;	;	PUNCT
ecj-11314	96	5	hct	hct	PROPN
ecj-11314	96	6	,	,	PUNCT
ecj-11314	96	7	hematocrit	hematocrit	PROPN
ecj-11314	96	8	;	;	PUNCT
ecj-11314	96	9	plt	plt	NOUN
ecj-11314	96	10	,	,	PUNCT
ecj-11314	96	11	platelets	platelet	NOUN
ecj-11314	96	12	;	;	PUNCT
ecj-11314	96	13	rdw	rdw	ADJ
ecj-11314	96	14	,	,	PUNCT
ecj-11314	96	15	red	red	ADJ
ecj-11314	96	16	cell	cell	NOUN
ecj-11314	96	17	distribution	distribution	NOUN
ecj-11314	96	18	width	width	NOUN
ecj-11314	96	19	;	;	PUNCT
ecj-11314	96	20	neu	neu	NOUN
ecj-11314	96	21	,	,	PUNCT
ecj-11314	96	22	neutrophil	neutrophil	ADJ
ecj-11314	96	23	;	;	PUNCT
ecj-11314	96	24	lym	lym	PROPN
ecj-11314	96	25	,	,	PUNCT
ecj-11314	96	26	lymphocyte	lymphocyte	PROPN
ecj-11314	96	27	;	;	PUNCT
ecj-11314	96	28	mon	mon	PROPN
ecj-11314	96	29	,	,	PUNCT
ecj-11314	96	30	monocyte	monocyte	NOUN
ecj-11314	96	31	;	;	PUNCT
ecj-11314	96	32	eos	eos	PROPN
ecj-11314	96	33	,	,	PUNCT
ecj-11314	96	34	eosinophil	eosinophil	ADJ
ecj-11314	96	35	;	;	PUNCT
ecj-11314	96	36	rlr	rlr	PROPN
ecj-11314	96	37	,	,	PUNCT
ecj-11314	96	38	rdw	rdw	VERB
ecj-11314	96	39	to	to	ADP
ecj-11314	96	40	lymphocyte	lymphocyte	ADJ
ecj-11314	96	41	ratio	ratio	NOUN
ecj-11314	96	42	;	;	PUNCT
ecj-11314	96	43	mlr	mlr	NOUN
ecj-11314	96	44	,	,	PUNCT
ecj-11314	96	45	monocyte	monocyte	NOUN
ecj-11314	96	46	to	to	ADP
ecj-11314	96	47	lymphocyte	lymphocyte	ADJ
ecj-11314	96	48	ratio	ratio	NOUN
ecj-11314	96	49	;	;	PUNCT
ecj-11314	96	50	nlr	nlr	PROPN
ecj-11314	96	51	,	,	PUNCT
ecj-11314	96	52	neutrophil	neutrophil	ADJ
ecj-11314	96	53	to	to	ADP
ecj-11314	96	54	lymphocyte	lymphocyte	ADJ
ecj-11314	96	55	ratio	ratio	NOUN
ecj-11314	96	56	;	;	PUNCT
ecj-11314	96	57	sii	sii	NUM
ecj-11314	96	58	,	,	PUNCT
ecj-11314	96	59	systemic	systemic	ADJ
ecj-11314	96	60	immune	immune	ADJ
ecj-11314	96	61	inflammation	inflammation	NOUN
ecj-11314	96	62	index	index	NOUN
ecj-11314	96	63	.	.	PUNCT
ecj-11314	97	1	table	table	NOUN
ecj-11314	97	2	4	4	NUM
ecj-11314	97	3	.	.	PUNCT
ecj-11314	98	1	diagnostic	diagnostic	ADJ
ecj-11314	98	2	accuracy	accuracy	NOUN
ecj-11314	98	3	of	of	ADP
ecj-11314	98	4	inflammatory	inflammatory	ADJ
ecj-11314	98	5	parameters	parameter	NOUN
ecj-11314	98	6	for	for	ADP
ecj-11314	98	7	differentiation	differentiation	NOUN
ecj-11314	98	8	of	of	ADP
ecj-11314	98	9	multiple	multiple	ADJ
ecj-11314	98	10	sclerosis	sclerosis	NOUN
ecj-11314	98	11	(	(	PUNCT
ecj-11314	98	12	ms	ms	NOUN
ecj-11314	98	13	)	)	PUNCT
ecj-11314	98	14	attack	attack	NOUN
ecj-11314	98	15	.	.	PUNCT
ecj-11314	99	1	ms	ms	PROPN
ecj-11314	99	2	attack	attack	NOUN
ecj-11314	99	3	:	:	PUNCT
ecj-11314	99	4	169	169	NUM
ecj-11314	99	5	auc	auc	NOUN
ecj-11314	99	6	cut	cut	NOUN
ecj-11314	99	7	-	-	PUNCT
ecj-11314	99	8	off	off	ADP
ecj-11314	99	9	sensitivity	sensitivity	NOUN
ecj-11314	99	10	%	%	NOUN
ecj-11314	99	11	specificity	specificity	NOUN
ecj-11314	99	12	%	%	NOUN
ecj-11314	99	13	auc	auc	NOUN
ecj-11314	99	14	95	95	NUM
ecj-11314	99	15	%	%	NOUN
ecj-11314	99	16	ci	ci	NOUN
ecj-11314	99	17	p	p	NOUN
ecj-11314	99	18	ppv	ppv	NOUN
ecj-11314	99	19	%	%	NOUN
ecj-11314	99	20	npv%	npv%	ADV
ecj-11314	99	21	ms	ms	ADJ
ecj-11314	99	22	non	non	ADJ
ecj-11314	99	23	-	-	NOUN
ecj-11314	99	24	attack	attack	ADJ
ecj-11314	99	25	:	:	PUNCT
ecj-11314	99	26	169	169	NUM
ecj-11314	99	27	nlr	nlr	PROPN
ecj-11314	99	28	0.87	0.87	NUM
ecj-11314	99	29	>	>	PUNCT
ecj-11314	99	30	3.33	3.33	NUM
ecj-11314	99	31	84.6	84.6	NUM
ecj-11314	99	32	76.9	76.9	NUM
ecj-11314	99	33	0.83	0.83	NUM
ecj-11314	99	34	-	-	SYM
ecj-11314	99	35	0.90	0.90	NUM
ecj-11314	99	36	<	<	NOUN
ecj-11314	99	37	0.001	0.001	NUM
ecj-11314	99	38	78.6	78.6	NUM
ecj-11314	99	39	83.3	83.3	NUM
ecj-11314	99	40	rlr	rlr	NOUN
ecj-11314	99	41	0.81	0.81	NUM
ecj-11314	99	42	>	>	SYM
ecj-11314	99	43	8.56	8.56	NUM
ecj-11314	99	44	75.1	75.1	NUM
ecj-11314	99	45	72.8	72.8	NUM
ecj-11314	99	46	0.76	0.76	NUM
ecj-11314	99	47	-	-	SYM
ecj-11314	99	48	0.85	0.85	NUM
ecj-11314	99	49	<	<	NOUN
ecj-11314	99	50	0.001	0.001	NUM
ecj-11314	99	51	73.4	73.4	NUM
ecj-11314	99	52	74.5	74.5	NUM
ecj-11314	99	53	mlr	mlr	NOUN
ecj-11314	99	54	0.86	0.86	NUM
ecj-11314	99	55	>	>	PUNCT
ecj-11314	99	56	0.36	0.36	NUM
ecj-11314	99	57	82.25	82.25	NUM
ecj-11314	99	58	77.51	77.51	NUM
ecj-11314	99	59	0.82	0.82	NUM
ecj-11314	99	60	-	-	SYM
ecj-11314	99	61	0.89	0.89	NUM
ecj-11314	99	62	<	<	NOUN
ecj-11314	99	63	0.001	0.001	NUM
ecj-11314	99	64	78.5	78.5	NUM
ecj-11314	99	65	81.84	81.84	NUM
ecj-11314	99	66	sii	sii	PROPN
ecj-11314	99	67	0.87	0.87	NUM
ecj-11314	99	68	>	>	PUNCT
ecj-11314	99	69	807.92	807.92	NUM
ecj-11314	99	70	87.6	87.6	NUM
ecj-11314	99	71	70.4	70.4	NUM
ecj-11314	99	72	0.83	0.83	NUM
ecj-11314	99	73	-	-	SYM
ecj-11314	99	74	0.90	0.90	NUM
ecj-11314	99	75	<	<	NOUN
ecj-11314	99	76	0.001	0.001	NUM
ecj-11314	99	77	74.7	74.7	NUM
ecj-11314	99	78	85.1	85.1	NUM
ecj-11314	99	79	auc	auc	NOUN
ecj-11314	99	80	,	,	PUNCT
ecj-11314	99	81	area	area	NOUN
ecj-11314	99	82	under	under	ADP
ecj-11314	99	83	curve	curve	NOUN
ecj-11314	99	84	;	;	PUNCT
ecj-11314	99	85	se	se	X
ecj-11314	99	86	,	,	PUNCT
ecj-11314	99	87	standard	standard	ADJ
ecj-11314	99	88	error	error	NOUN
ecj-11314	99	89	;	;	PUNCT
ecj-11314	99	90	ppv	ppv	NOUN
ecj-11314	99	91	,	,	PUNCT
ecj-11314	99	92	positive	positive	ADJ
ecj-11314	99	93	predictive	predictive	ADJ
ecj-11314	99	94	value	value	NOUN
ecj-11314	99	95	;	;	PUNCT
ecj-11314	99	96	npv	npv	NOUN
ecj-11314	99	97	,	,	PUNCT
ecj-11314	99	98	negative	negative	ADJ
ecj-11314	99	99	predictive	predictive	ADJ
ecj-11314	99	100	value	value	NOUN
ecj-11314	99	101	;	;	PUNCT
ecj-11314	99	102	ci	ci	NOUN
ecj-11314	99	103	,	,	PUNCT
ecj-11314	99	104	confidence	confidence	NOUN
ecj-11314	99	105	interval	interval	NOUN
ecj-11314	99	106	;	;	PUNCT
ecj-11314	99	107	nlr	nlr	PROPN
ecj-11314	99	108	,	,	PUNCT
ecj-11314	99	109	neutrophil	neutrophil	ADJ
ecj-11314	99	110	to	to	ADP
ecj-11314	99	111	lymphocyte	lymphocyte	ADJ
ecj-11314	99	112	ratio	ratio	NOUN
ecj-11314	99	113	;	;	PUNCT
ecj-11314	99	114	rdw	rdw	ADJ
ecj-11314	99	115	,	,	PUNCT
ecj-11314	99	116	red	red	ADJ
ecj-11314	99	117	cell	cell	NOUN
ecj-11314	99	118	distribution	distribution	NOUN
ecj-11314	99	119	width	width	NOUN
ecj-11314	99	120	;	;	PUNCT
ecj-11314	99	121	rlr	rlr	PROPN
ecj-11314	99	122	,	,	PUNCT
ecj-11314	99	123	rdw	rdw	VERB
ecj-11314	99	124	to	to	ADP
ecj-11314	99	125	lymphocyte	lymphocyte	ADJ
ecj-11314	99	126	ratio	ratio	NOUN
ecj-11314	99	127	;	;	PUNCT
ecj-11314	99	128	mlr	mlr	NOUN
ecj-11314	99	129	,	,	PUNCT
ecj-11314	99	130	monocyte	monocyte	NOUN
ecj-11314	99	131	to	to	ADP
ecj-11314	99	132	lymphocyte	lymphocyte	ADJ
ecj-11314	99	133	ratio	ratio	NOUN
ecj-11314	99	134	;	;	PUNCT
ecj-11314	99	135	sii	sii	NUM
ecj-11314	99	136	,	,	PUNCT
ecj-11314	99	137	systemic	systemic	ADJ
ecj-11314	99	138	immune	immune	ADJ
ecj-11314	99	139	inflammation	inflammation	NOUN
ecj-11314	99	140	index	index	NOUN
ecj-11314	99	141	.	.	PUNCT
ecj-11314	100	1	[	[	X
ecj-11314	100	2	page	page	NOUN
ecj-11314	100	3	40	40	NUM
ecj-11314	100	4	]	]	PUNCT
ecj-11314	101	1	[	[	X
ecj-11314	101	2	emergency	emergency	NOUN
ecj-11314	101	3	care	care	NOUN
ecj-11314	101	4	journal	journal	PROPN
ecj-11314	101	5	2023	2023	NUM
ecj-11314	101	6	;	;	PUNCT
ecj-11314	101	7	19:11314	19:11314	NUM
ecj-11314	101	8	]	]	X
ecj-11314	101	9	non	non	ADJ
ecj-11314	101	10	-co	-co	PROPN
ecj-11314	101	11	mmerc	mmerc	PROPN
ecj-11314	101	12	ial	ial	PROPN
ecj-11314	101	13	us	us	PROPN
ecj-11314	101	14	e	e	NOUN
ecj-11314	101	15	o	o	NOUN
ecj-11314	101	16	nly	nly	ADV
ecj-11314	101	17	and	and	CCONJ
ecj-11314	101	18	non	non	ADJ
ecj-11314	101	19	-	-	ADJ
ecj-11314	101	20	invasive	invasive	ADJ
ecj-11314	101	21	peripheral	peripheral	ADJ
ecj-11314	101	22	biomarker	biomarker	NOUN
ecj-11314	101	23	to	to	PART
ecj-11314	101	24	determine	determine	VERB
ecj-11314	101	25	systemic	systemic	ADJ
ecj-11314	101	26	inflammatory	inflammatory	ADJ
ecj-11314	101	27	status	status	NOUN
ecj-11314	101	28	in	in	ADP
ecj-11314	101	29	various	various	ADJ
ecj-11314	101	30	chronic	chronic	ADJ
ecj-11314	101	31	inflammatory	inflammatory	ADJ
ecj-11314	101	32	diseases.18,19	diseases.18,19	NOUN
ecj-11314	101	33	in	in	ADP
ecj-11314	101	34	our	our	PRON
ecj-11314	101	35	study	study	NOUN
ecj-11314	101	36	,	,	PUNCT
ecj-11314	101	37	we	we	PRON
ecj-11314	101	38	found	find	VERB
ecj-11314	101	39	higher	high	ADJ
ecj-11314	101	40	nlr	nlr	PROPN
ecj-11314	101	41	rates	rate	NOUN
ecj-11314	101	42	in	in	ADP
ecj-11314	101	43	patients	patient	NOUN
ecj-11314	101	44	with	with	ADP
ecj-11314	101	45	ms	ms	NOUN
ecj-11314	101	46	attacks	attack	NOUN
ecj-11314	101	47	.	.	PUNCT
ecj-11314	102	1	this	this	PRON
ecj-11314	102	2	could	could	AUX
ecj-11314	102	3	be	be	AUX
ecj-11314	102	4	due	due	ADJ
ecj-11314	102	5	to	to	ADP
ecj-11314	102	6	an	an	DET
ecj-11314	102	7	inflammatory	inflammatory	ADJ
ecj-11314	102	8	process	process	NOUN
ecj-11314	102	9	in	in	ADP
ecj-11314	102	10	ms	ms	PROPN
ecj-11314	102	11	,	,	PUNCT
ecj-11314	102	12	which	which	PRON
ecj-11314	102	13	accelerates	accelerate	VERB
ecj-11314	102	14	during	during	ADP
ecj-11314	102	15	ms	ms	NOUN
ecj-11314	102	16	attacks	attack	NOUN
ecj-11314	102	17	.	.	PUNCT
ecj-11314	103	1	bisgaarrd	bisgaarrd	PROPN
ecj-11314	103	2	et	et	PROPN
ecj-11314	103	3	al	al	PROPN
ecj-11314	103	4	.	.	PROPN
ecj-11314	103	5	discovered	discover	VERB
ecj-11314	103	6	higher	high	ADJ
ecj-11314	103	7	nlr	nlr	PROPN
ecj-11314	103	8	in	in	ADP
ecj-11314	103	9	patients	patient	NOUN
ecj-11314	103	10	with	with	ADP
ecj-11314	103	11	optic	optic	ADJ
ecj-11314	103	12	neuritis	neuritis	NOUN
ecj-11314	103	13	and	and	CCONJ
ecj-11314	103	14	ms	ms	NOUN
ecj-11314	103	15	compared	compare	VERB
ecj-11314	103	16	to	to	ADP
ecj-11314	103	17	the	the	DET
ecj-11314	103	18	healthy	healthy	ADJ
ecj-11314	103	19	control	control	NOUN
ecj-11314	103	20	group	group	NOUN
ecj-11314	103	21	.	.	PUNCT
ecj-11314	104	1	in	in	ADP
ecj-11314	104	2	addition	addition	NOUN
ecj-11314	104	3	,	,	PUNCT
ecj-11314	104	4	similar	similar	ADJ
ecj-11314	104	5	to	to	ADP
ecj-11314	104	6	our	our	PRON
ecj-11314	104	7	study	study	NOUN
ecj-11314	104	8	,	,	PUNCT
ecj-11314	104	9	higher	high	ADJ
ecj-11314	104	10	nlr	nlr	PROPN
ecj-11314	104	11	was	be	AUX
ecj-11314	104	12	reported	report	VERB
ecj-11314	104	13	in	in	ADP
ecj-11314	104	14	patients	patient	NOUN
ecj-11314	104	15	in	in	ADP
ecj-11314	104	16	relapse	relapse	NOUN
ecj-11314	104	17	than	than	ADP
ecj-11314	104	18	in	in	ADP
ecj-11314	104	19	patients	patient	NOUN
ecj-11314	104	20	in	in	ADP
ecj-11314	104	21	remission.20	remission.20	PROPN
ecj-11314	104	22	demirci	demirci	VERB
ecj-11314	104	23	et	et	PROPN
ecj-11314	104	24	al	al	PROPN
ecj-11314	104	25	.	.	PROPN
ecj-11314	104	26	revealed	reveal	VERB
ecj-11314	104	27	that	that	SCONJ
ecj-11314	104	28	nlr	nlr	PROPN
ecj-11314	104	29	predicted	predict	VERB
ecj-11314	104	30	disease	disease	NOUN
ecj-11314	104	31	activity	activity	NOUN
ecj-11314	104	32	with	with	ADP
ecj-11314	104	33	0.68	0.68	NUM
ecj-11314	104	34	auc	auc	NOUN
ecj-11314	104	35	,	,	PUNCT
ecj-11314	104	36	67	67	NUM
ecj-11314	104	37	%	%	NOUN
ecj-11314	104	38	sensitivity	sensitivity	NOUN
ecj-11314	104	39	and	and	CCONJ
ecj-11314	104	40	97	97	NUM
ecj-11314	104	41	%	%	NOUN
ecj-11314	104	42	specificity	specificity	NOUN
ecj-11314	104	43	in	in	ADP
ecj-11314	104	44	ms.11	ms.11	NOUN
ecj-11314	104	45	in	in	ADP
ecj-11314	104	46	a	a	DET
ecj-11314	104	47	retrospective	retrospective	ADJ
ecj-11314	104	48	study	study	NOUN
ecj-11314	104	49	of	of	ADP
ecj-11314	104	50	rrms	rrm	NOUN
ecj-11314	104	51	patients	patient	NOUN
ecj-11314	104	52	at	at	ADP
ecj-11314	104	53	an	an	DET
ecj-11314	104	54	ms	ms	PROPN
ecj-11314	104	55	center	center	PROPN
ecj-11314	104	56	in	in	ADP
ecj-11314	104	57	italy	italy	PROPN
ecj-11314	104	58	,	,	PUNCT
ecj-11314	104	59	a	a	DET
ecj-11314	104	60	high	high	ADJ
ecj-11314	104	61	nlr	nlr	PROPN
ecj-11314	104	62	was	be	AUX
ecj-11314	104	63	found	find	VERB
ecj-11314	104	64	to	to	PART
ecj-11314	104	65	be	be	AUX
ecj-11314	104	66	related	relate	VERB
ecj-11314	104	67	to	to	ADP
ecj-11314	104	68	disease	disease	NOUN
ecj-11314	104	69	activity.10	activity.10	NOUN
ecj-11314	104	70	in	in	ADP
ecj-11314	104	71	this	this	DET
ecj-11314	104	72	study	study	NOUN
ecj-11314	104	73	,	,	PUNCT
ecj-11314	104	74	nlr	nlr	PROPN
ecj-11314	104	75	was	be	AUX
ecj-11314	104	76	able	able	ADJ
ecj-11314	104	77	to	to	PART
ecj-11314	104	78	predict	predict	VERB
ecj-11314	104	79	the	the	DET
ecj-11314	104	80	active	active	ADJ
ecj-11314	104	81	period	period	NOUN
ecj-11314	104	82	in	in	ADP
ecj-11314	104	83	ms	ms	NOUN
ecj-11314	104	84	supporting	support	VERB
ecj-11314	104	85	the	the	DET
ecj-11314	104	86	literature	literature	NOUN
ecj-11314	104	87	.	.	PUNCT
ecj-11314	105	1	in	in	ADP
ecj-11314	105	2	ms	ms	PROPN
ecj-11314	105	3	pathogenesis	pathogenesis	NOUN
ecj-11314	105	4	,	,	PUNCT
ecj-11314	105	5	peripherally	peripherally	ADV
ecj-11314	105	6	activated	activate	VERB
ecj-11314	105	7	t	t	PROPN
ecj-11314	105	8	-	-	PUNCT
ecj-11314	105	9	cells	cell	NOUN
ecj-11314	105	10	recruit	recruit	VERB
ecj-11314	105	11	a	a	DET
ecj-11314	105	12	diverse	diverse	ADJ
ecj-11314	105	13	array	array	NOUN
ecj-11314	105	14	of	of	ADP
ecj-11314	105	15	myeloid	myeloid	ADJ
ecj-11314	105	16	cells	cell	NOUN
ecj-11314	105	17	,	,	PUNCT
ecj-11314	105	18	including	include	VERB
ecj-11314	105	19	monocytes	monocyte	NOUN
ecj-11314	105	20	/	/	SYM
ecj-11314	105	21	macrophages	macrophage	NOUN
ecj-11314	105	22	,	,	PUNCT
ecj-11314	105	23	to	to	PART
ecj-11314	105	24	promote	promote	VERB
ecj-11314	105	25	and	and	CCONJ
ecj-11314	105	26	drive	drive	VERB
ecj-11314	105	27	an	an	DET
ecj-11314	105	28	inflammatory	inflammatory	ADJ
ecj-11314	105	29	reaction	reaction	NOUN
ecj-11314	105	30	,	,	PUNCT
ecj-11314	105	31	often	often	ADV
ecj-11314	105	32	causing	cause	VERB
ecj-11314	105	33	axonal	axonal	ADJ
ecj-11314	105	34	transection	transection	NOUN
ecj-11314	105	35	and	and	CCONJ
ecj-11314	105	36	irreversible	irreversible	ADJ
ecj-11314	105	37	focal	focal	ADJ
ecj-11314	105	38	central	central	ADJ
ecj-11314	105	39	nervous	nervous	ADJ
ecj-11314	105	40	system	system	NOUN
ecj-11314	105	41	(	(	PUNCT
ecj-11314	105	42	cns	cns	NOUN
ecj-11314	105	43	)	)	PUNCT
ecj-11314	105	44	damage.2	damage.2	PROPN
ecj-11314	105	45	lmr	lmr	PROPN
ecj-11314	105	46	has	have	AUX
ecj-11314	105	47	been	be	AUX
ecj-11314	105	48	demonstrated	demonstrate	VERB
ecj-11314	105	49	to	to	PART
ecj-11314	105	50	be	be	AUX
ecj-11314	105	51	a	a	DET
ecj-11314	105	52	marker	marker	NOUN
ecj-11314	105	53	of	of	ADP
ecj-11314	105	54	the	the	DET
ecj-11314	105	55	systemic	systemic	ADJ
ecj-11314	105	56	inflammatory	inflammatory	ADJ
ecj-11314	105	57	response	response	NOUN
ecj-11314	105	58	and	and	CCONJ
ecj-11314	105	59	a	a	DET
ecj-11314	105	60	potential	potential	ADJ
ecj-11314	105	61	prognostic	prognostic	ADJ
ecj-11314	105	62	factor	factor	NOUN
ecj-11314	105	63	in	in	ADP
ecj-11314	105	64	a	a	DET
ecj-11314	105	65	number	number	NOUN
ecj-11314	105	66	of	of	ADP
ecj-11314	105	67	cancers.21	cancers.21	NOUN
ecj-11314	105	68	in	in	ADP
ecj-11314	105	69	this	this	DET
ecj-11314	105	70	study	study	NOUN
ecj-11314	105	71	,	,	PUNCT
ecj-11314	105	72	the	the	DET
ecj-11314	105	73	mlr	mlr	NOUN
ecj-11314	105	74	was	be	AUX
ecj-11314	105	75	higher	high	ADJ
ecj-11314	105	76	in	in	ADP
ecj-11314	105	77	the	the	DET
ecj-11314	105	78	attack	attack	NOUN
ecj-11314	105	79	periods	period	NOUN
ecj-11314	105	80	compared	compare	VERB
ecj-11314	105	81	to	to	ADP
ecj-11314	105	82	the	the	DET
ecj-11314	105	83	attack	attack	NOUN
ecj-11314	105	84	-	-	PUNCT
ecj-11314	105	85	free	free	ADJ
ecj-11314	105	86	period	period	NOUN
ecj-11314	105	87	may	may	AUX
ecj-11314	105	88	be	be	AUX
ecj-11314	105	89	the	the	DET
ecj-11314	105	90	reflection	reflection	NOUN
ecj-11314	105	91	of	of	ADP
ecj-11314	105	92	the	the	DET
ecj-11314	105	93	inflammatory	inflammatory	ADJ
ecj-11314	105	94	state	state	NOUN
ecj-11314	105	95	in	in	ADP
ecj-11314	105	96	the	the	DET
ecj-11314	105	97	central	central	ADJ
ecj-11314	105	98	nervous	nervous	ADJ
ecj-11314	105	99	system	system	NOUN
ecj-11314	105	100	in	in	ADP
ecj-11314	105	101	ms	ms	NOUN
ecj-11314	105	102	to	to	ADP
ecj-11314	105	103	the	the	DET
ecj-11314	105	104	peripheral	peripheral	ADJ
ecj-11314	105	105	immune	immune	ADJ
ecj-11314	105	106	status	status	NOUN
ecj-11314	105	107	.	.	PUNCT
ecj-11314	106	1	in	in	ADP
ecj-11314	106	2	the	the	DET
ecj-11314	106	3	study	study	NOUN
ecj-11314	106	4	of	of	ADP
ecj-11314	106	5	hemond	hemond	NOUN
ecj-11314	106	6	et	et	PROPN
ecj-11314	106	7	al	al	PROPN
ecj-11314	106	8	.	.	PROPN
ecj-11314	107	1	in	in	ADP
ecj-11314	107	2	ms	ms	ADJ
ecj-11314	107	3	patients	patient	NOUN
ecj-11314	107	4	,	,	PUNCT
ecj-11314	107	5	high	high	ADJ
ecj-11314	107	6	mlr	mlr	NOUN
ecj-11314	107	7	was	be	AUX
ecj-11314	107	8	significantly	significantly	ADV
ecj-11314	107	9	associated	associate	VERB
ecj-11314	107	10	with	with	ADP
ecj-11314	107	11	physical	physical	ADJ
ecj-11314	107	12	disability	disability	NOUN
ecj-11314	107	13	status	status	NOUN
ecj-11314	107	14	score	score	NOUN
ecj-11314	107	15	(	(	PUNCT
ecj-11314	107	16	edss	edss	ADV
ecj-11314	107	17	)	)	PUNCT
ecj-11314	107	18	and	and	CCONJ
ecj-11314	107	19	brain	brain	NOUN
ecj-11314	107	20	atrophy	atrophy	NOUN
ecj-11314	107	21	.	.	PUNCT
ecj-11314	108	1	that	that	PRON
ecj-11314	108	2	is	is	ADV
ecj-11314	108	3	,	,	PUNCT
ecj-11314	108	4	mlr	mlr	PROPN
ecj-11314	108	5	was	be	AUX
ecj-11314	108	6	high	high	ADJ
ecj-11314	108	7	in	in	ADP
ecj-11314	108	8	ms	ms	NOUN
ecj-11314	108	9	when	when	SCONJ
ecj-11314	108	10	clinical	clinical	ADJ
ecj-11314	108	11	and	and	CCONJ
ecj-11314	108	12	neuroimaging	neuroimaging	NOUN
ecj-11314	108	13	were	be	AUX
ecj-11314	108	14	poor.22	poor.22	NOUN
ecj-11314	108	15	similarly	similarly	ADV
ecj-11314	108	16	,	,	PUNCT
ecj-11314	108	17	in	in	ADP
ecj-11314	108	18	this	this	DET
ecj-11314	108	19	study	study	NOUN
ecj-11314	108	20	,	,	PUNCT
ecj-11314	108	21	mlr	mlr	PROPN
ecj-11314	108	22	was	be	AUX
ecj-11314	108	23	high	high	ADJ
ecj-11314	108	24	during	during	ADP
ecj-11314	108	25	the	the	DET
ecj-11314	108	26	ms	ms	PROPN
ecj-11314	108	27	attack	attack	NOUN
ecj-11314	108	28	period	period	NOUN
ecj-11314	108	29	when	when	SCONJ
ecj-11314	108	30	the	the	DET
ecj-11314	108	31	clinic	clinic	NOUN
ecj-11314	108	32	was	be	AUX
ecj-11314	108	33	exacerbated	exacerbate	VERB
ecj-11314	108	34	.	.	PUNCT
ecj-11314	109	1	sii	sii	PROPN
ecj-11314	109	2	is	be	AUX
ecj-11314	109	3	a	a	DET
ecj-11314	109	4	new	new	ADJ
ecj-11314	109	5	inflammatory	inflammatory	ADJ
ecj-11314	109	6	index	index	NOUN
ecj-11314	109	7	that	that	PRON
ecj-11314	109	8	exhaustively	exhaustively	ADV
ecj-11314	109	9	demonstrates	demonstrate	VERB
ecj-11314	109	10	the	the	DET
ecj-11314	109	11	host	host	NOUN
ecj-11314	109	12	immune	immune	ADJ
ecj-11314	109	13	and	and	CCONJ
ecj-11314	109	14	inflammatory	inflammatory	ADJ
ecj-11314	109	15	state	state	NOUN
ecj-11314	109	16	balance.23	balance.23	NOUN
ecj-11314	109	17	a	a	DET
ecj-11314	109	18	high	high	ADJ
ecj-11314	109	19	sii	sii	ADJ
ecj-11314	109	20	score	score	NOUN
ecj-11314	109	21	has	have	AUX
ecj-11314	109	22	been	be	AUX
ecj-11314	109	23	linked	link	VERB
ecj-11314	109	24	to	to	ADP
ecj-11314	109	25	poor	poor	ADJ
ecj-11314	109	26	outcomes	outcome	NOUN
ecj-11314	109	27	in	in	ADP
ecj-11314	109	28	cancer	cancer	NOUN
ecj-11314	109	29	patients	patient	NOUN
ecj-11314	109	30	,	,	PUNCT
ecj-11314	109	31	heart	heart	NOUN
ecj-11314	109	32	failure	failure	NOUN
ecj-11314	109	33	,	,	PUNCT
ecj-11314	109	34	and	and	CCONJ
ecj-11314	109	35	coronary	coronary	ADJ
ecj-11314	109	36	artery	artery	NOUN
ecj-11314	109	37	disease.15	disease.15	PROPN
ecj-11314	109	38	however	however	ADV
ecj-11314	109	39	,	,	PUNCT
ecj-11314	109	40	the	the	DET
ecj-11314	109	41	relationship	relationship	NOUN
ecj-11314	109	42	between	between	ADP
ecj-11314	109	43	sii	sii	PROPN
ecj-11314	109	44	and	and	CCONJ
ecj-11314	109	45	ms	ms	NOUN
ecj-11314	109	46	attacks	attack	NOUN
ecj-11314	109	47	is	be	AUX
ecj-11314	109	48	unclear	unclear	ADJ
ecj-11314	109	49	.	.	PUNCT
ecj-11314	110	1	this	this	DET
ecj-11314	110	2	study	study	NOUN
ecj-11314	110	3	found	find	VERB
ecj-11314	110	4	sii	sii	PROPN
ecj-11314	110	5	to	to	PART
ecj-11314	110	6	be	be	AUX
ecj-11314	110	7	closely	closely	ADV
ecj-11314	110	8	associated	associate	VERB
ecj-11314	110	9	with	with	ADP
ecj-11314	110	10	disease	disease	NOUN
ecj-11314	110	11	activity	activity	NOUN
ecj-11314	110	12	.	.	PUNCT
ecj-11314	111	1	an	an	DET
ecj-11314	111	2	all	all	ADV
ecj-11314	111	3	-	-	PUNCT
ecj-11314	111	4	encompassing	encompass	VERB
ecj-11314	111	5	inflammatory	inflammatory	ADJ
ecj-11314	111	6	biomarker	biomarker	NOUN
ecj-11314	111	7	like	like	SCONJ
ecj-11314	111	8	sii	sii	PROPN
ecj-11314	111	9	elevated	elevate	VERB
ecj-11314	111	10	during	during	ADP
ecj-11314	111	11	an	an	DET
ecj-11314	111	12	ms	ms	NOUN
ecj-11314	111	13	attack	attack	NOUN
ecj-11314	111	14	could	could	AUX
ecj-11314	111	15	be	be	AUX
ecj-11314	111	16	related	relate	VERB
ecj-11314	111	17	to	to	ADP
ecj-11314	111	18	the	the	DET
ecj-11314	111	19	peak	peak	NOUN
ecj-11314	111	20	of	of	ADP
ecj-11314	111	21	inflammatory	inflammatory	ADJ
ecj-11314	111	22	activity	activity	NOUN
ecj-11314	111	23	during	during	ADP
ecj-11314	111	24	this	this	DET
ecj-11314	111	25	time	time	NOUN
ecj-11314	111	26	.	.	PUNCT
ecj-11314	112	1	in	in	ADP
ecj-11314	112	2	a	a	DET
ecj-11314	112	3	recent	recent	ADJ
ecj-11314	112	4	study	study	NOUN
ecj-11314	112	5	,	,	PUNCT
ecj-11314	112	6	inflammatory	inflammatory	ADJ
ecj-11314	112	7	markers	marker	NOUN
ecj-11314	112	8	such	such	ADJ
ecj-11314	112	9	as	as	ADP
ecj-11314	112	10	interleukin	interleukin	NOUN
ecj-11314	112	11	4	4	NUM
ecj-11314	112	12	,	,	PUNCT
ecj-11314	112	13	parathormone	parathormone	NOUN
ecj-11314	112	14	,	,	PUNCT
ecj-11314	112	15	homocysteine	homocysteine	NOUN
ecj-11314	112	16	,	,	PUNCT
ecj-11314	112	17	and	and	CCONJ
ecj-11314	112	18	interleukin	interleukin	NOUN
ecj-11314	112	19	17	17	NUM
ecj-11314	112	20	were	be	AUX
ecj-11314	112	21	associated	associate	VERB
ecj-11314	112	22	with	with	ADP
ecj-11314	112	23	disability	disability	NOUN
ecj-11314	112	24	and	and	CCONJ
ecj-11314	112	25	disease	disease	NOUN
ecj-11314	112	26	activity	activity	NOUN
ecj-11314	112	27	in	in	ADP
ecj-11314	112	28	ms.24	ms.24	PROPN
ecj-11314	112	29	rlr	rlr	PROPN
ecj-11314	112	30	is	be	AUX
ecj-11314	112	31	one	one	NUM
ecj-11314	112	32	of	of	ADP
ecj-11314	112	33	the	the	DET
ecj-11314	112	34	novel	novel	NOUN
ecj-11314	112	35	defined	define	VERB
ecj-11314	112	36	inflammatory	inflammatory	ADJ
ecj-11314	112	37	indices	index	NOUN
ecj-11314	112	38	.	.	PUNCT
ecj-11314	113	1	wu	wu	PROPN
ecj-11314	113	2	et	et	PROPN
ecj-11314	113	3	al	al	PROPN
ecj-11314	113	4	.	.	PROPN
ecj-11314	113	5	discovered	discover	VERB
ecj-11314	113	6	that	that	SCONJ
ecj-11314	113	7	rlr	rlr	PROPN
ecj-11314	113	8	has	have	VERB
ecj-11314	113	9	high	high	ADJ
ecj-11314	113	10	sensitivity	sensitivity	NOUN
ecj-11314	113	11	and	and	CCONJ
ecj-11314	113	12	specificity	specificity	NOUN
ecj-11314	113	13	in	in	ADP
ecj-11314	113	14	predicting	predict	VERB
ecj-11314	113	15	hepatic	hepatic	ADJ
ecj-11314	113	16	impairment	impairment	NOUN
ecj-11314	113	17	in	in	ADP
ecj-11314	113	18	patients	patient	NOUN
ecj-11314	113	19	with	with	ADP
ecj-11314	113	20	the	the	DET
ecj-11314	113	21	hepatitis	hepatitis	PROPN
ecj-11314	113	22	e	e	PROPN
ecj-11314	113	23	virus.25	virus.25	NOUN
ecj-11314	113	24	meng	meng	PROPN
ecj-11314	113	25	et	et	PROPN
ecj-11314	113	26	al	al	PROPN
ecj-11314	113	27	.	.	PROPN
ecj-11314	113	28	demonstrated	demonstrate	VERB
ecj-11314	113	29	that	that	SCONJ
ecj-11314	113	30	rlr	rlr	PROPN
ecj-11314	113	31	could	could	AUX
ecj-11314	113	32	predict	predict	VERB
ecj-11314	113	33	the	the	DET
ecj-11314	113	34	severity	severity	NOUN
ecj-11314	113	35	of	of	ADP
ecj-11314	113	36	primary	primary	ADJ
ecj-11314	113	37	biliary	biliary	NOUN
ecj-11314	113	38	cirrhosis	cirrhosis	NOUN
ecj-11314	113	39	due	due	ADP
ecj-11314	113	40	to	to	ADP
ecj-11314	113	41	its	its	PRON
ecj-11314	113	42	high	high	ADJ
ecj-11314	113	43	diagnostic	diagnostic	ADJ
ecj-11314	113	44	specificity.26	specificity.26	NOUN
ecj-11314	113	45	the	the	DET
ecj-11314	113	46	relationship	relationship	NOUN
ecj-11314	113	47	between	between	ADP
ecj-11314	113	48	rlr	rlr	PROPN
ecj-11314	113	49	and	and	CCONJ
ecj-11314	113	50	ms	ms	PROPN
ecj-11314	113	51	attack	attack	NOUN
ecj-11314	113	52	has	have	AUX
ecj-11314	113	53	not	not	PART
ecj-11314	113	54	been	be	AUX
ecj-11314	113	55	addressed	address	VERB
ecj-11314	113	56	in	in	ADP
ecj-11314	113	57	any	any	DET
ecj-11314	113	58	previous	previous	ADJ
ecj-11314	113	59	study	study	NOUN
ecj-11314	113	60	.	.	PUNCT
ecj-11314	114	1	according	accord	VERB
ecj-11314	114	2	to	to	ADP
ecj-11314	114	3	this	this	DET
ecj-11314	114	4	study	study	NOUN
ecj-11314	114	5	’s	’s	PART
ecj-11314	114	6	results	result	NOUN
ecj-11314	114	7	,	,	PUNCT
ecj-11314	114	8	rlr	rlr	PROPN
ecj-11314	114	9	was	be	AUX
ecj-11314	114	10	observed	observe	VERB
ecj-11314	114	11	to	to	PART
ecj-11314	114	12	be	be	AUX
ecj-11314	114	13	higher	high	ADJ
ecj-11314	114	14	in	in	ADP
ecj-11314	114	15	the	the	DET
ecj-11314	114	16	ms	ms	PROPN
ecj-11314	114	17	attack	attack	NOUN
ecj-11314	114	18	period	period	NOUN
ecj-11314	114	19	.	.	PUNCT
ecj-11314	115	1	limitations	limitation	NOUN
ecj-11314	115	2	the	the	DET
ecj-11314	115	3	most	most	ADV
ecj-11314	115	4	critical	critical	ADJ
ecj-11314	115	5	limitation	limitation	NOUN
ecj-11314	115	6	of	of	ADP
ecj-11314	115	7	our	our	PRON
ecj-11314	115	8	study	study	NOUN
ecj-11314	115	9	is	be	AUX
ecj-11314	115	10	the	the	DET
ecj-11314	115	11	small	small	ADJ
ecj-11314	115	12	number	number	NOUN
ecj-11314	115	13	of	of	ADP
ecj-11314	115	14	patients	patient	NOUN
ecj-11314	115	15	.	.	PUNCT
ecj-11314	116	1	the	the	DET
ecj-11314	116	2	reason	reason	NOUN
ecj-11314	116	3	for	for	ADP
ecj-11314	116	4	this	this	PRON
ecj-11314	116	5	is	be	AUX
ecj-11314	116	6	the	the	DET
ecj-11314	116	7	low	low	ADJ
ecj-11314	116	8	frequency	frequency	NOUN
ecj-11314	116	9	of	of	ADP
ecj-11314	116	10	ms	ms	PROPN
ecj-11314	116	11	disease	disease	NOUN
ecj-11314	116	12	in	in	ADP
ecj-11314	116	13	the	the	DET
ecj-11314	116	14	community	community	NOUN
ecj-11314	116	15	and	and	CCONJ
ecj-11314	116	16	,	,	PUNCT
ecj-11314	116	17	therefore	therefore	ADV
ecj-11314	116	18	,	,	PUNCT
ecj-11314	116	19	the	the	DET
ecj-11314	116	20	low	low	ADJ
ecj-11314	116	21	number	number	NOUN
ecj-11314	116	22	of	of	ADP
ecj-11314	116	23	emergency	emergency	NOUN
ecj-11314	116	24	department	department	NOUN
ecj-11314	116	25	admissions	admission	NOUN
ecj-11314	116	26	.	.	PUNCT
ecj-11314	117	1	another	another	DET
ecj-11314	117	2	limitation	limitation	NOUN
ecj-11314	117	3	of	of	ADP
ecj-11314	117	4	our	our	PRON
ecj-11314	117	5	study	study	NOUN
ecj-11314	117	6	is	be	AUX
ecj-11314	117	7	that	that	SCONJ
ecj-11314	117	8	it	it	PRON
ecj-11314	117	9	was	be	AUX
ecj-11314	117	10	conducted	conduct	VERB
ecj-11314	117	11	retrospectively	retrospectively	ADV
ecj-11314	117	12	.	.	PUNCT
ecj-11314	118	1	however	however	ADV
ecj-11314	118	2	,	,	PUNCT
ecj-11314	118	3	we	we	PRON
ecj-11314	118	4	think	think	VERB
ecj-11314	118	5	that	that	SCONJ
ecj-11314	118	6	prospective	prospective	ADJ
ecj-11314	118	7	studies	study	NOUN
ecj-11314	118	8	planned	plan	VERB
ecj-11314	118	9	in	in	ADP
ecj-11314	118	10	the	the	DET
ecj-11314	118	11	long	long	ADJ
ecj-11314	118	12	term	term	NOUN
ecj-11314	118	13	will	will	AUX
ecj-11314	118	14	support	support	VERB
ecj-11314	118	15	the	the	DET
ecj-11314	118	16	findings	finding	NOUN
ecj-11314	118	17	of	of	ADP
ecj-11314	118	18	our	our	PRON
ecj-11314	118	19	research	research	NOUN
ecj-11314	118	20	.	.	PUNCT
ecj-11314	119	1	the	the	DET
ecj-11314	119	2	study	study	NOUN
ecj-11314	119	3	only	only	ADV
ecj-11314	119	4	included	include	VERB
ecj-11314	119	5	patients	patient	NOUN
ecj-11314	119	6	with	with	ADP
ecj-11314	119	7	rrms	rrm	NOUN
ecj-11314	119	8	from	from	ADP
ecj-11314	119	9	various	various	ADJ
ecj-11314	119	10	ms	ms	PROPN
ecj-11314	119	11	types	type	NOUN
ecj-11314	119	12	.	.	PUNCT
ecj-11314	120	1	therefore	therefore	ADV
ecj-11314	120	2	,	,	PUNCT
ecj-11314	120	3	the	the	DET
ecj-11314	120	4	results	result	NOUN
ecj-11314	120	5	we	we	PRON
ecj-11314	120	6	found	find	VERB
ecj-11314	120	7	are	be	AUX
ecj-11314	120	8	valid	valid	ADJ
ecj-11314	120	9	only	only	ADV
ecj-11314	120	10	for	for	ADP
ecj-11314	120	11	rrms	rrm	NOUN
ecj-11314	120	12	.	.	PUNCT
ecj-11314	121	1	moreover	moreover	ADV
ecj-11314	121	2	,	,	PUNCT
ecj-11314	121	3	since	since	SCONJ
ecj-11314	121	4	the	the	DET
ecj-11314	121	5	edss	edss	ADJ
ecj-11314	121	6	score	score	NOUN
ecj-11314	121	7	was	be	AUX
ecj-11314	121	8	not	not	PART
ecj-11314	121	9	calculated	calculate	VERB
ecj-11314	121	10	in	in	ADP
ecj-11314	121	11	the	the	DET
ecj-11314	121	12	study	study	NOUN
ecj-11314	121	13	,	,	PUNCT
ecj-11314	121	14	the	the	DET
ecj-11314	121	15	relationship	relationship	NOUN
ecj-11314	121	16	between	between	ADP
ecj-11314	121	17	it	it	PRON
ecj-11314	121	18	and	and	CCONJ
ecj-11314	121	19	inflammatory	inflammatory	ADJ
ecj-11314	121	20	markers	marker	NOUN
ecj-11314	121	21	could	could	AUX
ecj-11314	121	22	not	not	PART
ecj-11314	121	23	be	be	AUX
ecj-11314	121	24	determined	determine	VERB
ecj-11314	121	25	.	.	PUNCT
ecj-11314	122	1	in	in	ADP
ecj-11314	122	2	addition	addition	NOUN
ecj-11314	122	3	,	,	PUNCT
ecj-11314	122	4	the	the	DET
ecj-11314	122	5	duration	duration	NOUN
ecj-11314	122	6	of	of	ADP
ecj-11314	122	7	the	the	DET
ecj-11314	122	8	onset	onset	NOUN
ecj-11314	122	9	of	of	ADP
ecj-11314	122	10	ms	ms	NOUN
ecj-11314	122	11	attack	attack	NOUN
ecj-11314	122	12	at	at	ADP
ecj-11314	122	13	the	the	DET
ecj-11314	122	14	time	time	NOUN
ecj-11314	122	15	of	of	ADP
ecj-11314	122	16	being	be	AUX
ecj-11314	122	17	admitted	admit	VERB
ecj-11314	122	18	to	to	ADP
ecj-11314	122	19	the	the	DET
ecj-11314	122	20	emergency	emergency	NOUN
ecj-11314	122	21	department	department	NOUN
ecj-11314	122	22	is	be	AUX
ecj-11314	122	23	uncertain	uncertain	ADJ
ecj-11314	122	24	.	.	PUNCT
ecj-11314	123	1	thus	thus	ADV
ecj-11314	123	2	,	,	PUNCT
ecj-11314	123	3	it	it	PRON
ecj-11314	123	4	is	be	AUX
ecj-11314	123	5	unclear	unclear	ADJ
ecj-11314	123	6	in	in	SCONJ
ecj-11314	123	7	which	which	DET
ecj-11314	123	8	part	part	NOUN
ecj-11314	123	9	of	of	ADP
ecj-11314	123	10	the	the	DET
ecj-11314	123	11	attack	attack	NOUN
ecj-11314	123	12	period	period	NOUN
ecj-11314	123	13	the	the	DET
ecj-11314	123	14	hematological	hematological	ADJ
ecj-11314	123	15	markers	marker	NOUN
ecj-11314	123	16	were	be	AUX
ecj-11314	123	17	obtained	obtain	VERB
ecj-11314	123	18	.	.	PUNCT
ecj-11314	124	1	the	the	DET
ecj-11314	124	2	relapse	relapse	NOUN
ecj-11314	124	3	status	status	NOUN
ecj-11314	124	4	of	of	ADP
ecj-11314	124	5	the	the	DET
ecj-11314	124	6	patients	patient	NOUN
ecj-11314	124	7	was	be	AUX
ecj-11314	124	8	evaluated	evaluate	VERB
ecj-11314	124	9	clinically	clinically	ADV
ecj-11314	124	10	and	and	CCONJ
ecj-11314	124	11	history	history	NOUN
ecj-11314	124	12	,	,	PUNCT
ecj-11314	124	13	and	and	CCONJ
ecj-11314	124	14	mri	mri	NOUN
ecj-11314	124	15	lesions	lesion	NOUN
ecj-11314	124	16	were	be	AUX
ecj-11314	124	17	not	not	PART
ecj-11314	124	18	included	include	VERB
ecj-11314	124	19	in	in	ADP
ecj-11314	124	20	the	the	DET
ecj-11314	124	21	study	study	NOUN
ecj-11314	124	22	.	.	PUNCT
ecj-11314	125	1	the	the	DET
ecj-11314	125	2	attack	attack	NOUN
ecj-11314	125	3	period	period	NOUN
ecj-11314	125	4	status	status	NOUN
ecj-11314	125	5	was	be	AUX
ecj-11314	125	6	not	not	PART
ecj-11314	125	7	evaluated	evaluate	VERB
ecj-11314	125	8	according	accord	VERB
ecj-11314	125	9	to	to	ADP
ecj-11314	125	10	the	the	DET
ecj-11314	125	11	type	type	NOUN
ecj-11314	125	12	of	of	ADP
ecj-11314	125	13	treatment	treatment	NOUN
ecj-11314	125	14	received	receive	VERB
ecj-11314	125	15	by	by	ADP
ecj-11314	125	16	the	the	DET
ecj-11314	125	17	patients	patient	NOUN
ecj-11314	125	18	.	.	PUNCT
ecj-11314	126	1	this	this	DET
ecj-11314	126	2	issue	issue	NOUN
ecj-11314	126	3	may	may	AUX
ecj-11314	126	4	be	be	AUX
ecj-11314	126	5	investigated	investigate	VERB
ecj-11314	126	6	in	in	ADP
ecj-11314	126	7	future	future	ADJ
ecj-11314	126	8	studies	study	NOUN
ecj-11314	126	9	.	.	PUNCT
ecj-11314	127	1	conclusions	conclusion	NOUN
ecj-11314	127	2	it	it	PRON
ecj-11314	127	3	is	be	AUX
ecj-11314	127	4	crucial	crucial	ADJ
ecj-11314	127	5	in	in	ADP
ecj-11314	127	6	the	the	DET
ecj-11314	127	7	emergency	emergency	NOUN
ecj-11314	127	8	department	department	NOUN
ecj-11314	127	9	to	to	PART
ecj-11314	127	10	identify	identify	VERB
ecj-11314	127	11	the	the	DET
ecj-11314	127	12	patients	patient	NOUN
ecj-11314	127	13	with	with	ADP
ecj-11314	127	14	rrms	rrm	NOUN
ecj-11314	127	15	who	who	PRON
ecj-11314	127	16	are	be	AUX
ecj-11314	127	17	in	in	ADP
ecj-11314	127	18	the	the	DET
ecj-11314	127	19	attack	attack	NOUN
ecj-11314	127	20	phase	phase	NOUN
ecj-11314	127	21	.	.	PUNCT
ecj-11314	128	1	inflammatory	inflammatory	ADJ
ecj-11314	128	2	markers	marker	NOUN
ecj-11314	128	3	contribute	contribute	VERB
ecj-11314	128	4	to	to	ADP
ecj-11314	128	5	this	this	DET
ecj-11314	128	6	process	process	NOUN
ecj-11314	128	7	.	.	PUNCT
ecj-11314	129	1	according	accord	VERB
ecj-11314	129	2	to	to	ADP
ecj-11314	129	3	our	our	PRON
ecj-11314	129	4	findings	finding	NOUN
ecj-11314	129	5	,	,	PUNCT
ecj-11314	129	6	sii	sii	PROPN
ecj-11314	129	7	,	,	PUNCT
ecj-11314	129	8	mlr	mlr	PROPN
ecj-11314	129	9	,	,	PUNCT
ecj-11314	129	10	nlr	nlr	PROPN
ecj-11314	129	11	,	,	PUNCT
ecj-11314	129	12	and	and	CCONJ
ecj-11314	129	13	rlr	rlr	PROPN
ecj-11314	129	14	may	may	AUX
ecj-11314	129	15	be	be	AUX
ecj-11314	129	16	beneficial	beneficial	ADJ
ecj-11314	129	17	in	in	ADP
ecj-11314	129	18	confirming	confirm	VERB
ecj-11314	129	19	the	the	DET
ecj-11314	129	20	attack	attack	NOUN
ecj-11314	129	21	diagnosis	diagnosis	NOUN
ecj-11314	129	22	in	in	ADP
ecj-11314	129	23	patients	patient	NOUN
ecj-11314	129	24	with	with	ADP
ecj-11314	129	25	rrms	rrm	NOUN
ecj-11314	129	26	who	who	PRON
ecj-11314	129	27	present	present	VERB
ecj-11314	129	28	to	to	ADP
ecj-11314	129	29	the	the	DET
ecj-11314	129	30	emergency	emergency	NOUN
ecj-11314	129	31	department	department	NOUN
ecj-11314	129	32	.	.	PUNCT
ecj-11314	130	1	however	however	ADV
ecj-11314	130	2	,	,	PUNCT
ecj-11314	130	3	large	large	ADJ
ecj-11314	130	4	-	-	PUNCT
ecj-11314	130	5	scale	scale	NOUN
ecj-11314	130	6	studies	study	NOUN
ecj-11314	130	7	are	be	AUX
ecj-11314	130	8	required	require	VERB
ecj-11314	130	9	for	for	ADP
ecj-11314	130	10	more	more	ADV
ecj-11314	130	11	conclusive	conclusive	ADJ
ecj-11314	130	12	results	result	NOUN
ecj-11314	130	13	.	.	PUNCT
ecj-11314	131	1	references	reference	NOUN
ecj-11314	131	2	1	1	NUM
ecj-11314	131	3	.	.	PUNCT
ecj-11314	131	4	reich	reich	PROPN
ecj-11314	131	5	ds	ds	PROPN
ecj-11314	131	6	,	,	PUNCT
ecj-11314	131	7	lucchinetti	lucchinetti	PROPN
ecj-11314	131	8	cf	cf	PROPN
ecj-11314	131	9	,	,	PUNCT
ecj-11314	131	10	calabresi	calabresi	PROPN
ecj-11314	131	11	pa	pa	PROPN
ecj-11314	131	12	.	.	PROPN
ecj-11314	131	13	multiple	multiple	ADJ
ecj-11314	131	14	sclerosis	sclerosis	NOUN
ecj-11314	131	15	.	.	PUNCT
ecj-11314	132	1	longo	longo	PROPN
ecj-11314	132	2	dl	dl	PROPN
ecj-11314	132	3	,	,	PUNCT
ecj-11314	132	4	editor	editor	NOUN
ecj-11314	132	5	.	.	PUNCT
ecj-11314	133	1	n	n	PROPN
ecj-11314	133	2	engl	engl	PROPN
ecj-11314	133	3	j	j	PROPN
ecj-11314	133	4	med	med	PROPN
ecj-11314	133	5	2018;378:169	2018;378:169	PROPN
ecj-11314	133	6	-	-	SYM
ecj-11314	133	7	80	80	NUM
ecj-11314	133	8	.	.	PUNCT
ecj-11314	134	1	2	2	NUM
ecj-11314	134	2	.	.	PUNCT
ecj-11314	134	3	hemmer	hemmer	PROPN
ecj-11314	134	4	b	b	PROPN
ecj-11314	134	5	,	,	PUNCT
ecj-11314	134	6	kerschensteiner	kerschensteiner	PROPN
ecj-11314	134	7	m	m	PROPN
ecj-11314	134	8	,	,	PUNCT
ecj-11314	134	9	korn	korn	PROPN
ecj-11314	134	10	t.	t.	NOUN
ecj-11314	134	11	role	role	NOUN
ecj-11314	134	12	of	of	ADP
ecj-11314	134	13	the	the	DET
ecj-11314	134	14	innate	innate	ADJ
ecj-11314	134	15	and	and	CCONJ
ecj-11314	134	16	adaptive	adaptive	ADJ
ecj-11314	134	17	immune	immune	ADJ
ecj-11314	134	18	responses	response	NOUN
ecj-11314	134	19	in	in	ADP
ecj-11314	134	20	the	the	DET
ecj-11314	134	21	course	course	NOUN
ecj-11314	134	22	of	of	ADP
ecj-11314	134	23	multiple	multiple	ADJ
ecj-11314	134	24	sclerosis	sclerosis	NOUN
ecj-11314	134	25	.	.	PUNCT
ecj-11314	135	1	lancet	lancet	PROPN
ecj-11314	135	2	neurol	neurol	PROPN
ecj-11314	135	3	2015;14:406	2015;14:406	PROPN
ecj-11314	135	4	-	-	SYM
ecj-11314	135	5	19	19	NUM
ecj-11314	135	6	.	.	NOUN
ecj-11314	135	7	3	3	X
ecj-11314	135	8	.	.	X
ecj-11314	135	9	inojosa	inojosa	PROPN
ecj-11314	135	10	h	h	PROPN
ecj-11314	135	11	,	,	PUNCT
ecj-11314	135	12	schriefer	schriefer	NOUN
ecj-11314	135	13	d	d	PROPN
ecj-11314	135	14	,	,	PUNCT
ecj-11314	135	15	ziemssen	ziemssen	PROPN
ecj-11314	135	16	t.	t.	PROPN
ecj-11314	135	17	clinical	clinical	ADJ
ecj-11314	135	18	outcome	outcome	NOUN
ecj-11314	135	19	measures	measure	NOUN
ecj-11314	135	20	in	in	ADP
ecj-11314	135	21	multiple	multiple	ADJ
ecj-11314	135	22	sclerosis	sclerosis	NOUN
ecj-11314	135	23	:	:	PUNCT
ecj-11314	135	24	a	a	DET
ecj-11314	135	25	review	review	NOUN
ecj-11314	135	26	.	.	PUNCT
ecj-11314	136	1	autoimmun	autoimmun	PROPN
ecj-11314	136	2	rev	rev	PROPN
ecj-11314	136	3	2020;19	2020;19	NUM
ecj-11314	136	4	:	:	PUNCT
ecj-11314	136	5	102512	102512	NUM
ecj-11314	136	6	.	.	PUNCT
ecj-11314	137	1	4	4	X
ecj-11314	137	2	.	.	X
ecj-11314	137	3	olsson	olsson	PROPN
ecj-11314	137	4	t	t	PROPN
ecj-11314	137	5	,	,	PUNCT
ecj-11314	137	6	barcellos	barcellos	PROPN
ecj-11314	137	7	lf	lf	PROPN
ecj-11314	137	8	,	,	PUNCT
ecj-11314	137	9	alfredsson	alfredsson	PROPN
ecj-11314	137	10	l.	l.	PROPN
ecj-11314	137	11	interactions	interaction	NOUN
ecj-11314	137	12	between	between	ADP
ecj-11314	137	13	genetic	genetic	ADJ
ecj-11314	137	14	,	,	PUNCT
ecj-11314	137	15	lifestyle	lifestyle	NOUN
ecj-11314	137	16	and	and	CCONJ
ecj-11314	137	17	environmental	environmental	ADJ
ecj-11314	137	18	risk	risk	NOUN
ecj-11314	137	19	factors	factor	NOUN
ecj-11314	137	20	for	for	ADP
ecj-11314	137	21	multiple	multiple	ADJ
ecj-11314	137	22	sclerosis	sclerosis	NOUN
ecj-11314	137	23	.	.	PUNCT
ecj-11314	138	1	nat	nat	PROPN
ecj-11314	138	2	rev	rev	VERB
ecj-11314	138	3	neurol	neurol	PROPN
ecj-11314	138	4	2017;13:26	2017;13:26	PROPN
ecj-11314	138	5	-	-	SYM
ecj-11314	138	6	36	36	NUM
ecj-11314	138	7	.	.	PUNCT
ecj-11314	139	1	5	5	NUM
ecj-11314	139	2	.	.	PUNCT
ecj-11314	139	3	d’amico	d’amico	PROPN
ecj-11314	139	4	e	e	PROPN
ecj-11314	139	5	,	,	PUNCT
ecj-11314	139	6	zanghì	zanghì	X
ecj-11314	139	7	a	a	X
ecj-11314	139	8	,	,	PUNCT
ecj-11314	139	9	gastaldi	gastaldi	PROPN
ecj-11314	139	10	m	m	PROPN
ecj-11314	139	11	,	,	PUNCT
ecj-11314	139	12	et	et	PROPN
ecj-11314	139	13	al	al	PROPN
ecj-11314	139	14	.	.	PUNCT
ecj-11314	140	1	placing	place	VERB
ecj-11314	140	2	cd20	cd20	PROPN
ecj-11314	140	3	-	-	PUNCT
ecj-11314	140	4	targeted	target	VERB
ecj-11314	140	5	b	b	NOUN
ecj-11314	140	6	cell	cell	NOUN
ecj-11314	140	7	depletion	depletion	NOUN
ecj-11314	140	8	in	in	ADP
ecj-11314	140	9	multiple	multiple	ADJ
ecj-11314	140	10	sclerosis	sclerosis	NOUN
ecj-11314	140	11	therapeutic	therapeutic	ADJ
ecj-11314	140	12	scenario	scenario	NOUN
ecj-11314	140	13	:	:	PUNCT
ecj-11314	140	14	present	present	ADJ
ecj-11314	140	15	and	and	CCONJ
ecj-11314	140	16	future	future	ADJ
ecj-11314	140	17	perspectives	perspective	NOUN
ecj-11314	140	18	.	.	PUNCT
ecj-11314	141	1	autoimmun	autoimmun	PROPN
ecj-11314	141	2	rev	rev	VERB
ecj-11314	141	3	2019;18	2019;18	NUM
ecj-11314	141	4	:	:	PUNCT
ecj-11314	141	5	665	665	NUM
ecj-11314	141	6	-	-	SYM
ecj-11314	141	7	72	72	NUM
ecj-11314	141	8	.	.	NOUN
ecj-11314	142	1	6	6	NUM
ecj-11314	142	2	.	.	X
ecj-11314	142	3	de	de	PROPN
ecj-11314	142	4	bondt	bondt	PROPN
ecj-11314	142	5	m	m	PROPN
ecj-11314	142	6	,	,	PUNCT
ecj-11314	142	7	hellings	helling	NOUN
ecj-11314	142	8	n	n	CCONJ
ecj-11314	142	9	,	,	PUNCT
ecj-11314	142	10	opdenakker	opdenakker	NOUN
ecj-11314	142	11	g	g	PROPN
ecj-11314	142	12	,	,	PUNCT
ecj-11314	142	13	struyf	struyf	PROPN
ecj-11314	142	14	s.	s.	PROPN
ecj-11314	142	15	neutrophils	neutrophils	PROPN
ecj-11314	142	16	:	:	PUNCT
ecj-11314	142	17	underestimated	underestimate	VERB
ecj-11314	142	18	players	player	NOUN
ecj-11314	142	19	in	in	ADP
ecj-11314	142	20	the	the	DET
ecj-11314	142	21	pathogenesis	pathogenesis	NOUN
ecj-11314	142	22	of	of	ADP
ecj-11314	142	23	multiple	multiple	ADJ
ecj-11314	142	24	sclerosis	sclerosis	NOUN
ecj-11314	142	25	(	(	PUNCT
ecj-11314	142	26	ms	ms	NOUN
ecj-11314	142	27	)	)	PUNCT
ecj-11314	142	28	.	.	PUNCT
ecj-11314	143	1	int	int	PROPN
ecj-11314	143	2	j	j	PROPN
ecj-11314	143	3	mol	mol	ADP
ecj-11314	143	4	sci	sci	PROPN
ecj-11314	143	5	2020;21:1	2020;21:1	PROPN
ecj-11314	143	6	-	-	SYM
ecj-11314	143	7	25	25	NUM
ecj-11314	143	8	.	.	PUNCT
ecj-11314	144	1	7	7	X
ecj-11314	144	2	.	.	X
ecj-11314	144	3	olsson	olsson	PROPN
ecj-11314	144	4	a	a	PRON
ecj-11314	144	5	,	,	PUNCT
ecj-11314	144	6	gustavsen	gustavsen	NOUN
ecj-11314	144	7	s	s	PROPN
ecj-11314	144	8	,	,	PUNCT
ecj-11314	144	9	gisselø	gisselø	VERB
ecj-11314	144	10	lauridsen	lauridsen	ADV
ecj-11314	144	11	k	k	PROPN
ecj-11314	144	12	,	,	PUNCT
ecj-11314	144	13	et	et	PROPN
ecj-11314	144	14	al	al	PROPN
ecj-11314	144	15	.	.	PUNCT
ecj-11314	144	16	neutrophilto	neutrophilto	PROPN
ecj-11314	144	17	-	-	PUNCT
ecj-11314	144	18	lymphocyte	lymphocyte	NOUN
ecj-11314	144	19	ratio	ratio	NOUN
ecj-11314	144	20	and	and	CCONJ
ecj-11314	144	21	crp	crp	NOUN
ecj-11314	144	22	as	as	ADP
ecj-11314	144	23	biomarkers	biomarker	NOUN
ecj-11314	144	24	in	in	ADP
ecj-11314	144	25	multiple	multiple	ADJ
ecj-11314	144	26	sclerosis	sclerosis	NOUN
ecj-11314	144	27	:	:	PUNCT
ecj-11314	144	28	a	a	DET
ecj-11314	144	29	systematic	systematic	ADJ
ecj-11314	144	30	review	review	NOUN
ecj-11314	144	31	.	.	PUNCT
ecj-11314	145	1	acta	acta	PROPN
ecj-11314	145	2	neurol	neurol	PROPN
ecj-11314	145	3	scand	scand	PROPN
ecj-11314	145	4	2021;143:577	2021;143:577	PROPN
ecj-11314	145	5	-	-	SYM
ecj-11314	145	6	86	86	NUM
ecj-11314	145	7	.	.	NOUN
ecj-11314	145	8	8	8	NUM
ecj-11314	145	9	.	.	NOUN
ecj-11314	145	10	hasselbalch	hasselbalch	PROPN
ecj-11314	145	11	ic	ic	PROPN
ecj-11314	145	12	,	,	PUNCT
ecj-11314	145	13	søndergaard	søndergaard	PROPN
ecj-11314	145	14	hb	hb	PROPN
ecj-11314	145	15	,	,	PUNCT
ecj-11314	145	16	koch	koch	PROPN
ecj-11314	145	17	-	-	PUNCT
ecj-11314	145	18	henriksen	henriksen	PROPN
ecj-11314	145	19	n	n	CCONJ
ecj-11314	145	20	,	,	PUNCT
ecj-11314	145	21	et	et	PROPN
ecj-11314	145	22	al	al	PROPN
ecj-11314	145	23	.	.	PUNCT
ecj-11314	146	1	the	the	DET
ecj-11314	146	2	neutrophil	neutrophil	NOUN
ecj-11314	146	3	-	-	PUNCT
ecj-11314	146	4	to	to	ADP
ecj-11314	146	5	-	-	PUNCT
ecj-11314	146	6	lymphocyte	lymphocyte	ADJ
ecj-11314	146	7	ratio	ratio	NOUN
ecj-11314	146	8	is	be	AUX
ecj-11314	146	9	associated	associate	VERB
ecj-11314	146	10	with	with	ADP
ecj-11314	146	11	multiple	multiple	ADJ
ecj-11314	146	12	sclerosis	sclerosis	NOUN
ecj-11314	146	13	.	.	PUNCT
ecj-11314	147	1	mult	mult	PROPN
ecj-11314	147	2	scler	scler	PROPN
ecj-11314	147	3	j	j	PROPN
ecj-11314	147	4	exp	exp	PROPN
ecj-11314	147	5	transl	transl	PROPN
ecj-11314	147	6	clin	clin	PROPN
ecj-11314	147	7	2018;4:205521	2018;4:205521	NOUN
ecj-11314	147	8	7318813183	7318813183	NUM
ecj-11314	147	9	.	.	PUNCT
ecj-11314	148	1	9	9	NUM
ecj-11314	148	2	.	.	X
ecj-11314	148	3	wang	wang	PROPN
ecj-11314	148	4	x	x	PROPN
ecj-11314	148	5	,	,	PUNCT
ecj-11314	148	6	qiu	qiu	PROPN
ecj-11314	148	7	l	l	PROPN
ecj-11314	148	8	,	,	PUNCT
ecj-11314	148	9	li	li	PROPN
ecj-11314	148	10	z	z	PROPN
ecj-11314	148	11	,	,	PUNCT
ecj-11314	148	12	et	et	PROPN
ecj-11314	148	13	al	al	PROPN
ecj-11314	148	14	.	.	PUNCT
ecj-11314	149	1	understanding	understand	VERB
ecj-11314	149	2	the	the	DET
ecj-11314	149	3	multifaceted	multifaceted	ADJ
ecj-11314	149	4	role	role	NOUN
ecj-11314	149	5	of	of	ADP
ecj-11314	149	6	neutrophils	neutrophil	NOUN
ecj-11314	149	7	in	in	ADP
ecj-11314	149	8	cancer	cancer	NOUN
ecj-11314	149	9	and	and	CCONJ
ecj-11314	149	10	autoimmune	autoimmune	ADJ
ecj-11314	149	11	diseases	disease	NOUN
ecj-11314	149	12	.	.	PUNCT
ecj-11314	150	1	front	front	ADJ
ecj-11314	150	2	immunol	immunol	NOUN
ecj-11314	150	3	2018;9:2456	2018;9:2456	PROPN
ecj-11314	150	4	.	.	PUNCT
ecj-11314	151	1	10	10	NUM
ecj-11314	151	2	.	.	PUNCT
ecj-11314	151	3	d’amico	d’amico	PROPN
ecj-11314	151	4	e	e	PROPN
ecj-11314	151	5	,	,	PUNCT
ecj-11314	151	6	zanghì	zanghì	X
ecj-11314	151	7	a	a	X
ecj-11314	151	8	,	,	PUNCT
ecj-11314	151	9	romano	romano	NOUN
ecj-11314	151	10	a	a	X
ecj-11314	151	11	,	,	PUNCT
ecj-11314	151	12	et	et	PROPN
ecj-11314	151	13	al	al	PROPN
ecj-11314	151	14	.	.	PUNCT
ecj-11314	152	1	the	the	DET
ecj-11314	152	2	neutrophil	neutrophil	ADJ
ecj-11314	152	3	-	-	PUNCT
ecj-11314	152	4	tolymphocyte	tolymphocyte	NOUN
ecj-11314	152	5	ratio	ratio	NOUN
ecj-11314	152	6	is	be	AUX
ecj-11314	152	7	related	relate	VERB
ecj-11314	152	8	to	to	ADP
ecj-11314	152	9	disease	disease	NOUN
ecj-11314	152	10	activity	activity	NOUN
ecj-11314	152	11	in	in	ADP
ecj-11314	152	12	relapsing	relapse	VERB
ecj-11314	152	13	remitting	remit	VERB
ecj-11314	152	14	multiple	multiple	ADJ
ecj-11314	152	15	sclerosis	sclerosis	NOUN
ecj-11314	152	16	.	.	PUNCT
ecj-11314	153	1	cells	cell	NOUN
ecj-11314	153	2	2019;8:1114	2019;8:1114	NUM
ecj-11314	153	3	.	.	PUNCT
ecj-11314	154	1	11	11	NUM
ecj-11314	154	2	.	.	PUNCT
ecj-11314	155	1	demirci	demirci	PROPN
ecj-11314	155	2	s	s	PROPN
ecj-11314	155	3	,	,	PUNCT
ecj-11314	155	4	demirci	demirci	VERB
ecj-11314	155	5	s	s	PROPN
ecj-11314	155	6	,	,	PUNCT
ecj-11314	155	7	kutluhan	kutluhan	PROPN
ecj-11314	155	8	s	s	PART
ecj-11314	155	9	,	,	PUNCT
ecj-11314	155	10	et	et	PROPN
ecj-11314	155	11	al	al	PROPN
ecj-11314	155	12	.	.	PUNCT
ecj-11314	156	1	the	the	DET
ecj-11314	156	2	clinical	clinical	ADJ
ecj-11314	156	3	significance	significance	NOUN
ecj-11314	156	4	of	of	ADP
ecj-11314	156	5	the	the	DET
ecj-11314	156	6	neutrophil	neutrophil	NOUN
ecj-11314	156	7	-	-	PUNCT
ecj-11314	156	8	to	to	ADP
ecj-11314	156	9	-	-	PUNCT
ecj-11314	156	10	lymphocyte	lymphocyte	ADJ
ecj-11314	156	11	ratio	ratio	NOUN
ecj-11314	156	12	in	in	ADP
ecj-11314	156	13	multiple	multiple	ADJ
ecj-11314	156	14	sclerosis	sclerosis	NOUN
ecj-11314	156	15	.	.	PUNCT
ecj-11314	157	1	int	int	PROPN
ecj-11314	157	2	j	j	PROPN
ecj-11314	157	3	neurosci	neurosci	PROPN
ecj-11314	157	4	2016;126:700	2016;126:700	NUM
ecj-11314	157	5	-	-	SYM
ecj-11314	157	6	6	6	NUM
ecj-11314	157	7	.	.	NOUN
ecj-11314	157	8	12	12	NUM
ecj-11314	157	9	.	.	PUNCT
ecj-11314	158	1	guzel	guzel	PROPN
ecj-11314	158	2	i	i	PROPN
ecj-11314	158	3	,	,	PUNCT
ecj-11314	158	4	mungan	mungan	VERB
ecj-11314	158	5	s	s	NOUN
ecj-11314	158	6	,	,	PUNCT
ecj-11314	158	7	oztekin	oztekin	ADJ
ecj-11314	158	8	zn	zn	PROPN
ecj-11314	158	9	,	,	PUNCT
ecj-11314	158	10	ak	ak	PROPN
ecj-11314	158	11	f.	f.	PROPN
ecj-11314	158	12	is	be	AUX
ecj-11314	158	13	there	there	PRON
ecj-11314	158	14	an	an	DET
ecj-11314	158	15	association	association	NOUN
ecj-11314	158	16	between	between	ADP
ecj-11314	158	17	the	the	DET
ecj-11314	158	18	expanded	expand	VERB
ecj-11314	158	19	disability	disability	NOUN
ecj-11314	158	20	status	status	NOUN
ecj-11314	158	21	scale	scale	NOUN
ecj-11314	158	22	and	and	CCONJ
ecj-11314	158	23	inflammatory	inflammatory	ADJ
ecj-11314	158	24	markers	marker	NOUN
ecj-11314	158	25	in	in	ADP
ecj-11314	158	26	multiple	multiple	ADJ
ecj-11314	158	27	sclerosis	sclerosis	NOUN
ecj-11314	158	28	?	?	PUNCT
ecj-11314	159	1	j	j	PROPN
ecj-11314	159	2	chin	chin	PROPN
ecj-11314	159	3	med	med	PROPN
ecj-11314	159	4	assoc	assoc	PROPN
ecj-11314	159	5	2016;79:54	2016;79:54	PROPN
ecj-11314	159	6	-	-	PUNCT
ecj-11314	159	7	7	7	NUM
ecj-11314	159	8	.	.	NOUN
ecj-11314	159	9	13	13	NUM
ecj-11314	159	10	.	.	PUNCT
ecj-11314	160	1	thompson	thompson	PROPN
ecj-11314	160	2	aj	aj	PROPN
ecj-11314	160	3	,	,	PUNCT
ecj-11314	160	4	banwell	banwell	PROPN
ecj-11314	160	5	bl	bl	PROPN
ecj-11314	160	6	,	,	PUNCT
ecj-11314	160	7	barkhof	barkhof	PROPN
ecj-11314	160	8	f	f	PROPN
ecj-11314	160	9	,	,	PUNCT
ecj-11314	160	10	et	et	PROPN
ecj-11314	160	11	al	al	PROPN
ecj-11314	160	12	.	.	PUNCT
ecj-11314	160	13	diagnosis	diagnosis	NOUN
ecj-11314	160	14	of	of	ADP
ecj-11314	160	15	multiple	multiple	ADJ
ecj-11314	160	16	sclerosis	sclerosis	NOUN
ecj-11314	160	17	:	:	PUNCT
ecj-11314	160	18	2017	2017	NUM
ecj-11314	160	19	revisions	revision	NOUN
ecj-11314	160	20	of	of	ADP
ecj-11314	160	21	the	the	DET
ecj-11314	160	22	mcdonald	mcdonald	PROPN
ecj-11314	160	23	criteria	criterion	NOUN
ecj-11314	160	24	.	.	PUNCT
ecj-11314	161	1	lancet	lancet	PROPN
ecj-11314	161	2	neurol	neurol	PROPN
ecj-11314	161	3	2018;17:162	2018;17:162	PROPN
ecj-11314	161	4	-	-	PUNCT
ecj-11314	161	5	73	73	NUM
ecj-11314	161	6	.	.	PUNCT
ecj-11314	162	1	article	article	NOUN
ecj-11314	162	2	[	[	X
ecj-11314	162	3	emergency	emergency	NOUN
ecj-11314	162	4	care	care	NOUN
ecj-11314	162	5	journal	journal	PROPN
ecj-11314	162	6	2023	2023	NUM
ecj-11314	162	7	;	;	PUNCT
ecj-11314	162	8	19:11314	19:11314	NUM
ecj-11314	162	9	]	]	X
ecj-11314	163	1	[	[	X
ecj-11314	163	2	page	page	NOUN
ecj-11314	163	3	41	41	NUM
ecj-11314	163	4	]	]	PUNCT
ecj-11314	163	5	non	non	ADJ
ecj-11314	163	6	-co	-co	PROPN
ecj-11314	163	7	mmerc	mmerc	PROPN
ecj-11314	163	8	ial	ial	PROPN
ecj-11314	163	9	us	us	PROPN
ecj-11314	163	10	e	e	NOUN
ecj-11314	163	11	o	o	NOUN
ecj-11314	163	12	nly	nly	ADV
ecj-11314	163	13	14	14	NUM
ecj-11314	163	14	.	.	PUNCT
ecj-11314	164	1	brownlee	brownlee	PROPN
ecj-11314	164	2	wj	wj	PROPN
ecj-11314	164	3	,	,	PUNCT
ecj-11314	164	4	hardy	hardy	ADJ
ecj-11314	164	5	ta	ta	ADP
ecj-11314	164	6	,	,	PUNCT
ecj-11314	164	7	fazekas	fazekas	PROPN
ecj-11314	164	8	f	f	PROPN
ecj-11314	164	9	,	,	PUNCT
ecj-11314	164	10	miller	miller	PROPN
ecj-11314	164	11	dh	dh	PROPN
ecj-11314	164	12	.	.	PUNCT
ecj-11314	165	1	diagnosis	diagnosis	NOUN
ecj-11314	165	2	of	of	ADP
ecj-11314	165	3	multiple	multiple	ADJ
ecj-11314	165	4	sclerosis	sclerosis	NOUN
ecj-11314	165	5	:	:	PUNCT
ecj-11314	165	6	progress	progress	NOUN
ecj-11314	165	7	and	and	CCONJ
ecj-11314	165	8	challenges	challenge	NOUN
ecj-11314	165	9	.	.	PUNCT
ecj-11314	166	1	lancet	lancet	PROPN
ecj-11314	166	2	2017;389	2017;389	NUM
ecj-11314	166	3	:	:	PUNCT
ecj-11314	166	4	1336	1336	NUM
ecj-11314	166	5	-	-	SYM
ecj-11314	166	6	46	46	NUM
ecj-11314	166	7	.	.	NOUN
ecj-11314	167	1	15	15	NUM
ecj-11314	167	2	.	.	PUNCT
ecj-11314	168	1	yaşar	yaşar	PROPN
ecj-11314	168	2	e	e	PROPN
ecj-11314	168	3	,	,	PUNCT
ecj-11314	168	4	bayramoğlu	bayramoğlu	NOUN
ecj-11314	168	5	a.	a.	NOUN
ecj-11314	168	6	systemic	systemic	ADJ
ecj-11314	168	7	ımmune	ımmune	ADJ
ecj-11314	168	8	-	-	PUNCT
ecj-11314	168	9	ınflammation	ınflammation	NOUN
ecj-11314	168	10	ındex	ındex	NOUN
ecj-11314	168	11	as	as	ADP
ecj-11314	168	12	a	a	DET
ecj-11314	168	13	predictor	predictor	NOUN
ecj-11314	168	14	of	of	ADP
ecj-11314	168	15	microvascular	microvascular	ADJ
ecj-11314	168	16	dysfunction	dysfunction	NOUN
ecj-11314	168	17	in	in	ADP
ecj-11314	168	18	patients	patient	NOUN
ecj-11314	168	19	with	with	ADP
ecj-11314	168	20	cardiac	cardiac	ADJ
ecj-11314	168	21	syndrome	syndrome	NOUN
ecj-11314	168	22	x.	x.	NOUN
ecj-11314	168	23	angiology	angiology	PROPN
ecj-11314	168	24	2022;73:615	2022;73:615	NUM
ecj-11314	168	25	-	-	SYM
ecj-11314	168	26	21	21	NUM
ecj-11314	168	27	.	.	PUNCT
ecj-11314	169	1	16	16	NUM
ecj-11314	169	2	.	.	PUNCT
ecj-11314	170	1	norman	norman	PROPN
ecj-11314	170	2	g.	g.	PROPN
ecj-11314	170	3	likert	likert	PROPN
ecj-11314	170	4	scales	scale	NOUN
ecj-11314	170	5	,	,	PUNCT
ecj-11314	170	6	levels	level	NOUN
ecj-11314	170	7	of	of	ADP
ecj-11314	170	8	measurement	measurement	NOUN
ecj-11314	170	9	and	and	CCONJ
ecj-11314	170	10	the	the	DET
ecj-11314	170	11	“	"	PUNCT
ecj-11314	170	12	laws	law	NOUN
ecj-11314	170	13	”	"	PUNCT
ecj-11314	170	14	of	of	ADP
ecj-11314	170	15	statistics	statistic	NOUN
ecj-11314	170	16	.	.	PUNCT
ecj-11314	171	1	adv	adv	PROPN
ecj-11314	171	2	health	health	PROPN
ecj-11314	171	3	sci	sci	PROPN
ecj-11314	171	4	educ	educ	PROPN
ecj-11314	171	5	theory	theory	PROPN
ecj-11314	171	6	pract	pract	PROPN
ecj-11314	171	7	2010;15:625	2010;15:625	PROPN
ecj-11314	171	8	-	-	SYM
ecj-11314	171	9	32	32	NUM
ecj-11314	171	10	.	.	PUNCT
ecj-11314	172	1	17	17	NUM
ecj-11314	172	2	.	.	PUNCT
ecj-11314	173	1	ziemssen	ziemssen	PROPN
ecj-11314	173	2	t	t	PROPN
ecj-11314	173	3	,	,	PUNCT
ecj-11314	173	4	akgün	akgün	NOUN
ecj-11314	173	5	k	k	NOUN
ecj-11314	173	6	,	,	PUNCT
ecj-11314	173	7	brück	brück	ADJ
ecj-11314	173	8	w.	w.	PROPN
ecj-11314	173	9	molecular	molecular	ADJ
ecj-11314	173	10	biomarkers	biomarker	NOUN
ecj-11314	173	11	in	in	ADP
ecj-11314	173	12	multiple	multiple	ADJ
ecj-11314	173	13	sclerosis	sclerosis	NOUN
ecj-11314	173	14	.	.	PUNCT
ecj-11314	174	1	j	j	PROPN
ecj-11314	174	2	neuroinflammation	neuroinflammation	PROPN
ecj-11314	174	3	2019;16:1	2019;16:1	NUM
ecj-11314	174	4	-	-	SYM
ecj-11314	174	5	11	11	NUM
ecj-11314	174	6	.	.	PUNCT
ecj-11314	175	1	18	18	NUM
ecj-11314	175	2	.	.	PUNCT
ecj-11314	175	3	dirican	dirican	PROPN
ecj-11314	175	4	n	n	PROPN
ecj-11314	175	5	,	,	PUNCT
ecj-11314	175	6	anar	anar	PROPN
ecj-11314	175	7	c	c	PROPN
ecj-11314	175	8	,	,	PUNCT
ecj-11314	175	9	kaya	kaya	PROPN
ecj-11314	175	10	s	s	PROPN
ecj-11314	175	11	,	,	PUNCT
ecj-11314	175	12	et	et	PROPN
ecj-11314	175	13	al	al	PROPN
ecj-11314	175	14	.	.	PUNCT
ecj-11314	176	1	the	the	DET
ecj-11314	176	2	clinical	clinical	ADJ
ecj-11314	176	3	significance	significance	NOUN
ecj-11314	176	4	of	of	ADP
ecj-11314	176	5	hematologic	hematologic	NOUN
ecj-11314	176	6	parameters	parameter	NOUN
ecj-11314	176	7	in	in	ADP
ecj-11314	176	8	patients	patient	NOUN
ecj-11314	176	9	with	with	ADP
ecj-11314	176	10	sarcoidosis	sarcoidosis	NOUN
ecj-11314	176	11	.	.	PUNCT
ecj-11314	177	1	clin	clin	PROPN
ecj-11314	177	2	respir	respir	VERB
ecj-11314	177	3	j	j	PROPN
ecj-11314	177	4	2016;10:32	2016;10:32	NUM
ecj-11314	177	5	-	-	PUNCT
ecj-11314	177	6	9	9	NUM
ecj-11314	177	7	.	.	NOUN
ecj-11314	177	8	19	19	NUM
ecj-11314	177	9	.	.	PUNCT
ecj-11314	178	1	sen	sen	PROPN
ecj-11314	178	2	bb	bb	PROPN
ecj-11314	178	3	,	,	PUNCT
ecj-11314	178	4	rifaioglu	rifaioglu	PROPN
ecj-11314	178	5	en	en	PROPN
ecj-11314	178	6	,	,	PUNCT
ecj-11314	178	7	ekiz	ekiz	PROPN
ecj-11314	178	8	o	o	PROPN
ecj-11314	178	9	,	,	PUNCT
ecj-11314	178	10	et	et	PROPN
ecj-11314	178	11	al	al	PROPN
ecj-11314	178	12	.	.	PROPN
ecj-11314	179	1	neutrophil	neutrophil	ADJ
ecj-11314	179	2	to	to	ADP
ecj-11314	179	3	lymphocyte	lymphocyte	ADJ
ecj-11314	179	4	ratio	ratio	NOUN
ecj-11314	179	5	as	as	ADP
ecj-11314	179	6	a	a	DET
ecj-11314	179	7	measure	measure	NOUN
ecj-11314	179	8	of	of	ADP
ecj-11314	179	9	systemic	systemic	ADJ
ecj-11314	179	10	inflammation	inflammation	NOUN
ecj-11314	179	11	in	in	ADP
ecj-11314	179	12	psoriasis	psoriasis	NOUN
ecj-11314	179	13	.	.	PUNCT
ecj-11314	180	1	cutan	cutan	PROPN
ecj-11314	180	2	ocul	ocul	NOUN
ecj-11314	180	3	toxicol	toxicol	PROPN
ecj-11314	180	4	2014;33:223	2014;33:223	PROPN
ecj-11314	180	5	-	-	SYM
ecj-11314	180	6	7	7	NUM
ecj-11314	180	7	.	.	NOUN
ecj-11314	180	8	20	20	NUM
ecj-11314	180	9	.	.	PUNCT
ecj-11314	181	1	bisgaard	bisgaard	PROPN
ecj-11314	181	2	ak	ak	PROPN
ecj-11314	181	3	,	,	PUNCT
ecj-11314	181	4	pihl	pihl	NOUN
ecj-11314	181	5	-	-	PUNCT
ecj-11314	181	6	jensen	jensen	PROPN
ecj-11314	181	7	g	g	PROPN
ecj-11314	181	8	,	,	PUNCT
ecj-11314	181	9	frederiksen	frederiksen	ADJ
ecj-11314	181	10	jl	jl	PROPN
ecj-11314	181	11	.	.	PUNCT
ecj-11314	182	1	the	the	DET
ecj-11314	182	2	neutrophil	neutrophil	ADJ
ecj-11314	182	3	-	-	PUNCT
ecj-11314	182	4	tolymphocyte	tolymphocyte	NOUN
ecj-11314	182	5	ratio	ratio	NOUN
ecj-11314	182	6	as	as	ADP
ecj-11314	182	7	disease	disease	NOUN
ecj-11314	182	8	actvity	actvity	NOUN
ecj-11314	182	9	marker	marker	NOUN
ecj-11314	182	10	in	in	ADP
ecj-11314	182	11	multiple	multiple	ADJ
ecj-11314	182	12	sclerosis	sclerosis	NOUN
ecj-11314	182	13	and	and	CCONJ
ecj-11314	182	14	optic	optic	ADJ
ecj-11314	182	15	neuritis	neuritis	NOUN
ecj-11314	182	16	.	.	PUNCT
ecj-11314	183	1	mult	mult	PROPN
ecj-11314	183	2	scler	scler	PROPN
ecj-11314	183	3	relat	relat	PROPN
ecj-11314	183	4	disord	disord	PROPN
ecj-11314	183	5	2017;18:213	2017;18:213	NOUN
ecj-11314	183	6	-	-	SYM
ecj-11314	183	7	7	7	NUM
ecj-11314	183	8	.	.	NUM
ecj-11314	183	9	21	21	NUM
ecj-11314	183	10	.	.	PUNCT
ecj-11314	184	1	hutterer	hutterer	PROPN
ecj-11314	184	2	gc	gc	PROPN
ecj-11314	184	3	,	,	PUNCT
ecj-11314	184	4	sobolev	sobolev	PROPN
ecj-11314	184	5	n	n	PROPN
ecj-11314	184	6	,	,	PUNCT
ecj-11314	184	7	ehrlich	ehrlich	PROPN
ecj-11314	184	8	gc	gc	PROPN
ecj-11314	184	9	,	,	PUNCT
ecj-11314	184	10	et	et	PROPN
ecj-11314	184	11	al	al	PROPN
ecj-11314	184	12	.	.	PUNCT
ecj-11314	184	13	pretreatment	pretreatment	NOUN
ecj-11314	184	14	lymphocyte	lymphocyte	ADJ
ecj-11314	184	15	-	-	PUNCT
ecj-11314	184	16	monocyte	monocyte	NOUN
ecj-11314	184	17	ratio	ratio	NOUN
ecj-11314	184	18	as	as	ADP
ecj-11314	184	19	a	a	DET
ecj-11314	184	20	potential	potential	ADJ
ecj-11314	184	21	prognostic	prognostic	ADJ
ecj-11314	184	22	factor	factor	NOUN
ecj-11314	184	23	in	in	ADP
ecj-11314	184	24	a	a	DET
ecj-11314	184	25	cohort	cohort	NOUN
ecj-11314	184	26	of	of	ADP
ecj-11314	184	27	patients	patient	NOUN
ecj-11314	184	28	with	with	ADP
ecj-11314	184	29	upper	upper	ADJ
ecj-11314	184	30	tract	tract	NOUN
ecj-11314	184	31	urothelial	urothelial	ADJ
ecj-11314	184	32	carcinoma	carcinoma	NOUN
ecj-11314	184	33	.	.	PUNCT
ecj-11314	185	1	j	j	PROPN
ecj-11314	185	2	clin	clin	PROPN
ecj-11314	185	3	pathol	pathol	PROPN
ecj-11314	185	4	2015;68:351	2015;68:351	NUM
ecj-11314	185	5	-	-	SYM
ecj-11314	185	6	5	5	NUM
ecj-11314	185	7	.	.	NOUN
ecj-11314	185	8	22	22	NUM
ecj-11314	185	9	.	.	PUNCT
ecj-11314	186	1	hemond	hemond	PROPN
ecj-11314	186	2	cc	cc	PROPN
ecj-11314	186	3	,	,	PUNCT
ecj-11314	186	4	glanz	glanz	PROPN
ecj-11314	186	5	bi	bi	PROPN
ecj-11314	186	6	,	,	PUNCT
ecj-11314	186	7	bakshi	bakshi	PROPN
ecj-11314	186	8	r	r	PROPN
ecj-11314	186	9	,	,	PUNCT
ecj-11314	186	10	et	et	PROPN
ecj-11314	186	11	al	al	PROPN
ecj-11314	186	12	.	.	PUNCT
ecj-11314	187	1	the	the	DET
ecj-11314	187	2	neutrophil	neutrophil	ADJ
ecj-11314	187	3	-	-	PUNCT
ecj-11314	187	4	tolymphocyte	tolymphocyte	NOUN
ecj-11314	187	5	and	and	CCONJ
ecj-11314	187	6	monocyte	monocyte	NOUN
ecj-11314	187	7	-	-	PUNCT
ecj-11314	187	8	to	to	ADP
ecj-11314	187	9	-	-	PUNCT
ecj-11314	187	10	lymphocyte	lymphocyte	ADJ
ecj-11314	187	11	ratios	ratio	NOUN
ecj-11314	187	12	are	be	AUX
ecj-11314	187	13	independently	independently	ADV
ecj-11314	187	14	associated	associate	VERB
ecj-11314	187	15	with	with	ADP
ecj-11314	187	16	neurological	neurological	ADJ
ecj-11314	187	17	disability	disability	NOUN
ecj-11314	187	18	and	and	CCONJ
ecj-11314	187	19	brain	brain	NOUN
ecj-11314	187	20	atrophy	atrophy	NOUN
ecj-11314	187	21	in	in	ADP
ecj-11314	187	22	multiple	multiple	ADJ
ecj-11314	187	23	sclerosis	sclerosis	NOUN
ecj-11314	187	24	.	.	PUNCT
ecj-11314	188	1	bmc	bmc	PROPN
ecj-11314	188	2	neurol	neurol	NOUN
ecj-11314	188	3	2019;23:19	2019;23:19	NUM
ecj-11314	188	4	.	.	PUNCT
ecj-11314	189	1	23	23	NUM
ecj-11314	189	2	.	.	PUNCT
ecj-11314	190	1	li	li	PROPN
ecj-11314	190	2	s	s	PROPN
ecj-11314	190	3	,	,	PUNCT
ecj-11314	190	4	liu	liu	PROPN
ecj-11314	190	5	k	k	PROPN
ecj-11314	190	6	,	,	PUNCT
ecj-11314	190	7	gao	gao	PROPN
ecj-11314	190	8	y	y	PROPN
ecj-11314	190	9	,	,	PUNCT
ecj-11314	190	10	et	et	PROPN
ecj-11314	190	11	al	al	PROPN
ecj-11314	190	12	.	.	PROPN
ecj-11314	191	1	prognostic	prognostic	ADJ
ecj-11314	191	2	value	value	NOUN
ecj-11314	191	3	of	of	ADP
ecj-11314	191	4	systemic	systemic	ADJ
ecj-11314	191	5	immune	immune	ADJ
ecj-11314	191	6	-	-	PUNCT
ecj-11314	191	7	inflammation	inflammation	NOUN
ecj-11314	191	8	index	index	NOUN
ecj-11314	191	9	in	in	ADP
ecj-11314	191	10	acute	acute	ADJ
ecj-11314	191	11	/	/	SYM
ecj-11314	191	12	subacute	subacute	ADJ
ecj-11314	191	13	patients	patient	NOUN
ecj-11314	191	14	with	with	ADP
ecj-11314	191	15	cerebral	cerebral	ADJ
ecj-11314	191	16	venous	venous	ADJ
ecj-11314	191	17	sinus	sinus	NOUN
ecj-11314	191	18	thrombosis	thrombosis	NOUN
ecj-11314	191	19	.	.	PUNCT
ecj-11314	192	1	stroke	stroke	NOUN
ecj-11314	192	2	vasc	vasc	ADP
ecj-11314	192	3	neurol	neurol	PROPN
ecj-11314	192	4	2020;5:368	2020;5:368	PROPN
ecj-11314	192	5	.	.	PUNCT
ecj-11314	193	1	24	24	NUM
ecj-11314	193	2	.	.	X
ecj-11314	193	3	de	de	PROPN
ecj-11314	193	4	carvalho	carvalho	PROPN
ecj-11314	193	5	jennings	jennings	PROPN
ecj-11314	193	6	pereira	pereira	PROPN
ecj-11314	193	7	wl	wl	PROPN
ecj-11314	193	8	,	,	PUNCT
ecj-11314	193	9	flauzino	flauzino	PROPN
ecj-11314	193	10	t	t	PROPN
ecj-11314	193	11	,	,	PUNCT
ecj-11314	193	12	alfieri	alfieri	PROPN
ecj-11314	193	13	df	df	PROPN
ecj-11314	193	14	,	,	PUNCT
ecj-11314	193	15	et	et	PROPN
ecj-11314	193	16	al	al	PROPN
ecj-11314	193	17	.	.	PUNCT
ecj-11314	193	18	immune	immune	NOUN
ecj-11314	193	19	-	-	PUNCT
ecj-11314	193	20	inflammatory	inflammatory	ADJ
ecj-11314	193	21	,	,	PUNCT
ecj-11314	193	22	metabolic	metabolic	NOUN
ecj-11314	193	23	and	and	CCONJ
ecj-11314	193	24	hormonal	hormonal	ADJ
ecj-11314	193	25	biomarkers	biomarker	NOUN
ecj-11314	193	26	are	be	AUX
ecj-11314	193	27	associated	associate	VERB
ecj-11314	193	28	with	with	ADP
ecj-11314	193	29	the	the	DET
ecj-11314	193	30	clinical	clinical	ADJ
ecj-11314	193	31	forms	form	NOUN
ecj-11314	193	32	and	and	CCONJ
ecj-11314	193	33	disability	disability	NOUN
ecj-11314	193	34	progression	progression	NOUN
ecj-11314	193	35	in	in	ADP
ecj-11314	193	36	patients	patient	NOUN
ecj-11314	193	37	with	with	ADP
ecj-11314	193	38	multiple	multiple	ADJ
ecj-11314	193	39	sclerosis	sclerosis	NOUN
ecj-11314	193	40	:	:	PUNCT
ecj-11314	193	41	a	a	DET
ecj-11314	193	42	follow	follow	VERB
ecj-11314	193	43	-	-	PUNCT
ecj-11314	193	44	up	up	ADP
ecj-11314	193	45	study	study	NOUN
ecj-11314	193	46	.	.	PUNCT
ecj-11314	194	1	j	j	PROPN
ecj-11314	194	2	neurol	neurol	PROPN
ecj-11314	194	3	sci	sci	PROPN
ecj-11314	194	4	2020;410:116630	2020;410:116630	PROPN
ecj-11314	194	5	.	.	PUNCT
ecj-11314	195	1	25	25	NUM
ecj-11314	195	2	.	.	PUNCT
ecj-11314	196	1	wu	wu	PROPN
ecj-11314	196	2	j	j	PROPN
ecj-11314	196	3	,	,	PUNCT
ecj-11314	196	4	zhang	zhang	PROPN
ecj-11314	196	5	x	x	PROPN
ecj-11314	196	6	,	,	PUNCT
ecj-11314	196	7	liu	liu	PROPN
ecj-11314	196	8	h	h	PROPN
ecj-11314	196	9	,	,	PUNCT
ecj-11314	196	10	et	et	PROPN
ecj-11314	196	11	al	al	PROPN
ecj-11314	196	12	.	.	PROPN
ecj-11314	196	13	rdw	rdw	PROPN
ecj-11314	196	14	,	,	PUNCT
ecj-11314	196	15	nlr	nlr	PROPN
ecj-11314	196	16	and	and	CCONJ
ecj-11314	196	17	rlr	rlr	PROPN
ecj-11314	196	18	in	in	ADP
ecj-11314	196	19	predicting	predict	VERB
ecj-11314	196	20	liver	liver	NOUN
ecj-11314	196	21	failure	failure	NOUN
ecj-11314	196	22	and	and	CCONJ
ecj-11314	196	23	prognosis	prognosis	NOUN
ecj-11314	196	24	in	in	ADP
ecj-11314	196	25	patients	patient	NOUN
ecj-11314	196	26	with	with	ADP
ecj-11314	196	27	hepatitis	hepatitis	PROPN
ecj-11314	196	28	e	e	PROPN
ecj-11314	196	29	virus	virus	NOUN
ecj-11314	196	30	infection	infection	NOUN
ecj-11314	196	31	.	.	PUNCT
ecj-11314	197	1	clin	clin	PROPN
ecj-11314	197	2	biochem	biochem	PROPN
ecj-11314	197	3	2019;63:24	2019;63:24	NUM
ecj-11314	197	4	-	-	SYM
ecj-11314	197	5	31	31	NUM
ecj-11314	197	6	.	.	PUNCT
ecj-11314	197	7	26	26	NUM
ecj-11314	197	8	.	.	PUNCT
ecj-11314	198	1	meng	meng	PROPN
ecj-11314	198	2	j	j	PROPN
ecj-11314	198	3	,	,	PUNCT
ecj-11314	198	4	xu	xu	PROPN
ecj-11314	199	1	h	h	PROPN
ecj-11314	199	2	,	,	PUNCT
ecj-11314	199	3	liu	liu	PROPN
ecj-11314	199	4	x	x	PROPN
ecj-11314	199	5	,	,	PUNCT
ecj-11314	199	6	et	et	PROPN
ecj-11314	199	7	al	al	PROPN
ecj-11314	199	8	.	.	PROPN
ecj-11314	199	9	increased	increase	VERB
ecj-11314	199	10	red	red	ADJ
ecj-11314	199	11	cell	cell	NOUN
ecj-11314	199	12	width	width	ADJ
ecj-11314	199	13	distribution	distribution	NOUN
ecj-11314	199	14	to	to	ADP
ecj-11314	199	15	lymphocyte	lymphocyte	ADJ
ecj-11314	199	16	ratio	ratio	NOUN
ecj-11314	199	17	is	be	AUX
ecj-11314	199	18	a	a	DET
ecj-11314	199	19	predictor	predictor	NOUN
ecj-11314	199	20	of	of	ADP
ecj-11314	199	21	histologic	histologic	ADJ
ecj-11314	199	22	severity	severity	NOUN
ecj-11314	199	23	in	in	ADP
ecj-11314	199	24	primary	primary	ADJ
ecj-11314	199	25	biliary	biliary	NOUN
ecj-11314	199	26	cholangitis	cholangitis	NOUN
ecj-11314	199	27	.	.	PUNCT
ecj-11314	200	1	med	med	PROPN
ecj-11314	200	2	(	(	PUNCT
ecj-11314	200	3	united	united	PROPN
ecj-11314	200	4	states	states	PROPN
ecj-11314	200	5	)	)	PUNCT
ecj-11314	200	6	2018;97:48	2018;97:48	NUM
ecj-11314	200	7	.	.	PUNCT
ecj-11314	201	1	article	article	NOUN
ecj-11314	202	1	[	[	X
ecj-11314	202	2	page	page	NOUN
ecj-11314	202	3	42	42	NUM
ecj-11314	202	4	]	]	PUNCT
ecj-11314	203	1	[	[	X
ecj-11314	203	2	emergency	emergency	NOUN
ecj-11314	203	3	care	care	NOUN
ecj-11314	203	4	journal	journal	PROPN
ecj-11314	203	5	2023	2023	NUM
ecj-11314	203	6	;	;	PUNCT
ecj-11314	203	7	19:11314	19:11314	NUM
ecj-11314	203	8	]	]	X
ecj-11314	203	9	non	non	ADJ
ecj-11314	203	10	-co	-co	PROPN
ecj-11314	203	11	mmerc	mmerc	PROPN
ecj-11314	203	12	ial	ial	PROPN
ecj-11314	203	13	us	us	PROPN
ecj-11314	203	14	e	e	NOUN
ecj-11314	203	15	o	o	NOUN
ecj-11314	203	16	nly	nly	ADV